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ABSTRACT
GERMAN P. GARCIA-FRESCO:  The Molecular Organization and Function of 
Paranodal Septate Junctions
(Under the direction of Manzoor Bhat)
Close communication between axons and glial cells is required and necessary for 
maturation, organization and maintenance of the nervous system. The axon provides 
signals to promote differentiation, survival and proliferation of both oligodendrocytes and 
Schwann cells in the central and peripheral nervous systems respectively, while providing 
instructions to regulate myelin thickness. Conversely, glial cells provide reciprocal 
signals that regulate and control axonal mechanisms such as axonal thickness and 
transport. The combined efforts of glial and axonal signals result in a mature myelinated 
fiber that has a structural organization optimal for a maximum conduction velocity. 
One characteristic feature of myelinated fibers is their ability to organize 
specialized domains with distinctive molecular and structural characteristics. The 
myelinated domains include the node of Ranvier, the paranodal junction, the 
juxtaparanodal junction and the internodal region. This domain organization is a result of 
the fine bi-directional communication between the axon and the overlying glial cell. 
The paranodal axo-glial junction is a complex of proteins including: NCP1, 
Contactin (CN), Neurofascin 155 (NF155) and band 4.1B. NF155 is expressed by the 
overlying glial cell while the others are clustered on the axonal membrane. All proteins 
are necessary for the maintenance and establishment of the paranodal domain and provide 
a link to the axonal cytoskeleton.  
We and others have previously characterized two knockout mice (NCP1 and 
CGT) that display several signs of cerebellar deficits, including abnormal motor 
coordination, tremors at rest and ataxia. These knockouts share the same phenotypes one 
of which is their inability to form paranodal junctions properly. Interestingly NCP1 is an 
axonal protein and CGT is a glial protein suggesting a common mechanism of action by 
both cell types and the importance of axo-glial interactions in proper axonal development 
and organization.
The goal of this project is to further understand the role, molecular composition 
and organization of axo-glial junctions in vertebrate systems, in particular the paranodal 
junction of myelinated nerve fibers. We will use these two knockout mouse model 
systems to identify new key components that play a role in establishing a link between 
the axon and glial cells.  
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CHAPTER I
INTRODUCTION
1  - A Historical Perspective
The nervous system did not emerge until the discovery of special techniques that 
allowed viewing entire nerve cells. There were distinct periods in the history of the nervous 
system that defined key structural components that lead to what we know today. These 
periods were marked by Ramon y Cajal and are known as the pre-Cajalian, the Cajalian, and 
the post Cajalian periods.
The pre-Cajalian period (1860-1885) was characterized by the different staining 
methods used by Golgi, Virchow, Dieters, Nissl and others (Lazzarini, 2004). In this period, 
nervous structures were identified using methods used today such as Nissl, hematoxylin and 
Golgi. The first successful method (1865) used was the microdissection of whole nerve cells 
from hardened specimens of brain and spinal cord which allowed Dieters to distinguish 
between the numerous branching processes that we now call dendrites and the single 
processes known as the axon. Towards the end of this period Golgi developed a method 
called “black reaction” which allowed investigators to see the whole nerve cell in situ for the 
first time.  
When Cajal stepped into the neuroscience field (the Cajalian period 1885-1910) his 
initial attempts were using the Golgi technique. With this he was successful enough to 
2publish a detailed study on the nervous systems of birds (Cajal, 1888a). He particularly 
demonstrated differences in the nervous system of the avian cerebellum. That same year and 
again using the same technique he identified for the first time the presence of Nodes of 
Ranvier in fibers of the brains white matter (Cajal, 1888b) and later in the spinal cord and 
cerebellum (Cajal 1889). He was the first one to identify that axon collaterals bifurcate at 
sites of nodes of Ranvier. One of Cajal’s marvelous insights was that neurons are 
topographically polarized so that its cell body and dendrites receive impulses from the axonal 
endings they are connected to and axons convey the information received away from the cell 
body towards its terminal arborization. 
The post Cajalian period was an era in which one of cajal’s disciple, Rio Hortega, 
challenged some of Cajal’s theories and descriptions of the structures of the nervous system; 
not that Cajal was wrong but his techniques became limited. Rio Hortega innovated some of 
cajal’s and Golgi’s techniques and found for instance that most of the a-polar or a-dendritic 
cells described by Cajal indeed had processes. Rio Hortega and Cajal engaged in an intense 
dispute that ended in the dismissal of Ortega from Cajal’s laboratory,  which lead him to start 
his own laboratory and eventually his own journal. 
One of Hortegas main discoveries was that of microglia and the fact that they are of 
mesodermic nature respectively. Cajal’s view on microglia was not in agreement but later on 
in the early 1920’s he published an article describing the same microglial cells in the 
cerebellum and acknowledging their existence as proclaimed by his former student (Cajal, 
1920a, 1920b). In 1921 Ortega identified what he called oligodendroglia and their ectodermal 
origin (Rio Hortega 1921b). He found these cells by playing with fixation times and 
increasing the strength of the staining solution. He not only described its morphology but 
3also he reported that it was present in huge numbers in all regions of the central nervous 
system with strong predominance in the white matter areas. They were grouped along nerve 
fibers and rapidly increased in numbers about the time of birth coinciding with a period of 
active myelogenesis. He finally suggested that the membrane indicated by Cajal around the 
central fibers is in fact a derivative of these oligodendroglial cells that have functions similar 
to Schwann cells of peripheral nerve fibers. 
In 1928 Rio Hortega came out with yet another publication on the structure of 
oligodendrocytes. He again, in the best Cajalian tradition developed another modification of 
the Golgi method obtaining excellent impregnations of oligodendroglia. In this report not 
only he shows illustrations, but for the first time ever in a publication he used 
photomicrographs to show the real staining. The most important finding in his article though 
was that oligodendrocytes acquire close relationships with nerve fibers forming delicate 
wrappings of laminar, fenestrated appearance, reinforced by rings and inter-annular 
trabecules. He then concluded that all of these structures are morphologically equivalent to 
those present in the cells and sheaths of Schwann in the peripheral nerves. Based on the 
presented evidence he also suggested that oligodendrocytes could potentially play a role in 
myelogenesis. 
In the same year Ramon y Cajal stated in Degeneration and Regeneration of the 
Nervous System (Cajal, 1928) “Myelin is an organ which is adjunct of the axon, and as such, 
it is entirely foreign to Schwann cells”. This was obviously one of the few misinterpretations 
in Cajal’s light microscopic experiment observations. The misinterpretation of determining 
the source of myelin was merely technical, since it was impossible and even today to resolve 
the cellular boundaries of the axon and myelin at the light microscopic level. It was not until 
4the late 1950’s that these fundamental questions regarding the structures of the myelinated 
axons could be addressed. As the methods of ultramicroscopy took place, myelin was able to 
be described accurately. In 1954 Dr. Geren was able to demonstrate unequivocally that 
myelin was a spiraled extension of the Schwann cell plasma membrane in the peripheral 
nervous system (PNS). Bunge and colleagues in 1962 then demonstrated the same findings 
but in oligodendrocytes of the central nervous system (CNS). Furthermore he demonstrated 
that oligodendrocytes were able to wrap more than one axon in contrast to one as observed 
by Schwann cells (Bunge et al., 1962).  Eventually, other concepts emerged such as the 
notion of distinct domains in both CNS and PNS nerve fibers. The domain organization and 
structure of PNS and CNS fibers seem to play distinct roles in the fiber but are all interrelated 
and in relationship with the overlying glial cells. The development of the nerve fiber is in a 
close symbiotic relationship with the Schwann cell or oligodendrocyte it comes in contact 
with. 
2 - Domains of a Myelinated Fiber
The main functions of the myelinating cell are to: 1) insulate axons by means 
of the high lipid content of the lipid bilayer; 2) reduce the current flow across the axonal 
membrane thereby reducing its capacitance and increasing its transverse resistance which 
allows a fast saltatory conduction of action potentials; 3) regulate aspects of the formation 
and maintenance of the nerve fiber such as axon caliber and domain organization. As a result 
of the high level of communication between the glial cell and the axon, the myelinated nerve 
fibers acquire distinct features that allow them to maximize the conduction velocity of the 
5nerve impulse. One of these features is the generation of specific domains throughout the 
length of the axon. These domains have distinct molecular, structural and functional 
properties, and include the node of Ranvier, the paranodal junction, the Juxtaparanodal 
junction, the internodal region and the compact and non compact myelin (Figure 1). 
Figure 1 – Domain organization of a myelinated fiber
2a - The Node of Ranvier
The node of Ranvier has evolved into a highly efficient signal generator in the 
nervous system. Action potentials that propagate through a human peripheral nerve may pass 
through more than 1000 nodes in a single axon to reach their target. The nodes are short 
periodic interruptions of the myelin sheath spaced at intervals about 100 times the axonal 
diameter. CNS and PNS nodes are almost identical with slight structural differences between 
them. In the PNS, the entire myelin unit is covered by a basal lamina. The outer most layer of 
the Shwann cell covers the node by interdigitating microvilli projecting from the end of the 
6Schwann cell that closely appose the nodal axolema.  By contrast, the CNS fibers do not 
contain a basal lamina and the nodes of Ranvier are contacted by perinodal astrocytes or 
synantocytes (except in small diameter fibers which are devoid of astrocytic processes 
(Ichimura and Elisman 1991; Bjatmar et al., 1994; Black and Waxman 1988; Butt et al., 
2002). 
 Nodes of Ranvier are rich in Na+ channels (>1200/µm2) that are essential for the 
generation of the action potential during saltatory conduction (Waxman et al., 1980). Voltage 
gated Na+ channels are multimeric complexes that consist of a pore forming  subunit and 
two auxiliary  subunits one disulfide linked and the other non-covalently associated 
(Caterrall 2000; Figure 2). So far 10 different  subunits have been identified which comprise 
a multigene family referred to by a common nomenclature following Nav1.X format (Goldin, 
et al 2000). Nodes of Ranvier in CNS and PNS are comprised primarily of Nav1.6 (Caldwell 
et al., 2000) and associate with the 1 subunit (Ratclife et al., 2001). Additionally Nav1.2 and 
1.8 are found in many CNS nodes (Arroyo et al., 2002), whereas Nav1.9 is only found in 
PNS nodes (Fjell, et. al.,2000). During development, the  subunit undergoes an isoform 
transition in both the CNS and PNS. In early stages fibers express Nav1.2 which is later 
replaced by Nav1.6 in adults (Kaplan et al., 2001; Boiko et al., 2001). This physiological 
transition is not completely understood but it is suggested that it might allow neurons to 
adapt to high frequency firing (Goldin 2001). 
Besides Na+ channels, there are many other transmembrane proteins expressed in the 
nodal axolema: the cytoskeletal structural adaptor Ankryn-G (ank-G; Kordeli et al., 1995), 
cell adhesion molecules (CAMs) of the immunoglobulin (Ig) family Neurofascin 186 
(NF186) and NrCAM (Davis et al., 1996), the actin binding spectrin IV (Berghs et al., 
72000), and two new identified K+ channels Kv3.1 and Kcnq2 (Devaux et al., 2003a-b). Other 
components at the nodal environ include the glycosyl phosphatidilinositol (GPI) –anchored 
adhesion molecule contactin (CN; Rios et al., 2000), that may associate with Nav1.2 and 1 
subunit to enhance channel expression during development (Kazarinova-Noyes et al., 2001). 
In the CNS there are extracellular components at the nodes of Ranvier including tenascin R, 
which may stabilize the sodium channel complex by binding to CN, the 2 subunit of the Na+
channel (Weber et al., 1999), and phosphacan, the secreted form of receptor protein tyrosine 
phosphatase  (RPTPbeta; Ratclife et al., 2000).
Figure 2 – Nodal complex of the myelinated peripheral nerve fiber. ANK – Ankryn; Na+ 
- Sodium channel; NF-186 – neurofascin 186.
Ank-G links integral membrane proteins to the spectrin cytoskeleton, it interacts with 
both  and  Na+ channel  subunits, NF186, Nrcam, and Kv3.1 (Garver et al., 1997; Malhotra 
et al., 2000; Lemaillet et al., 2003; Devaux et al., 2003a). The binding of Ank-G to the Na+
8channel  subunit is regulated by tyrosine phosphorylation (Malhotra et al., 2002) and is 
required for the recruitment of Ank-G to the nodal gap. Ank-G also binds spectrin IV, an 
isoform that is enriched at the axon initial segments and the nodes of Ranvier. This binding 
anchors the whole nodal complex to the axonal cytoskeleton providing stability (Berghs et 
al., 2000). 
 As mentioned earlier the PNS nodes are contacted by Schwann cell microvilli. Ezrin, 
radixin, moesin as well as the ezrin binding protein EBP50 and Rho-A GTPase are localized 
at the microvilli (Gatto et al., 2003; Melendez-Vasquez et al., 2001; Scherer et al., 2001). 
These proteins form a complex that may link the microvilli with the nodal gap complex 
possibly via interactions with NF186. 
In addition to the microvilli proteins there are other proteins present in the 
extracellular matrix (ECM) under the basal lamina, including proteoglycan versican, tenascin 
C and proteoglycan NG2 in the PNS and tenascin R, phosphacan and Bral1 in the CNS 
(Bretscher et al., 2001; Rieger et al., 1986; Martini et al., 1990; Martin et al., 2001; Saito et 
al., 1999; Weber et al., 1999; Ratclife et al., 2000). The function of most of these proteins is 
not yet clear, but based on the presence of acidic disaccharides; they could provide a negative 
environment that serves as an extracellular Na+ channel reservoir in the perinodal space 
(Oohashi et al., 2002).
92b - The Paranodal Junction
Paranodal junctions (PJs) are located between the nodes of Ranvier and the 
juxtaparanodal junctions (Figure 1). At this region the compact myelin forms cytoplasm 
filled loops (paranodal loops) that envelop the axons spirally. The interaction between the 
paranodal junctions and the glial cells is mediated by the paranodal complex (Figure 3) 
which, when represented by electron microscopy, appear as an array of dense bands 
(transverse bands) between the loops and the axon (Rosenbluth 1995). The development of 
axoglial junctions is somewhat a late event and it is directly linked to the myelination process 
(Tao-Cheng and Rosenbluth 1983). The first junctions occur closer to the node of the outer 
most paranodal loop, and continue inward towards the juxtaparanode as additional loops are 
formed and attached to the axon (Tao-Cheng and Rosenbluth 1983). 
Figure 3 – Paranodal complex of the myelinated peripheral nerve fiber (adopteed from Bhat, 2003).
The paranodal junction contains a complex of cell adhesion and structural molecules 
including NCP1 and CN (Rios et al., 2000; Einheber et al., 1997; Menegoz et al., 1997) that 
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attach the complex to the axonal cytoskeleton. The NCP family belongs to a subgroup of 
neurexins and in humans is comprised of five genes (NCP1-5; Figure 4; Peles et al., 1997; 
Poliak et al., 1999; Spiegel et al., 2002). NCP1 is a type I transmembrane protein, it contains 
several domains involved in protein-protein interactions, including discoidin, a fibrogen-like 
domain, laminin G, and epidermal growth factor motifs. On its cytoplasmic tail NCP1 
contains a domain shown to bind to paranodal protein 4.1B and an SH3 domain (Gollan et 
al., 2002; Poliak et al., 2001). 
NCP1 protein interacts with CN in cis (Peles et al., 1997) and it is essential for the efficient 
transport of NCP1 out of the endoplasmic reticulum and it regulates the glycosylation of CN 
(Faivre-Sarrailh et al., 2003). Supporting these results, CN null mice showed an accumulation 
of NCP1 in neuronal cell bodies (Boyle et al., 2001). On the other hand, NCP1 is required for 
the proper localization of CN at paranodal junctions. Mice lacking NCP1 protein fail to 
concentrate CN at paranodes (Bhat et al., 2001). This then indicates that both NCP1 and CN 
are essential for the proper formation and maintenance of paranodal axoglial junctions since 
their absence results in the disappearance of the paranodal transverse bands as observed by 
electron microscopy (Boyle et al., 2001; Bhat et al., 2001). 
A similar phenotype was also observed in other  mutant mice: mice lacking UDP 
galactose ceramide galactosyltransferase (CGT) which do not synthesize galactocerebrosides 
(Galc) and sulfatides,  and cerebroside sulfonotransferase (CST) null mice which only lack 
sulfatides (Bosio et al., 1996; Coetzee et al., 1998; Honke et al., 2002; Ishibashi et al., 2002). 
There is no direct evidence on the mechanism of complex disruption due to the absence of 
Galc and/or sulfatides. One possibility is that sulfatides might directly bind to the CN-NCP1 
dimer. 
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Figure 4 – NCP protein family.
As mentioned earlier, 4.1B binds to and colocalizes with both NCP1 and Caspr2 at 
the paranodes and juxtaparanodes respectively (Menegoz et al., 1997; Peles et al., 1997; 
Gollan et al., 2002; Poliak et al., 2001; Denisenko-Neherbass et al., 2003; Ohara et al., 2000; 
Parra et al., 2000). In addition, 4.1B contains an actin-spectrin binding motif that could 
potentially link the paranodal domain to the cytoskeleton, therefore immobilizing it (Gollan 
et al., 2002). 
Mice lacking paranodal junctions show a disrupted localization of 4.1B at paranodes 
(Polliak et al., 2001; Gollan et al., 2002). On the glial side, an attractive candidate to mediate 
the interaction between glia and the axon in paranodal junctions is neurofascin 155 (NF155), 
a CAM molecule. Addition of soluble RPTP to co-cultured myelinated cells expressing both 
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NCP1 and CN perturbs the accumulation of NCP1, indicating that the localization of NCP1-
CN at paranodes is also mediated by a glial ligand (Rios et al., 2000; Tait et al., 2000). In the 
absence of NCP1 and/or CN, NF155 does not localize to the paranodal junctions (Boyle et 
al., 2001; Bhat et al., 2001; Poliak et al., 2001; Marcus et al., 2002).
Paranodal junctions were initially believed to solely mediate the attachment between 
myelin and the axon, and in that way separate the electrical activity present at the node from 
the internodal region. It has now been proposed to serve as a fence that limits lateral 
diffusion of proteins in the axolema (Rosenbluth 1976; Bhat et al., 2001). The results 
presented in this proposal provide new insights of paranodal junction functions and new key 
molecular players, suggesting novel links to axonal neuropathies and neurodegenerative 
diseases.
2c - The Juxtaparanodal Junction
The juxtaparanodal junction lies just under the compact myelin beyond the innermost 
paranodal junction (Figure 1 and 5) and is enriched with two delayed rectifier potassium 
channels of the shaker family: Kv1.1, Kv1.2 and its  subunits Kv2 (Rhodes et al., 1997; 
Wang et al., 1993). These channels colocalize and create a complex with a member of the 
Caspr family, Caspr2 (Poliak et al., 1999). Additionally Caspr2 contains a PDZ binding motif 
in its carboxy terminal which might regulate the Caspr2- K+ channel interaction with a yet 
unidentified PDZ domain protein. PSD95 contains three PDZ domains on its cytoplasmic 
tail. It has been shown that PSD-95 colocalizes and coimmunoprecipitates with Kv2 at the 
juxtaparanodes (Baba et al., 1999). However, it does not interact directly with Caspr2 (Poliak 
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et al., 1999), suggesting other proteins are involved in the complex. Indeed, mice deficient in 
PSD-95 still accumulate K+ channels at the juxtaparanodes (Rasband et al., 2002). Caspr2 
also contains a FERM binding sequence that interacts with protein 4.1B, providing an anchor 
to the axon cytoskeleton maintaining the position of the juxtaparanodal complex along the 
axon (Denisenko-Nehrbass et al., 2003).
Figure 5 – Juxtaparanodal complex of the myelinated nerve fiber (adopted from Bhat, 2003).
Two other proteins found at the juxtaparanodal junction are transient axonal 
glycoprotein-1 (TAG1), a GPI motif containing protein related to contactin found on both 
axons and glia; and connexin 29 (Cnx29) found only along the glial membrane (Traka et al., 
2002; Altevogt et al., 2002; Li et al., 2002). Two recent studies have shown that axonal 
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TAG1 interacts with Caspr2 in cis and also has a homophilic trans interaction with glial 
TAG1 (Figure 7; Traka et al., 2003; Poliak et al., 2003). The entire juxtaparanodal junction is 
dispersed in both TAG1 and Caspr2 null mutants, indicating the importance of these proteins 
in the formation or maintenance of the juxtaparanodal complex (Traka et al., 2003; Poliak et 
al., 2003).
Although the role of juxtaparanodal junction is not well defined, juxtaparanodal K+
channels were proposed to prevent backfiring and hyper excitation (Zhou et al., 1999). 
However, despite the marked reduction of K+ channel concentration at the juxtaparanodes in 
Caspr2 and TAG1 knockouts, there is no change in excitability of knockout nerve fibers 
(Traka et al., 2003; Poliak et al., 2003). Another proposed function of the juxtaparanodal 
junction is a role in the communication between the axon and the overlaying glial cell. One 
candidate for this function is Cnx29, which forms hemi channels that could provide a direct 
pathway for K+ ions from the axon to the overlying glia (Altevogt et al., 2002). 
The most extended site of interaction between axons and glia is the internodal region, 
which comprises 99% of the total length of the myelinated axon. There are no specialized 
junctions between the axonal membrane and the myelin observed throughout the internodal 
region. However, freeze fracture electron microscopy reveals that internodal axolema 
contains longitudinal lines (juxtamesaxonal lines) of intramembranous particles containing 
proteins  found in paranodes and juxtaparanodes. These structures appear as if they are a 
continuation of these two structures (Miller and Da Silva 1977; Stolinski et al., 1985; Peles 
and Salzer 2000). Paranodal proteins NCP1 and CN are two paranodal proteins that are 
expressed throughout the internodal region as well as juxtaparanodal proteins Caspr2 and K+
channels which are both expressed on both sides of the NCP1-CN dimer. These structures 
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then form a circumferential ring around the axon just below the inner aspect of the Schmidt-
Lanterman incisures (a cytoplasmic channel connecting the adaxonal and abaxonal layers of 
the myelin sheath; Poliak et al., 2001; Arroyo et al., 1999). Concomitantly to the 
juxtamesaxonal line of the axonal surface, NF155, Cnx29 and TAG1 are localized in a 
complimentary distribution along the line but on the glial surface (the adaxonal surface), 
suggesting an adhesion complex keeping the glial cell closely apposed to the axon along the 
internodal region (Tait et al., 2000; Altevogt et al., 2002; Traka et al., 2002). One candidate 
glial protein that might also mediate the axoglial interaction is the myelin associated 
glycoprotein (MAG) which is expressed in the inner glial membrane along the internodal 
region (Trapp 1990).  It has been shown that MAG interacts with sialylated glycoconjugates 
in the axonal surface (Kelm et al., 1994), and seems to be involved in signaling mechanisms 
(Garcia et al., 2003).  
3 - The internodal region
In simple morphological terms, the myelin internode can be divided into two domains 
based on the compaction of myelin: compact and non-compact. Compact Myelin comprises 
about 99% of a myelinated nerve. It extends from node to node but does not include the 
paranodal junction nor the Schmidt-Lanterman incisures since those belong to non-compact 
myelin areas. It is noteworthy to mention though that Schmidt-Lanterman incisures are not a 
prominent feature of CNS internodes (Blackmore, 1969). Oligodendrocytes differ from 
Schwann cells as mentioned earlier in their ability to form multiple internodes in comparison 
to only one internode per cell in the case of Schwann cells. Oligodendrocytes have also de 
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ability to discern thick axons from thin axons. This then tells oligodendrocytes how many 
axons they can wrap at one time. They can wrap more thin axons at one time than they do 
thick axons (Fanarraga et. al, 1998). CNS internodes surrounding small diameter axons are 
shorter and thinner than those surrounding large diameter axons. This all suggests then that 
oligodendrocytes more or less have the ability to synthesize similar amounts of myelin 
whether it is multiple small internodes or few larger internodes. 
Myelin is responsible to promote rapid and repetitive communication between 
neurons and it modulates the maturation and survival of axons. Neurons communicate with 
myelin by depolarizing the electrical potential of their axons, and they perform this task by 
exchanging Na+ through Na+ channels in an energy dependent manner. Unmyelinated axons 
generate action potentials along their surface at a speed that is proportional to the axonal 
radius. For an unmyelinated fiber to propagate rapid axonal communication it would require 
lots of energy and larger axons. Therefore a mechanism to overcome this was adapted 
throughout evolution that could propagate communication through thin axons in an efficient 
manner. Myelin-forming cells serve this function by producing a series of discontinuous 
insulation units called internodes along individual axons. The internodal region formed by 
myelin inhibits ion exchange during nerve conduction by having a low capacitance and a 
high resistance. The myelin then allows conductivities of up to 100m/sec in comparison to 
naked (unmyelinated) axons of velocities less than 1m/sec. This means that for a naked axon 
to achieve similar velocities as a myelinated nerve it would have to be about 100 times 
greater in size. This would present an enormous problem of space requirements to 
accommodate such quantities of large axons.
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As I mentioned earlier most of the myelin present at internodes consists of compact 
myelin that appears as lamellar structures when visualized by transmission electron 
microscope (TEM; Figure 6A-B). Although compact myelin looks like a simple structure is 
not that simple to understand. It is best understood if it is considered a spiraled cellular 
process or sheet that contains two plasma membranes and no cytoplasm. Conventional TEM 
micrographs show an internal translucent core and two electron dense lines or leaflets at the 
extracellular and intracellular surface. In the compacted spiral, apposing extracellular leaflets 
(called intraperiod lines or intermediate lines) are separated by 2.0nm in the CNS and 2.5nm 
in the PNS. The cytoplasmic leaflets appear to be fussed and form the major dense lines 
(Alberts et al. 1994; Figure 6A-B). 
There are slight differences between PNS and CNS. When both these structures are 
compared ultrastructurally, one is struck by the similar appearances of both the compact 
myelin and the axon. One needs to do morphometric comparisons in order to see a clear 
difference. CNS and PNS axons can be easily distinguished by one particular feature, and 
that is the presence of a basal lamina in the PNS fibers which is absent in the CNS nerves. At 
a more molecular level they differ by the distribution and ultrastructure of cytoplasmic 
channels at the outer margin of the internodes. The basal lamina which is a product of 
Schwann cells, contain laminin-2 and collagens II and IV (Carey et al., 1983).
The main function of compact myelin is to insulate the underlying axon, for this reason this 
region of the myelin need not be biochemically or molecularly complex. The myelin 
membrane has a high content of lipids (about 75%), this imparts high buoyancy to 
homogenized myelin membranes upon sucrose gradient extractions and thus it is easy to 
separate them from other membrane samples where the lipid: protein composition is more 
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likely to be in a 1:1 ratio (Norton and Podulso, 1973). Because of this and for its abundance, 
myelin was the first membrane samples to be isolated biochemically and molecularly 
characterized. Several proteins are present in myelin which includes P0 protein, myelin basic 
proteins (MBP), and PMP-22 in the PNS myelin (Greenfield et al, 1973), and proteolipid 
protein (PLP) and MBP in the CNS (Lees and Brostoff, 1984; Figure 7). One of the 
breakthroughs in myelin biology started in the early 90’s and is commonly being used today: 
the ability to generate gene knock-out mice. 
One main interesting finding was that multilammellar myelin is still produced in the 
absence of P0, PLP, MAG and double mutants of PLP/MBP or even triple mutants 
PLP/MBP/MAG (Giese et al, 1992; Duncan et al., 1987; Privat et al., 1979; Montag et al., 
1994; Stoeffel et al., 1997; and Uschkureit et al., 2000). This suggests that spiral expansion 
of myelin sheaths do not depend on these proteins. It has been established though that MBP 
and PLP are required for the normal spacing of compact CNS myelin (Duncan et al., 1987). 
On the other hand, P0 is essential for the normal spacing of myelin in the PNS (Giese et al., 
1992). In order to better understand the role and formation of compact myelin I have 
summarized the most outstanding features of the main molecular components (Figure 7).
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Figure 6 -  Coronal (A-B)  and Sagital (C-D) cerebellar sections of a myelinated nerve fiber. NF –
neurofilament; MT – microtubule; IPL – intraperiod line; MDL – major dense line; PM – periaxonal mesaxon; 
PNJ – paranodal junctions. B and D are insets from A and C respectively.
20
Protein P0 contributes to approximately 65% of the total myelin proteins. It is a type I 
transmembrane glycoprotein with an apparent molecular weight of 30kD. It has a single 
extracellular immunoglobulin (Ig) like domain and a C-terminal (Lemke and Axel, 1985). It 
mediates homophilic plasma membrane adhesion and it also interacts in Cis via its 
extracellular domains with other P0 proteins forming tetramers from the opposite side of the 
membrane (Figure 7). The main function of this protein is to stabilize the intraperiod line by 
its homophilic interaction in the same and opposing side of the myelin membrane in PNS 
fibers. In P0 mice the spacing between extracellular leaflets is altered but overall the major 
dense line is similar to that of wild type (Diese et al., 1992).
Myelin Basic Protein (MBP) is localized at the cytoplasmic surface of compact CNS 
and PNS myelin. The MBP are composed of several members that arise from alternative 
splicing and they are highly charged (Zeller et al., 1984). These charges allow the MBP 
proteins to bind negatively charged lipids, especially phosphatidylserine residues. The MBP
null mice were named the shiverer mice based on the constant shivering these mice express 
during adulthood. In these mutants the cytoplasmic leaflets of compact CNS myelin are not 
fused (Privat et al., 1979). In contrast the major dense line in PNS of shiverer mice is not 
affected. Thus MBP maintains the major dense line of CNS but not of PNS.
Proteolipid Protein (PLP) is most abundant protein in the CNS myelin. It contains 
four transmembrane domains and has a molecular weight (MW) of 26kD. PLP knock outs 
result in the fusion of the extracellular leaflets of the compact CNS myelin (Duncan, et al.,
1987). PLP also contains a splice variant that is functionally distinct: DM20. This protein is 
expressed early in development in both PNS and CNS myelinating cells. Like PLP, DM20 is 
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essential for the formation of the myelin sheath and it is required to fill out the bulk of the 
intraperiod line in compact myelin.
Peripheral Myelin Protein 22 (PMP22) is found exclusively in PNS compact myelin 
(Snipes et al., 1992). Like PLP it is also hydrophilic and it also contains four transmembrane 
domains and it has a MW of 22 kD. Knockouts of PMP22 do not have any apparent effect on 
compact myelin, but they do show severe hypomyelination early in development but it is 
compensated as the animals reach adulthood (Adlkofer et al., 1995).
Myelin Associated Glycoprotein (MAG) is a type I transmembrane glycoprotein 
comprised of a single membrane domain, a C terminus and an extracellular N terminus with 
five immunoglobulin like domains. MAG contains two differential splice isoforms that are 
regulated developmentally, one with a MW of 72kD (Large or L-MAG) and one with a MW 
of 67 kD (Small or S-MAG; Salzer et al., 1987). The differences in their domain lies in their 
cytoplasmic region, which often contain targeting or sorting signals. In CNS, MAG is 
enriched in the periaxonal membranes in CNS myelin as well as in the membrane (Trapp 
1988) whereas in the PNS MAG is enriched also in mesaxons, Schmidt-Lanterman incisures, 
and the paranodal loops.
As mentioned earlier, the internodal myelin covers most of the axon’s length. This 
region of the axon is highly rich in structural components such as, microtubules and 
neurofilaments (Figure 6 A-D). They provide the means of antero and retrograde transport to 
and from the cell body as well as the structural support of the axon.
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Figure 7 – Schematic representation of compact myelin. MBP – myelin basic protein; PLP –
proteolipid protein; PMP22 – peripheral myelin protein 22; P0 – protein zero; CNS – central nervous 
system.
Microtubules are essentially tubes of tubulin, a globular polypeptide comprised of 
two forms:  and  tubulin. Each of these tubulins have a molecular weight of 50 kD. When 
tubulin is assembled into microtubules the dimers line up to form protofilaments in which the 
-tubulin of one dimmer in the filament is joined to the -tubulin of the next one in the chain. 
Normally 13 of these protofilaments become arranged parallel to each other and assemble to 
form the wall of the microtubule. Like actin filaments, microtubules also show the 
phenomenon of tread milling, a process that essentially consists of head-to-tail 
polymerization such that, as subunits are added to one end of the microtubule, other units are 
released from the other end. The ends in which microtubules subunits are added quickly are 
referred to as the plus end and the end where they are released is the minus end. The energy 
for this whole process is supplied by guanine triphosphate (GTP). 
23
Neurofilaments are essential for axonal diameter (Hoffman et al., 1987). They are 
obligate heteropolymers composed of neurofilament light (NF-L) neurofilament medium 
(NF-M) and neurofilament heavy (NF-H). These are the most abundant structural 
components of large myelinated axons. They are synthesized in the cell body or soma and are 
then transported via slow axonal mechanisms to the axon. They are extremely long lived 
proteins and are involved in establishing and maintaining the three dimensional structure of
the axoplasm. 
Analysis of mutant mice confirmed indeed that neurofilaments are required for 
determining the axonal diameter of a mature axon. In these mice the loss of neurofilaments 
decreased remarkably the growth in axonal diameter (Elder et al., 1998; Jacomy et al., 1999; 
Zhu et al., 1997). It is noteworthy to mention that axonal diameter is not only affected by the 
loss of neurofilament subunits but also altered stoichiometry of the subunits as well. 
Increased expression of any single neurofilament subunit inhibits radial growth, whereas 
simultaneous overexpression of NF-L, M and H increases axonal diameter (Wong et al., 
1995; Marszalek et al., 1996; Xu et al., 1996). It is widely known that neurofilaments form 
COOH-terminal phosphorylated cross-bridges which seem to span between adjacent 
neurofilaments and between neurofilaments and microtubules as well (Nakagawa et al., 
1995; Rao et al., 2002). Radial growth in neurofilaments is associated with phosphorylation 
of the COOH-terminal tail domains of NF-M and H which contain a series of KSP repeats. 
These repeats are stoichimotrically phosphorylated in the internodal regions of the axons but 
are unphosphorylated in the unmyelinated regions such as the nodes of Ranvier or axons 
initial segments (Hsieh et al., 1994).
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There are no specialized junctions between the axonal membrane and the myelin 
observed throughout the internodal region. However, freeze fracture electron microscopy 
reveals that internodal axolemma contains longitudinal lines (juxtamesaxonal lines) of 
intramembranous particles containing proteins found in paranodes and juxtaparanodes (see 
below). These structures appear as if they are a continuation of these two structures (Miller 
and Da Silva 1977; Stolinski et al., 1985; Peles and Salzer 2000). Paranodal proteins NCP1 
and CN are expressed throughout the internodal region as well as the juxtaparanodal proteins 
Caspr2 and K+ channels which are both expressed on both sides of the NCP1-CN dimer. 
These structures then form a circumferential ring around the axon just below the inner aspect 
of the Schmidt-Lanterman incisures (a cytoplasmic channel connecting the adaxonal and 
abaxonal layers of the myelin sheath; Poliak et al., 2001; Arroyo et al., 1999). Concomitantly 
to the juxtamesaxonal line of the axonal surface, NF155, Cnx29 and TAG1 are localized in a 
complimentary distribution along the line but on the glial surface (the adaxonal surface), 
suggesting an adhesion complex keeping the glial cell closely apposed to the axon along the 
internodal region (Tait et al., 2000; Altevogt et al., 2002; Traka et al., 2002). One candidate 
glial protein that might also mediate the axo-glial interaction is the myelin associated 
glycoprotein (MAG) which is expressed in the inner glial membrane along the internodal 
region (Trapp 1990).  It has been shown that MAG interacts with sialylated glycoconjugates 
in the axonal surface (Kelm et al., 1994), and seems to be involved in signaling mechanisms 
(Garcia et al., 2003).  
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4 - Myelination
“The cell biological hallmark of myelination is membrane biosynthesis to produce a unique 
extension of the oligodendrocyte and Schwann cell plasma membrane that spirally wraps 
around the axons.”  (Lazzarini, 2004).
It is widely accepted that axons regulate the myelinating phenotype of
oligodendrocytes and Schwann cells. Both the axon and the overlying glial cell engage in a 
bidirectional communication to ensure the proper development and maturation of a complete 
myelinated nerve. Both cell types are necessary and required for normal survival. There is 
little evidence as of what molecules are involved in this process, however electron 
microscopy has provided axonal parameters that indeed affect myelination as well as myelin 
pathology. Myelination is responsible for the increase of the axons maximum diameter 
(Windbank et al., 1985) as well as for the direction of Na+ channels to nodes of Ranvier and 
some associated proteins (Pedraza et al., 2001). This is a crucial event in the development of 
axonal fibers since axonal diameter has a direct effect on the conduction velocity (Arbuthnott 
et al., 1980).
Myelination results in the increase of phosphorylation states of neurofilament side 
arms (de Waegh et al., 1992; Hsieh et al., 1994; Sanchez et al., 1996). This increases the 
negative charge and lateral extension of the side arms which in turn increases neurofilament 
spacing and axonal caliber. In contrast to myelinated fibers, non myelinated fibers as well as 
non myelinated regions of the axon such as the nodes of Ranvier, have fewer neurofilaments 
and less neurofilament phosphorylation which results in less spacing of the filaments and 
smaller diameters (de Waegh et al., 1992; Hsieh et al., 1994). Many extrinsic factors also 
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affect axonal caliber such as mechanical compression of the nerve, alterations of conduction 
frequency, toxins, mutations that affect axonal cytoskeleton or molecules involved in the 
signaling pathways that lead to phosphorylation (Garcia et al., 2003) It is still uncertain how 
myelin recognizes properties of the axon to accommodate myelination to the axonal 
diameter. However oligodendrocytes use different axonal cues than Schwann cells to regulate 
myelin thickness (Elder et al., 2001). The ultimate dimensions of an axon are determined by 
a complex communication between both the axon and the myelinating cell. Although the 
axonal diameter is an intrinsic property of the axon it cannot be achieved without the process 
of myelination (Windbank et al., 1985).
As development of the myelinated nerve fiber takes place the different fiber domains 
are formed gradually. The nodal domain formed first followed by the transient formation of 
the juxtaparanodal domain which is displaced from the paranodal region as the paranodes 
begin their formation (Boiko et al., 2001; Vabnick et al., 1996; Vabnick et al., 1999; Figure 
8). In both PNS and CNS, there is an initial clustering of the Na+ channels at the edges of the 
myelinating cells. Ultimately two neighboring edges cluster to form a mature node (Rasband 
et al., 1999; Boiko et al., 2001; Ching et al., 1999). This suggests that Na+ channel clustering 
is directed by the overlying glial cell. In support of this mechanism, the optic nerve has a 
myelinated and a non myelinated portion separated by the lamina cribosa. Na+ channels are 
diffused in the nonmyelinated portion whereas the myelinated fragment contains Na+ channel 
clusters (Boiko et al., 2001). Also, ablation of oligodendrocytes or Schwann cells abolishes 
Na+ channel clustering as well (Vabnick et al., 1996; Mathis et al., 2001).
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Figure 8 – developmental time points (A-D) schematic of a Schwann cell myelinating an axonal fiber and the 
establishment of a domain (adopted from Bhat, 2003).
During the process of myelination in the PNS, Nrcam and  NF186 are detected at the 
nodes of Ranvier before Na+ channel clusters. Subsequently Na+ channel and Ank-G proteins 
cluster where NF186 and Nrcam are expressed (Lambert et al., 1997). In the CNS clustering 
of nodal proteins is formed in a different manner. Initially, Ank-G clusters at the nodes 
followed by the appearance of NF186 and Na+ channels (Jenkins and Bennett 2002). After 
the clustering of the nodal components in the PNS, NF155 and the NCP1-CN dimmer begin 
their gradual accumulation at the paranodal junction followed by an accumulation of Caspr2 
and K+ channels at the juxtaparanodal junction (Boiko et al., 2001; Rios et al., 2000; Poliak 
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et al., 2001; Vabnick et al., 1999). Initially Caspr2, K+ channels and TAG are first detected at 
the paranodes and subsequently relocate to the juxtaparanodal region as the paranodes 
become more compact (Poliak et al., 2001; Traka et al., 2003; Rasband et al., 1998). In 
paranodal mutants (NCP1, CN, CGT and CST), K+ channel and Caspr2, fail to relocate to the 
juxtaparanode (Boyle et al., 2001; Bhat et al., 2001; Traka et al., 2003; Poliak et al., 2003; 
Ishibashi et al., 2002; Dupree et al., 1999; Poliak et al., 2001). In addition failure to express 
either Caspr2 or TAG1 results in a failure to concentrate K+ channels to the juxtaparanodal 
domain (Traka et al., 2003; Poliak et al., 2003). 
It is evident that distinct protein domains on axonal membranes are established via 
tight regulated communication between the axon and the opposing glial cell. This 
communication enables the proper sorting of proteins to their respective locations followed 
by clustering and anchoring of the respective complexes to the axonal membrane and 
cytoskeleton. Several distinct proposed molecular mechanisms by which the protein domains 
are formed have been proposed. One such mechanism proposed by Pedraza et al. (2001) 
suggests the existence of a sieve or molecular filter found at paranodes. They propose that 
such a sieve would selectively exclude large protein complexes such as the nodal complex 
and allow through only small proteins such as K+ channels. This process would require an 
axoglial interaction without the need of the NCP1-CN complex, since in their absence the 
nodal proteins still clusters properly, which implies that the generation of paranodal 
transverse bands are not required for the efficient clustering of Na+ channels. In fact the 
accumulation of NCP1 at paranodes and the nodal clustering of Na+ channels happen before 
the formation of the transverse bands (Marcus et al., 2002). It is worthy of mentioning that 
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after Na+ channels have clustered, the paranodal junctions play a role in maintaining the 
nodal complex in place. 
Analysis of paranodal mutants showed that with time the Na+ channel clusters 
broaden, indicating that once the nodal cluster is formed there is a necessity for the paranodal 
junctions to keep it compact (Ishibashi et al., 2002; Rios et al., 2003; Rosenbluth et al., 
2003). A similar mechanism might be responsible for the proper clustering of the 
juxtaparanodal complex. Although in this case the molecular sieve might be a different one. 
In contrast to the clustering of the Na+ channels at the nodes, the generation of the 
juxtaparanodal complex does require the paranodal axoglial junctions (Bhat et al., 2001; 
Dupree et al., 1999) thus indicating that it works as a molecular sieve. Finally there seems to 
be a molecular sieve at the nodal complex itself. Evidence for this comes from the fact that in 
paranodal mutants juxtaparanodal complex localizes to the paranodes (Bhat et al., 2001; 
Boyle et al., 2001), and it does not move into the nodal environment, suggesting that there 
might be a fencing mechanism limiting the entry of molecules to the nodal domain (Bhat et 
al., 2001; Dupree et al., 1999). 
5 - Pathology and Deficiency of the Myelinated Fibers
Axonal loss is a major cause of neurological disability in inherited and/or acquired 
diseases of myelin which tends to occur as a late onset manifestation of dysmyelination. The 
early symptoms of patients are usually slow conduction velocities which is an indication of 
dysmyelination. As age prolongs conduction velocities remain constant but conduction block, 
an indication of axonal loss, correlates with disease onset and progression. These and other 
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observations have lead to the hypothesis that axons require glial-derived extrinsic trophic 
support for their survival (Lazzarini, 2004). 
Late onset axonal pathology and degeneration has been described in mice deficient in 
PLP, MAG, P0, and complex gangliosides (Sheikh et al., 1999; Yin et al., 1998; Griffiths et 
al., 1998; and Giese et al., 1992) as well as other mice lacking paranodal proteins such as 
CN, and NCP1 (Bhat, et al., 2001; Boyle  et al., 2001). The mechanism by how the loss of 
function of these proteins culminates in axonal pathology is still unclear, but axonal 
pathologies that precede axonal degeneration include axonal atrophy, axonal swellings, 
reduced axonal transport, and altered axonal cytoskeleton. 
Protein dosage of compact myelin plays an important role in the normal generation of 
stable myelin, their stoichiometry is as important as the presence of these proteins. For 
instance three copies of the human gene PMP22 cause Charcot Marrie Tooth disease type 1A 
and duplication of the PLP gene on the X chromosome causes inherited CNS 
hypomyelination disorder Pelizaeus Merzbacher disease. It is now clear that having altered 
copy numbers of either PLP or PMP22 is major cause for inherited diseases of myelin. 
There is increasing evidence suggesting that disturbances of the axonal domain 
organization and function are an important source of neurological disorders (see Poliak and 
Peles, 2003 for review). Disorders can arise from mislocalized channels, improper domain 
formation, defects of the axonal cytoarchitecture or from a miscommunication between the 
axon and the overlaying glial cell (Bhat et al., 2001; Boyle et al., 2001; Boiko et al., 2001; 
Boiko et al., 2003; Tait et al., 2000; Rasband et al., 1999a-b; Rasband et al., 2003; Lambert et 
al., 1997; Ishibashi et al., 2002; Ishibashi et al., 2003; Dupree et al., 1998, Dupree et al., 
1999; Poliak et al., 2001;  Poliak et al., 2003; Rosenbluth et al., 2003; Traka et al., 2002; 
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Gollan et al., 2002; Rios et al., 2003; Honke et al., 2003; Mathis et al., 2001; Vabnick and 
Shrager 1998). Although communication between neuron and glial cells is essential, loss of 
myelin does not have an immediate detrimental effect as observed in some demyelinating 
diseases (Mathis et al, 2001; Vabnick and Shrager 1998). One such disease has been 
described over one hundred years ago (1868) by Charcot: multiple sclerosis (MS). Although 
considered an autoimmune disease, MS is now beginning to fall into the field of axoglial 
neuropathies (Arroyo et al., 2002; Mathis et al., 2001; Wolswijk and Balesar 2003). Evidence 
for this came from studies of MS patient’s myelinated fibers. MS axons have aberrant Na+
channel isoform switching as seen in NCP1 mutant mice and paranodal markers are lost 
earlier than nodal markers following demyelination (Rios et al., 2003; Kearney et al., 2002; 
Arroyo et al., 2002; Mathis et al., 2001; Wolswijk and Balesar 2003). These results suggest 
that paranodes can be a potential target for pathogenic mechanisms that lead to dispersion of 
the node and paranodal markers. 
Another feature of MS nerve fibers is the abnormalities observed in the 
phosphorylation of neurofilaments (Trapp et al., 1998). Neurofilaments, the intermediate 
filaments of axons, are a major component of the axonal cytoskeleton. One of the main 
functions of neurofilaments is to control axonal caliber, which is crucial since the speed of 
conductivity of an impulse down the axon is proportional to the axonal caliber. Tempering 
with the neurofilament network has been shown to cause deficits in axonal transport and 
caliber of myelinated fibers, leading to axonal accumulations (axonal swellings) and 
degeneration (Griffiths et al., 1998; Popko 2003). Axonal swellings have been shown in a 
number of myelin deficient mice such as CGT, CST, CN, Jimpy, and PLP (Jenkins et al., 
2002; Griffiths et al., 1998; Boyle et al., 2001; Dupree et al., 1998; Honke et al., 2002). 
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A direct connection between deficits in myelin and a downstream effect on the axonal 
cytoskeleton has not yet been made. We propose to establish such a link using two model 
systems namely CGT and NCP1 knockout mice. CGT knockout mice have a deficiency in a 
glial enzyme that is responsible for the synthesis of galactolipids, whereas NCP1 knockout 
mice are missing an axonal protein. Interestingly both knockout mice express the same 
phenotype, suggesting the existence of a common downstream mechanism, one coming from 
the overlying glial cell and the other from the axonal fiber. We suspect that the link is 
provided by NCP1 since this is the only protein from the paranodal complex that has 
extracellular as well as intracellular domains which can link both the glial cell and the axon 
cytoskeleton. 
CHAPTER II
Axon-Glia Interactions and the Domain Organization of Myelinated 
Axons Requires Neurexin IV/Caspr/Paranodin
ABSTRACT
Myelinated fibers are organized into distinct domains that are necessary for saltatory 
conduction. These domains include the nodes of Ranvier and the flanking paranodal regions 
where glial cells closely appose and form specialized septate-like junctions with axons. 
These junctions contain a Drosophila Neurexin IV-related protein, Caspr/Paranodin (NCP1). 
Mice that lack NCP1 exhibit tremor, ataxia, and significant motor paresis. In the absence of 
NCP1, normal paranodal junctions fail to form, and the organization of the paranodal loops is 
disrupted. Contactin is undetectable in the paranodes, and K+ channels are displaced from the 
juxtaparanodal into the paranodal domains. Loss of NCP1 also results in a severe decrease in 
peripheral nerve conduction velocity. These results show a critical role for NCP1 in the 
delineation of specific axonal domains and the axon-glia interactions required for normal 
saltatory conduction.
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INTRODUCTION
The ability of myelinated axons to conduct action potentials by saltatory conduction 
depends on the distribution of numerous molecular components, notably voltage-gated ion 
channels, into distinct domains. These domains—the internode, the paranodal and 
juxtaparanodal regions, and the node of Ranvier—form as the result of specific interactions 
between axons and myelinating glial cells, e.g., Schwann cells in the PNS and 
oligodendrocytes in the CNS (Peles and Salzer, 2000). The molecular composition of these 
domains and the nature of the axon-glia interactions that are required for their formation are 
poorly understood.
Voltage-gated sodium (Na+) channels are highly concentrated at the nodes of Ranvier, 
whereas delayed rectifier potassium (K+) channels are localized to the juxtaparanodes. A 
series of cytoplasmic loops of the glial cells are interposed between these domains and flank 
the nodes of Ranvier. These glial loops spiral tightly around and form specialized septate-like 
junctions with the axon. In electron micrographs of longitudinal sections of myelinated 
axons, the paranodal junctions display periodic intercellular transverse bands. These 
junctions have several proposed functions: anchoring the paranodal loops to the axon, 
providing an ion diffusion barrier into the periaxonal space that prevents current loss, and 
serving as a physical barrier that maintains distinct axonal domains (Rosenbluth, 1995).
Support for the role of these junctions in domain organization has emerged from 
studies of ceramide galactosyl transferase (CGT) mutant mice (Bosio et al. 1998 and 
Coetzee et al. 1996). CGT mutant mice are unable to synthesize galactocerebroside and 
sulfatide, two abundant myelin glycolipids. These mice display a variety of paranodal and 
35
nodal abnormalities, including absence of the transverse bands—the hallmark of the 
paranodal junctions (Dupree et al., 1999). Although the mechanisms underlying the 
paranodal defects in these mice are not understood (Dupree and Popko, 1999), the 
observation that K+ channels are mislocalized in these mice (Dupree et al., 1999) suggested 
that the paranodal junctions play a key role in the delineation of channel domains.
The first molecular constituent of the paranodal junctions to be identified was the rat 
contactin-associated protein, Caspr (Einheber et al., 1997). This protein was independently 
identified and localized to these junctions and named Paranodin (Menegoz et al., 1997). 
Caspr/Paranodin exhibits significant homology in its ectodomain to Neurexins I, II, and III 
(Missler and Südhof, 1998) but is more similar to Drosophila Neurexin IV (NRX IV) 
(Baumgartner et al., 1996) and Caspr2 (Poliak et al., 1999). Hence, NRX IV and 
Caspr/Paranodin constitute a subfamily of Neurexin-like proteins referred to as NCPs (Bellen 
et al., 1998); we will refer to Caspr/Paranodin as NCP1. Drosophila NRX IV has been 
localized to pleated septate junctions of epithelial and glial cells. These junctions display a 
ladder-like electron-dense structure and are crucial to the integrity of the blood-nerve barrier 
in Drosophila (Baumgartner et al., 1996).
Biochemical studies have shown that NCP1 associates in cis with the GPI-anchored 
neural cell adhesion molecule contactin (Peles et al., 1997). Contactin is required for the 
surface expression of NCP1 (Faivre-Sarrailh et al., 2000) and both proteins form a high 
molecular weight complex in the paranodal junctions (Rios et al., 2000). The glial ligands for 
NCP1 or contactin in the paranodes have not been established. A potential candidate is the 
155 kDa isoform of neurofascin, which is expressed by myelinating glia in the paranodal 
region (Davis et al. 1996; Collinson et al. 1998 and Tait et al. 2000). Based on the paranodal 
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abnormalities of the CGT mutant mice, galactocerebroside and sulfatide may also be 
considered potential glial ligands.
In this study, we address the role of mouse NCP1 in the formation and function of 
paranodal junctions. We show that loss of NCP1 in mice causes severe neurologic defects 
and aberrant organization, and axo-glial interactions in the paranodal region. In addition, the 
strict separation between Na+ channels at the node and K+ channels at the juxtaparanode is 
abolished and nerve conduction velocity is substantially reduced in the absence of NCP1. 
Hence, NCP1 plays a key role in the formation of the paranodal junction.
RESULTS
1 - Cloning of the Mouse NCP1 Gene and Generation of Null Mutants
Human Neurexin IV sequences were identified through database searches using the 
Drosophila Neurexin IV (nrx IV) sequence. One of the human ESTs was used to screen a 
mouse embryonic cDNA library and overlapping clones were isolated, sequenced, and 
compiled as a cDNA sequence of 4496 base pairs (accession number AF039833). This 
sequence contains an open reading frame (ORF) of 1385 amino acids (153 kDa) with 93% 
identity to rat Caspr/Paranodin (Menegoz et al. 1997 and Peles et al. 1997) and is named 
NCP1 (Bellen et al., 1998). NCP1 contains an amino-terminal discoidin domain, a laminin G 
domain, two Neurexin domains, and a PGY-enriched segment in the extracellular region. The 
cytoplasmic domain contains a band 4.1 binding motif and a proline-rich sequence with at 
least one consensus SH3 domain binding site. In contrast to Drosophila NRX IV and Caspr2, 
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NCP1 lacks a PDZ binding domain consensus sequence at its carboxyl terminus 
(Baumgartner et al. 1996; Poliak et al. 1999 and Bhat et al. 1999).
Using the NCP1 cDNA as a probe, 30kb of genomic DNA was cloned and mapped 
Bhat et al. 2001; Figure 1A). Based on a partial intron-exon structure of the NCP1 locus, a 
targeting construct was designed to delete the first 7 exons, or 327 N-terminal amino acids.
Figure 1 - (A) NCP1 targeting vector. A restriction map of  30 kb genomic DNA containing the 5 region of the 
NCP1 gene and a partial intron-exon structure. The exons are represented as blue boxes. A targeting construct was 
designed with a pol II-neo resistance cassette flanked by genomic fragments that should delete the first 7 exons of the 
NCP1 gene, including the 5 regulatory sequences. This construct produced a targeted allele disrupting the NCP1
gene. The numerical numbers 1–3 with small arrows indicate the PCR primers used for genotyping. (B-D) NCP1 
expression. The protein lysates were prepared from brains of wild-type, heterozygous, and homozygous animals and 
processed for immunoblotting. The wild-type and heterozygous animals showed a predominant protein band 
migrating at 185–190 kDa that was not detected from homozygous animals demonstrating the loss of the NCP1 
protein in NCP1 mutant mice (B). Immunohistochemical analysis of sciatic nerves from heterozygous animals 
showed normal expression of NCP1 at the paranodal junctions (C), whereas the nerve fibers from homozygous 
animals did not reveal any immunostaining (D). The intensity of the green color in (D) was enhanced to reveal the 
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background of nerve fibers. (E) Genotyping by PCR used three primers. Two primers (1 and 2, see [A]) were directed 
against wild-type sequences to amplify a 578 bp fragment representing the wild-type allele, and one primer against 
the neo sequence (3, see [A]) with primer 2 to amplify a 710 bp fragment representing the mutant allele. The 
heterozygous animals amplify both fragments (as reported in Bhat et al. 2001).
The targeting construct contained a pol II-neo resistance cassette flanked by a 2.6 kb 
BamHI-XhoI fragment   (5 homology) and a 4.5 kb EcoRI-SmaI (3 homology) (Figure 1A). 
Upon recombination, this construct deletes the first 7 exons of NCP1 and the putative 
regulatory sequences. The linearized targeting vector was electroporated into ES cells, and 
clones carrying the targeted allele were isolated (data not shown).
The clones were injected into mouse blastocysts, and a chimeric male was obtained 
that transmitted the targeted allele to its progeny. Heterozygous and homozygous mice were 
confirmed by genomic Southern analysis (data not shown) and PCR amplification ( Figure 
1E). Mice homozygous for the mutant allele are born at the expected Mendelian frequency 
from heterozygous intercrosses. The following data indicate that the NCP1 mutation is a null 
mutation. First, the NCP1 protein was not detected in whole brain and sciatic nerve 
homogenates from homozygous mutant mice by Western blot analysis using two independent 
anti-sera generated to the C-terminal domain of NCP1; the same antisera revealed the 185–
190 kDa NCP1 protein in wild-type tissues (Figure 1B). Second, the NCP1 protein could not 
be detected by immunohistochemical analysis of mutant sciatic nerves ( Figure 1D) or in the 
CNS (see below), whereas wild-type or heterozygous littermates showed strong expression in 
the paranodal regions ( Figure 1C). Taken together these data show that we have generated a 
complete loss-of-function of NCP1.
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2 - NCP1 Mutant Mice Display Sever Neurological Defects
The NCP1 mutant mice are indistinguishable from their wild-type littermates until 
approximately postnatal day 10 (P10). Starting at P11, the mice become identifiable by their 
smaller stature and progressive neurologic defects that reach maximal severity in the third 
postnatal week (Figures 2A and 2B). The defects include hypomotility, a tremor that is 
accentuated with movement and a wide-based gait suggestive of a cerebellar defect. These 
mice cannot maintain their balance on a stationary beam and are nearly immobile in open 
field tests (Figure 2C). They also exhibit generalized motor paresis that is worse in the lower 
extremities and are unable to support their weight against gravity, climb ropes, or hold onto 
the edge of the cage. 
Figure 2 - Phenotype of NCP1 Mutant Mice(A) Appearance of NCP1 mutant mice. Wild-type (on left) and 
NCP1 mutant (on right) littermates at day 35 are shown; the NCP1 mutant mouse is approximately half the 
weight (8 g versus 17 g) of the wild-type mouse and also exhibits a characteristic wide base in the hind 
limbs.(B) Weight charts. The chart illustrates the weights of wild-type (+/+), heterozygous (+/−) and 
homozygous (−/−) male littermates. Wild-type and heterozygous mice were weaned at P19; homozygous mice 
were left with their mothers.(C) Motor activity in open field tests. The number of 5 cm × 5 cm squares crossed 
by each mouse was recorded over a one minute period at P21, P40, and P100. At all times examined, the NCP1
mutant mice were hypomotile compared to their heterozygous and wild-type littermates although the activity 
improves at later developmental time points (as reported in Bhat et al. 2001).
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The mutant mice also exhibit occasional extensor spasms of the lower extremities and 
a hunchback appearance. Most of the mutant mice die at weaning (P21) or shortly thereafter 
(up to P33), possibly reflecting impaired feeding and maternal care. Removal of wild-type 
and heterozygous littermates from the cage significantly improves survival but does not alter 
the neurologic phenotype. These mice slowly increase in size and, in the case of males, 
approach the weight of their wild-type littermates (Figure 2B). The tremors, hypomotility, 
and weakness improve slightly (Figure 2C) but then worsen after about 5 months of age. At 
all ages, heterozygotes appear normal.
3 - Compact Myelin Formation in NCP1 Mutant Mice
To determine whether the histological organization 
of the nervous system, including myelination, is affected in 
the NCP1 mutant mice, we examined various regions of the 
CNS and PNS by light and electron microscopy (EM). 
Light microscopy did not demonstrate any obvious 
abnormalities in the histological organization or the extent 
of myelination. 
To assess whether loss of NCP1 affected myelin 
composition, the levels of proteins expressed in compact 
myelin in the CNS were analyzed by Western blotting 
(Figure 3). Expression of two components of compact 
myelin, proteolipid protein (PLP), and myelin basic protein 
(MBP) was unchanged in heterozygous and homozygous 
Figure 3 –  Western blot analysis of 
myelin related proteins. Western 
blots of total brain extracts from 
wild-type (+/+), heterozygous (+/−), 
and NCP1 mutants (−/−) were 
probed with antibodies to contactin 
(Cn), proteolipid protein (PLP), and 
myelin basic protein (MBP). No 
significant change in expression was 
observed (as reported in Bhat et al. 
2001).
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mutant mice. Expression of contactin, a protein that is complexed with NCP1 in the 
paranodal junctions (Rios et al., 2000), was also examined and found to be comparable to 
that of wild-type littermates (Figure 3B). Taken together with the histological analyses, these 
results indicate that loss of NCP1 does not affect compact myelin formation.
4 - NCP1 is Required for Formation of Paranodal Junctions
Since NCP1 is localized to paranodal junctions, we examined the ultrastructure of this 
region (Figure 4). As shown in Figure 4A, paranodal loops are arrayed sequentially and in 
close apposition to the axonal membrane in the CNS of wild-type mice. Between the loops 
and axon, periodic densities corresponding to the septate-like transverse bands are readily 
apparent (Figure 4C, black arrowheads). In contrast, in the CNS of animals lacking NCP1, 
the paranodal and nodal morphology is frequently grossly perturbed (Figures 4B-D). A 
consistent abnormality is the absence of the regular array of transverse bands between 
paranodal loops and the axon (Figures 4B and 4D). The most striking paranodal abnormality 
consists of "everted" loops, i.e., paranodal loops that face away from, instead of toward, the 
axonal membrane (labeled IL, Figure 4B.
Other striking abnormalities include occlusion of the node of Ranvier by paranodal 
loops from one myelin segment that override those from the opposite side, thereby creating a 
"pseudonode". In the example shown in Figure 4B (black arrows), paranodal loops from the 
myelin segment on the left (arrow 1) come to an almost contact from loops coming from the 
right (arrow 2), leaving little or no space for the node of Ranvier (asterisk). Additional 
defects included astrocytic processes that are interposed between the paranodal loops and the 
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axon and the presence of Schmidt-Lanterman-like incisures in the myelin sheaths of the 
spinal cord (data not shown); these incisures are normally rare in CNS myelin (Bhat et al. 
2001).
Figure 4 - Perturbation of the paranodal organization of NCP1 mutant mice. Electron micrographs through the 
cerebellar  paranodal region of wild-type (A,C) and NCP1 mutant mice (B,D) are shown; (A) shows wild-type 
sagital section with paranodal loops tightly apposed to and indenting the axon, the characteristic transverse 
bands are also apparent (arrowheads in B). (B) Shows mutant sagital section with everted paranodal loops (IL); 
the node of Ranvier (*) is covered by paranodal junctions coming from opposite ends (Arrows 1 & 2). (D) 
Demonstrates closely apposed paranodal loops in the mutants that display electron dense intramembranous 
material (Black arrows) but lack transverse bands.
5 - Altered Distribution of Junctional Components in NCP1 Mutant Mice
Our ultrastructural studies showed that the septate-like paranodal junctions are 
lacking in the absence of NCP1. We therefore examined the distribution of other proteins 
localized to this region. Contactin (CN) normally forms a cis complex with NCP1 (Peles et 
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al. 1997 and Rios et al. 2000) on the axon in the paranodes of both the PNS and CNS 
(Figures 5A and 5I); it is also present at nodes of Ranvier in the CNS (Figure 5G; Rios et al., 
2000). In NCP1 mutant mice, contactin is not detectable in either the nodes or the paranodes 
of sciatic nerve fibers (Figure 5B). In contrast, contactin expression remains robust in mutant 
optic nerves but its distribution is altered. In wild-type optic nerves, much of contactin is 
confined to paranodal regions and low levels of protein are present in the nodal region 
(Figure 5G). In mutant optic nerves, contactin localization is more diffuse and higher levels 
of this protein are observed in the nodes than in the paranodes (Figures 5H and 5J, 
arrowheads). These data indicate that NCP1 is required for the proper localization of 
contactin to the paranodal domain.
The failure to detect contactin in sciatic nerves may result from a diffuse distribution 
along the axon that is below the limits of detection or the loss of the protein altogether. To 
distinguish these possibilities, we performed Western blot analysis of the expression of 
contactin in peripheral nerves. We found that both the large and small molecular weight 
isoforms of contactin are present in wild-type sciatic nerves. These correspond to free (e.g., 
non-NCP1-associated) and NCP1-associated forms, respectively (Rios et al., 2000). 
However, only the higher molecular weight isoform is detectable in the mutant peripheral 
nerves (data not shown). These results suggest that loss of NCP1 does not affect the free 
isoform of contactin, which is likely to be predominately expressed by nonmyelinated axons 
in the peripheral nerve (Rios et al., 2000).
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Figure 5. Expression of Paranodal Markers in Sciatic and Optic Nerves Teased sciatic nerves (PNS, A–D) and 
cryosections of optic nerves (CNS, E–J) from wild-type (+/+) and NCP1 mutant (−/−) mice were stained for 
paranodal markers. Sciatic nerves were stained with NCP1 and MBP, and either contactin (Cn, A and B) or 
neurofascin (Nfas, C and D). The insets highlight a single node, indicated with an asterisk. In the wild-type 
nerves, NCP1 colocalizes with Cn in the paranodes; Nfas is present in both the node and paranodes. In the 
mutant nerve, NCP1 and Cn are not detectable in the paranodes and Nfas is largely present at the node. A 
second node is shown in (B) (white arrowhead). Bar, 20 µm.Optic nerves were stained for NCP1, Cn, and Na+
channels (NaCh); several nodes are highlighted by the white arrowheads. In the wild-type nerves (E, G, and I), 
Na+ channels at the nodes are flanked by NCP1 and Cn in the paranodal regions; Cn is also present at low levels 
at the node (G, arrowheads). In mutant nerves (F, H, and J), much of the Cn colocalizes with NaCh in the nodes 
(J, yellow in the merged images), whereas low levels are present in the paranodes. Bar, 5 µm (as reported in 
Bhat et al. 2001).
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Neurofascin is another protein localized to nodes and paranodes. Two neurofascin 
isoforms have been described: a 155 kDa isoform expressed by myelinating glia in paranodes 
(Davis et al. 1996 and Tait et al. 2000) and a 186 kDa axonal isoform localized to nodes of 
Ranvier. The 186 kDa isoform is thought to be part of a complex that contains ankyrin and 
Na+ channels (Bennett and Lambert, 1999). To determine whether the distribution of 
neurofascin was affected in NCP1 mutants, we stained peripheral nerves with a polyclonal 
antibody that recognizes both isoforms of neurofascin. In wild-type peripheral nerves, 
neurofascin is present in both nodes and paranodes (Figure 5C, red inset). In contrast, in the 
absence of NCP1, neurofascin is enriched in nodes but reduced in paranodes ( Figure 5D, red 
inset). Taken together, these data demonstrate that absence of NCP1 is associated with a loss 
of paranodal components, indicating that it plays an important role in the molecular 
organization of these junctions.
6 - Ion Channel Distribution in the Absence of NCP1
A hallmark of myelinated axons is the localization of ion channels within discrete 
domains. Na+ channels are concentrated at the nodes, whereas K+ channels are largely 
restricted to the juxtaparanodes and to those regions of the internode that appose the 
noncompacted myelin membranes, e.g., the Schmidt-Lanterman incisures and the internal 
mesaxon (Peles and Salzer, 2000). To determine whether the defects at paranodal junctions 
in the mutant mice affect the distribution of these channels, we performed 
immunofluorescence staining of sciatic and optic nerves (Figure 6). 
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Figure 6. Voltage-Gated Channel Distribution Is Perturbed in NCP1 Mutant Mice Teased sciatic nerves 
(SN) and cryosections of optic nerves (ON) from wild-type (+/+) and NCP1 mutant (-/-) mice were 
stained with antibodies to ion channels. In the wild-type sciatic and optic nerves, the Na+ channels 
(NaCh, green) and K+ channels (Kv 1.1, red) are completely separated by NCP1 (NCP, blue) in the 
paranodes. In the mutant nerves, K+ channels are aberrantly localized to the paranodes and overlap 
slightly with Na+ channels (regions of overlap are yellow). In the PNS, there is also prominent K+
channel staining in vertical stripes that appose Schmidt Lanterman incisures. Bars, 20 µm (SN); 10 µm 
(ON) (as reported in Bhat et al. 2001).
In wild-type and mutant mice, Na+ channels (green) are largely confined to the nodes 
of Ranvier. The distribution of the Na+ channels is wider and more diffuse at the nodes of 
mutant mice, particularly in the optic nerve (Figure 6, ON). In contrast, the distribution of the 
K+ channels (red) differs markedly between wild-type and NCP1 mutant mice. In wild-type 
nerves, K+ channels are completely separated from the Na+ channels by the paranodes. In the 
mutant mice, K+ channels are mislocalized to the paranodal region, immediately adjacent to 
and, in some cases, slightly overlapping with Na+ channels (areas of overlap appear as yellow 
in the merged images). K+ channel staining remained robust in the internodal axolemma of 
mutant mice. Interestingly, there is an increase in the number of stripes of K+ channels along 
the axon. These stripes are apposed to the Schmidt-Lanterman clefts as confirmed by double 
staining with myelin-associated glycoprotein (MAG) antibody, a marker of these incisures 
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(data not shown). Hence, these data indicate that paranodal junctions are required for the 
segregation of Na+ and K+ channels into distinct, nonoverlapping domains
DISCUSSION
The ultrastructure of the paranodal region was first described over four decades ago 
(Robertson 1957; Andres 1965 and Bargmann and Lindner 1964), but its molecular 
composition remained elusive until the identification of NCP1 as a major junctional 
component (Einheber et al. 1997 and Menegoz et al. 1997). Our data show that NCP1 is an 
essential component of the paranodal junctions. The NCP1 mutant mice therefore provide a 
unique model to dissect the function of paranodal junctions in myelinated axons.
1 - Phenotypic Abnormalities of NCP1 Mutant Mice
In the absence of NCP1, mice exhibit tremors, paresis, and ataxia. We believe that 
these neurologic defects reflect the function of NCP1 in the nervous system since we did not 
observe its expression in non-neuronal tissues (e.g., lung, heart, kidney, stomach, intestine, 
pancreas, and testes) by Western blotting analysis (data not shown). While we have focused 
our efforts on the paranodal junctions and the organization of myelinated fibers, NCP1 is also 
expressed by nonmyelinated axons and in the central gray matter (Einheber et al. 1997 and 
Menegoz et al. 1997). Therefore, the neurologic abnormalities may be due to paranodal and 
extrajunctional defects.
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The neurologic defects of these mice resemble those of the contactin mutant mice 
(Berglund et al., 1999). As contactin is also localized to the paranodes (Rios et al., 2000) and 
is required for the cell surface expression of NCP1 (Faivre-Sarrailh et al., 2000), it will be of 
interest to determine the organization of the paranodal region in these mutant mice. Contactin 
mutant mice are ataxic and have striking defects in cerebellar development, reflecting its 
expression by several types of cerebellar neurons and its role in mediating neurite outgrowth 
and neuronal interactions (Faivre-Sarrailh and Rougon, 1997). NCP1 has been suggested to 
function as a co receptor for contactin and is highly expressed within the cerebellum (Peles et 
al., 1997; G.P.G.-F. and M.B., For review). Although the cerebellar development of NCP1
mutant mice has not been examined, the ataxia, wide-based gait, and tremor of these mice 
may reflect defects of cerebellar development rather than abnormalities of the paranodal 
region per se. Contactin mutant mice are likely to exhibit more widespread defects than 
NCP1 mutant mice in view of the extrajunctional expression of this protein at central nodes 
of Ranvier, by oligodendrocytes, and, potentially, specific neurons.
2 – Abnormal Axon-Glial Interaction at the Nodes and Paranodes of  NCP1 Mutant 
Mice
A major defect of the mutant mice is the absence of transverse bands, the hallmark of 
the paranodal junctions. These findings provide formal evidence that NCP1 is a key axonal 
component of these junctions, consistent with its striking localization to these junctions 
(Einheber et al. 1997 and Menegoz et al. 1997). In addition, the close apposition and 
indentation of the axon by the paranodal loops was frequently absent and, in the most severe 
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cases, the paranodal loops were detached from the axon ( Figure 4D). These results indicate 
that NCP1 is required to stabilize the adhesion of these loops to the axon, either directly or in 
combination with other junctional components. Interestingly, the paranodal loops 
occasionally retain a close association with the axon and, in these cases, some 
intramembranous density is apparent by EM (see Figure 4D arrows). These findings suggest 
that other components of the junctions, yet to be identified, may be able to promote axon 
attachment in the absence of NCP1. Alternatively, Caspr2, which shares high homology to 
NCP1 in its ectodomain (Poliak et al., 1999) and which is mislocalized from the 
juxtaparanodes into the paranodal region of NCP1 mutant mice (data not shown), may 
contribute to this adhesion.
In the CNS, the morphologic organization of the paranodal region is often grossly 
perturbed—most strikingly represented by the eversion of the glial loops (Figures 4B IL). 
Defective attachment of the paranodal loops to the axon in these mice seems likely to 
account for this anomalous morphologic organization. The myelin sheath is elaborated by 
circumferential growth of the inner turn of the glial cell membrane that spirals around the 
axon (Bunge et al., 1989). In the NCP1 mutant mice, frequently only the paranodal loops of 
the innermost myelin turns remained attached to the axon, whereas the lateral loops of the 
outermost turns were often unattached, everted, and displaced medially. It is not known when 
the loops detach: potentially the inner turn of the myelin sheath may displace existing glial 
contacts with the axon as it spirals around the axon, or alternatively, the loops may detach 
after myelin sheaths have already formed. Other abnormalities, including loops from a single 
myelin sheath that appose each other and myelin segments that overlap, also suggest 
defective glial attachment. In PNS the paranodal abnormalities are not as abrupt (data not 
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shown). Potentially, the presence of a well-formed basal lamina and/or the Schwann cell 
microvilli which project to the node (Melendez-Vasquez et al., 2001), both of which are 
unique features of PNS myelin, may stabilize the paranodal loop organization sufficiently to 
prevent severe abnormalities. As the amount and organization of compact myelin was not 
affected in the mutant mice, radial growth of the myelin sheath does not require NCP1.
3 – NCP1 Mutant Mice Are Deficient in Junctional Components
Based on immunofluorescence staining of peripheral nerves, two other components of 
the paranodal junctions, contactin and neurofascin, which are expressed by neurons and 
Schwann cells, respectively (Rios et al. 2000 and Tait et al. 2000), are undetectable or 
substantially reduced in the paranodal region. Initial immunoblotting studies of sciatic nerve 
extracts show that a lower molecular weight isoform of contactin that specifically associates 
with NCP1 (Rios et al., 2000) is undetectable and that the 155 kDa isoform of neurofascin is 
significantly reduced (data not shown). Thus, there is a global deficiency of the known 
paranodal components in the NCP1 mutant mice. Whether the loss of these components 
reflects the failure of the paranodal loops to attach to axons properly in the absence of NCP1 
or, alternatively, that these components are not properly targeted or are unstable in the 
absence of NCP1, is not yet known. However, loss of contactin and neurofascin is likely to 
further contribute to the defects of glial loop adhesion.
In the CNS, contactin is expressed at comparable levels in wild-type and NCP1
mutant mice (Figure 3B) but its localization is perturbed. Specifically, staining of contactin 
in the paranodes is reduced whereas that in the nodes of Ranvier is increased and appears 
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diffuse (Figure 5). These findings suggest that in the absence of NCP1, contactin 
redistributes from the paranodes to the nodes and provide further evidence that NCP1 is 
required for the appropriate targeting of contactin to the paranodes (Rios et al., 2000). The 
normal expression levels of contactin seen by Western blotting may reflect a non-NCP1-
interacting pool of this protein in oligodendrocytes (Einheber et al. 1997 and Koch et al. 
1997) and at nodes of Ranvier in the CNS. These findings may also indicate that neuronal 
expression of contactin in extrajunctional sites is not dependent on NCP1.
4 – Paranodal Junctions and Domain Organization in Myelinated Axons
A striking finding of this study is that the delineation between channel domains 
requires NCP1 and the transverse bands. In their absence, the delayed rectifier K+ channels 
are displaced into the paranodes adjacent to the node. The data also indicate that Na+ and K+
channels still cluster in the absence of these junctions. This is consistent with previous 
studies demonstrating that nodal clustering occurs prior to mature paranodal junction 
formation in the developing PNS (Melendez-Vasquez et al., 2001) and in the CGT mutant 
mice, which fail to form normal junctions (Dupree et al., 1999). It is of note that Na+ and K+
channel domains remain largely segregated, suggesting that even in the absence of the 
transverse bands, unique molecular interactions, possibly involving distinct scaffolding 
proteins (Peles and Salzer, 2000), maintain the separation of these channel domains. K+
channels associate with the closely related Caspr2 protein (Poliak et al., 1999), which is also 
mislocalized to the paranodes (data not shown).
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The paranodal defects of the NCP1 mutant mice strikingly mirror those in the CGT
mutant mice (Coetzee et al., 1996). Common features of both mutant mice include the 
absence of transverse bands, everted loops, and other paranodal abnormalities in the CNS, an 
increase in the number of Schmidt-Lanterman incisures in CNS myelin, and the relatively 
normal morphology of the paranodal region in the PNS. These common findings are reflected 
in the loss of the delineation between the channel domains and a reduction in the nerve 
conduction velocity and amplitude in the PNS (Dupree et al., 1998). Our results, therefore, 
indicate that the defects in the K+ channel distribution in the CGT mutant mice are likely to 
be secondary to the loss of the paranodal junctions rather than a more generalized effect on 
myelin. There are, however, differences between the CGT and NCP1 mutant mice. In 
particular, we did not observe the extensive myelin splitting or vacuolar degeneration in the 
NCP1 mutant mice that has been reported for the CGT mutants (Coetzee et al., 1996). This 
degeneration had been suggested to result from increased permeability resulting from the loss 
of junctional integrity and entrance of fluid into the periaxonal space (Dupree et al., 1998). 
As such degeneration is limited in the NCP1 mutant mice, the vacuolar degeneration may 
instead reflect abnormalities in the glycolipid composition of the CGT mutant mice. In 
addition, the K+ channels in the CGT mutant mice exhibit a more diffuse distribution within 
the internodes rather than the discrete paranodal distribution characteristic of the NCP1
mutant mice (see Figure 6). These latter results suggest that the glial interactions that regulate 
the distribution of K+ channels may be more globally affected in the CGT mutant mice than 
in the NCP1 mutant mice.
The striking homology between these mutants provides further support for a role of 
Gal C and/or sulfatides in the formation of the paranodal region. An interesting possibility is 
53
that these glycolipids are themselves ligands for NCP1. Indeed, NCP1 is diffusely distributed 
throughout the internode in the CGT mutant mice, rather than confined to the paranodal 
region (Dupree et al., 1999). In addition, NCP1 contains a discoidin domain and laminin G 
domains that exhibit structural homology to lectins (Rudenko et al., 1999). Interestingly, 
laminin G domains bind several ligands including sulfatides (Talts et al., 1999). 
Alternatively, defects of these glycolipids may have generalized effects on the myelin sheath, 
including the composition or trafficking of glial junctional components.
5 – Conserved Function of the NCP Family During Evolution
Septate junctions form between the ensheathing glial cells that surround the nerve 
bundles in Drosophila and are essential for establishment of the blood-nerve barrier (Bellen 
et al., 1998). We have previously shown that the Drosophila NRX IV protein localizes to and 
is required for the formation of the ladder-like septae characteristic of these junctions 
(Baumgartner et al., 1996). In nrx IV mutants, these septae were absent, and another 
component of these junctions, Coracle, a band 4.1 homolog, was mislocalized (Baumgartner 
et al. 1996 and Ward et al. 1998). The current studies demonstrate that the septate and 
paranodal junctions appear to serve conserved functions in maintaining the axonal milieu 
required for action potential propagation. However, the topology and localization of the 
proteins is clearly different. In Drosophila, NRX IV is expressed by and localized between 
glial cells. In mice and other vertebrates, NCP1 is expressed by neurons and localized 
between the axon and glial cells. Hence, even though there is functional conservation, 
significant changes in expression occurred during evolution.
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In summary, we have demonstrated that NCP1 has a key role in the formation of the 
paranodal junctions and, thereby, in the delineation of the axonal domains of myelinated 
axons. Future studies focused on the identification of other components of these junctions, 
including the glial ligands for NCP1 and the cytoskeletal protein(s) with which it interacts, 
should clarify how these junctions assemble and the mechanisms by which they promote 
separation of distinct populations of voltage-gated ion channels.
EXPERIMENTAL PROCEDURES
1 – Antibodies
Sequences corresponding to the cytoplasmic region of NCP1 were cloned into an 
expression vector, pET-28a(+) (Novagen). The recombinant protein was expressed in E. coli
BL21(DE3), resolved by SDS-PAGE, and used to immunize guinea pigs as described in Bhat 
et al. (1996). Other antibodies used included rabbit polyclonal antibodies to contactin-Fc 
(Rios et al., 2000), to human contactin/F3 (J. Hemperly, Becton Dickinson), to neurofascin 
(P. Brophy, University of Edinburgh, Scotland), to PLP (D. Colman, Mount Sinai, New 
York), a chicken antibody to ankyrinG (S. Lambert, University of Massachusetts Medical
Center), and mouse monoclonal antibodies to the  subunit of the voltage-gated Na+ channel 
(J. Trimmer, SUNY, Stony Brook) and to MBP (SMI 94; Sternberger Monoclonals). The 
secondary antibodies conjugated to rhodamine, fluorescein, or Cy-5 were obtained from 
Jackson Laboratories.
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2 – Preparation of Teased Sciatic Nerve and Optic Nerve Fibers
Sciatic nerves were removed from litter-matched wild-type and mutant mice and 
fixed in phosphate buffer saline (PBS) with 1% or 4% paraformaldehyde for 1.5 hr. The
nerves were then stored in PBS at 4°C until teased. Using fine needles, the individual fibers 
of the sciatic nerve were teased while in ice-cold PBS. Teased sciatic nerve fibers (TSNs) 
were then mounted on glass slides and dried overnight at RT followed by treatment with 
acetone at −20°C for 20 min. The slides were washed with PBS several times before 
immunostaining; in some cases, slides were stored at −80°C until processed further. Optic 
nerves were dissected out and fixed in 1% paraformaldehyde in PBS for 1.5 hr. Nerves were 
stored in PBS, cryoprotected with 30% sucrose, and frozen in Tissue-Tek OCT with 
isopentane cooled in liquid nitrogen. The tissue was sectioned at 10 µm on a Leica CM1900 
cryostat with a chamber temperature of −26°C and stage temperature of −28°C.
3 – Immunofluorescence and Western Blot Analysis
Fixed tissue samples (TSNs and optic nerve sections) were permeabilized with 
acetone at −20°C, washed with dPBS, and blocked for 1 hr at room temperature in a blocking 
solution consisting of dPBS, 5% BSA, 1% normal donkey serum, and 0.2% Triton X-100 
(Sigma Chemical). Primary antibodies diluted in blocking solution were added and left 
overnight in a humidifying chamber at 4°C. After washing several times with dPBS plus 
0.2% Triton X-100, the tissue was incubated with corresponding secondary antibodies at a 
dilution of 1:100 in blocking solution for 1 hr at RT. For labeling with anti-contactin, tissue 
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was incubated with anti-contactin alone overnight and stained with donkey anti-rabbit 
rhodamine, prior to incubation with anti-NCP1 and anti-sodium channel antibodies. The 
tissue was then washed several times with dPBS, washed once with water, and mounted in 
Citifluor (Ted Pella, Redding, CA). The tissue was examined by epifluorescence on a Zeiss 
LSM 510 confocal microscope.
Whole brain or sciatic nerve lysates were prepared in 25 mM Tris-HCl buffer, pH 7.4, 
containing 2% SDS, 95 mM NaCl, 10 mM EDTA, 0.2 mM sodium vanadate, 10 mM sodium 
pyrophosphate, 1 mM PMSF, 10 µg/ml aprotinin, and 20 µM leupeptin, boiled for 5 min, and 
centrifuged for 10 min. The lysates were quantitated and subjected to SDS gel 
electrophoresis, blotted onto nitrocellulose, probed with primary antibodies and developed 
using the SuperSignal chemiluminescent substrate (Pierce).
4 – Electron Microscopy
Wild-type and mutant littermates (P20) were anesthetized with pentobarbital and 
perfused through the heart with either 3% glutaraldehyde/2% paraformaldehyde in 0.1 M 
cacodylate buffer, pH 7.3 (fixative 1), or 4% paraformaldehyde/2.5% glutaraldehyde in 0.1 
M phosphate buffer, pH 7.4 (fixative 2). Samples of cerebellum prepared with fixative 1 
were rinsed and postfixed in osmic acid/ferricyanide in 0.1 M cacodylate buffer. They were 
rinsed, dehydrated in an ascending series of methanol solutions, and embedded in Araldite. 
One micron sections were stained with toluidine blue for light microscopy, and 0.1 µm 
sections were stained with potassium permanganate followed by uranyl acetate for 
ultrastructural examination. The Cerebelli prepared with fixative 2 were postfixed in the 
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same solution for an additional 18–24 hr at 4°C. Vibratome sections (40 µm) of the samples 
were processed, embedded in Epon 812, and sectioned for electron microscopy as previously 
described (Einheber et al., 1997). Thin sections were examined with Philips 300, CM10, or 
CM 12 electron microscopes at 60 kV. 
5 – Phenotypic Analysis of Mice
Weights were obtained daily up to P30, with data collected from 19 homozygous 
males, 44 heterozygous males, 24 wild-type males, 20 homozygous females, 30 heterozygous 
females, and 20 wild-type females; later time points correspond to fewer numbers of animals. 
To measure the motor activity, an open field test was performed at P21, P40, and P100 as 
described (Thullier et al., 1999). Briefly, animals were placed one at a time in standing 
position in the same middle square in a rectangular area 55 cm long by 30 cm wide with 
walls 30 cm high; this testing area was divided into a grid of 66 equally sized squares. Ink 
foot printing and careful observation allowed the number of crossed squares to be recorded 
for each mouse over a 1 min period.
CHAPTER III
Disruption of Axo-glial Junctions in the Cerebellum Causes
Degeneration of Purkinje Neuron Axons
ABSTRACT
Axo-glial junctions (AGJs) play a critical role in the organization and maintenance of 
molecular domains in myelinated axons. Here, we report that a disruption of AGJs in 
Neurexin IV/Caspr/Paranodin (NCP1) and Ceramide galactosyltransferase (CGT) mutant 
mice results in cytoskeletal disorganization which is accompanied by large axonal swellings 
in cerebellar Purkinje neurons. Ultrastructural analysis shows abundant accumulation of 
mitochondria and smooth endoplasmic reticulum (SER) at paranodal regions, indicating
impairment in axonal transport. Biochemical experiments indicate that NCP1 associates with 
key cytoskeletal proteins, band 4.1B, actin and IIspectrin (fodrin), to establish a molecular 
link between AGJs and axonal cytoskeleton that is indispensable for the organization and 
function of the paranodal domain. Our findings indicate that AGJ disruption leads to axonal 
cytoskeletal disorganization and axonal degeneration resulting in severe motor deficits 
raising the possibility that some forms of human ataxia may be linked to components of the 
AGJs.
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INTRODUCTION
The anatomical organization of myelinated fibers into distinct domains is the basis for 
the saltatory mode of action potential propagation. These molecular domains-- internode, 
juxtaparanode, paranode, and node of Ranvier-- form as a result of yet unknown signaling 
mechanisms between the myelinating glial cells and neurons. In the paranodal region closely 
apposed axon-glial membranes form specialized cell junctions which resemble the ladder-
like invertebrate septate junctions, and are referred to as paranodal septate junctions or 
paranodal axo-glial junctions (AGJs) (Bhat, 2003a; Pedraza et al., 2001; Popko, 2003; Salzer, 
2003) The formation, maintenance and distribution of the paranodal AGJs involves a number 
of proteins such as UDP-galactose:ceramide galactosyltransferase (CGT), proteolipid protein 
(PLP), 2’, 3’-cyclic nucleotide phosphodiesterase, myelin basic protein, and myelin 
associated glycoprotein (MAG). (Coetzee et al., 1996; Honke et al., 2002; Klugmann et al., 
1997; Lappe-Siefke et al., 2003; Rosenbluth, 1981; Trapp et al., 1989). Recently, three major 
proteins have been identified that localize to the paranodal AGJs: NCP1 and a GPI-anchored 
neural cell adhesion molecule, Contactin (CN) on the axonal side and Neurofascin 155 kDa 
isoform (NF155) on the glial side (Bhat et al., 2001; Boyle et al., 2001; Charles et al., 2002; 
Menegoz et al., 1997). NCP1 and CN are the only known axonal proteins that participate in 
the formation and/or organization of the paranodal AGJs. Mutations in NCP1 and CONT 
result in the loss of paranodal AGJs and a failure to segregate Na+ and K+ channels at the 
nodes and juxtaparanodes respectively (Bhat et al., 2001; Boyle et al., 2001). Similar 
phenotypes were observed at the paranodal regions in CGT mutants (Dupree et al., 1999). 
CGT encodes an enzyme that is essential for the production of galactocerebroside and 
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sulfatide (Coetzee et al., 1996; Dupree et al., 1999). The mechanisms that underlie the 
paranodal defects in CGT mutant mice are not well understood (Dupree and Popko, 1999). 
Biochemical studies established that NCP1 associates in cis with CONT (Peles et al., 1997). 
CN on the other hand is required for proper surface expression of NCP1 (Faivre-Sarrailh et 
al., 2000) and both proteins form a high molecular weight complex in the paranodal junctions 
(Rios et al., 2000). Recently, the Drosophila homologs of NCP1 and CN have been shown to 
interact and colocalizes at the epithelial and glial septate junctions (Faivre-Sarrailh et al., 
2004). To date NCP1 is the only identified axonal AGJ protein that contains a cytoplasmic 
domain and may therefore participate in signaling and/or mediate interactions with the axonal 
cytoskeleton (Bhat, 2003b), however, definitive evidence to support these assumptions has 
not been presented. Here we report that genetic ablation of NCP1 and CGT in mice results in 
severe ataxia and motor coordination defects. Ultrastructural analysis of the mutant Purkinje 
neurons showed axons undergoing degeneration and axons with cytoskeletal abnormalities 
and heavy local accumulation of mitochondria, SER and phosphorylated neurofilaments near 
the paranodal regions. Biochemical experiments demonstrate for the first time that NCP1 at 
the AGJs is linked to axonal cytoskeleton via a complex containing an actin- spectrin binding 
protein, band 4.1B, actin and a neuronal spectrin, fodrin or II spectrin. Taken together, our 
studies establish a new parallel between phenotypes caused by deficits in AGJ formation and 
neurodegenerative diseases and provide new insights for studies involving axonal 
degeneration in myelinated neurons.
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RESULTS
1 - Genomic Organization of the NCP1 Gene, Generation of the NCP1- lacZ Knock-in
Mice and NCP1- lacZ Expression
We first determined the genomic structure of the NCP1 gene by comparing the mouse 
cDNA sequence of NCP1 (Genebank Accession #AF039833) with the genomic database 
sequences. This analysis revealed that the NCP1 gene spans a total of ~14 kilobases (kb) and 
is composed of 24 exons. Northern blot analysis revealed that the NCP1 gene does not seem 
to undergo any detectable alternative splicing. Based on the intron-exon structure of the 
NCP1 locus, a targeting construct was designed to insert a lacZ-neo cassette at an appropriate 
restriction site within the NCP1 coding sequence to mimic the expression of NCPI, which 
could be detected by -galactosidase staining. A lacZ-pgk-neo cassette was flanked by a 4.5 
kb EcoRI-SmaI fragment (5'-homology) (Fig. 1A) and a 2 kb SmaI fragment (3'-homology). 
This design placed the lacZ gene in the coding sequence of NCP1 which would result in the 
transcription of lacZ mRNA in a pattern similar to that of NCP1. To generate NCP1- lacZ 
knock in mice, standard procedures were used (Bhat et al., 2001). The linearized targeting 
vector was electroporated into ES cells and clones carrying the targeted allele were injected 
into mouse blastocysts and a chimeric male was obtained that transmitted the targeted allele 
to its progeny. Heterozygous and homozygous mice were confirmed by genomic PCR 
analysis (Fig. 1Ba). Mice homozygous for the NCP1-lacZ allele are born at the expected 
Mendelian frequency from heterozygous intercrosses although they are severely affected. 
These mice display an identical phenotype as that of the NCP1 mutant mice generated 
previously (Bhat et al., 2001). 
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Figure 1. Generation of NCP1-lacZ Knock in Mutants. (A) NCP1 genomic locus and NCP1-lacZ targeting vector. 
A restriction map of ~15 kb genomic DNA containing the entire NCP1 gene. The exons are represented as blue boxes 
and some of the key restriction sites are indicated that were used to generate the NCP1-lacZ targeting vector. The 
lacZ-neo cassette was inserted between a SmaI site with a 4.5kb EcoRI-SmaI as the 5’ homology region and a 2 kb 
SmaI-SmaI as the 3’ homology region. Upon homologous recombination in the ES cells, the NCP1-lacZ targeting 
construct generated the NCP1-lacZ targeted allele. The lacZ transcript is expressed as a fusion transcript with NCP1 
transcript, but is translated independent of NCP1 translation as it contains a vertebrate translation initiation sequence 
(NTR). The numerical numbers 1, 2 and 3, 4 with small arrows indicate the PCR primers used for genotyping the wild 
type and NCP1-lacZ mutant alleles, respectively. (B) Genotyping. (Ba) Genotyping by PCR used two primers (1+2) 
amplifying a 467 bp fragment for the wild type (+/+) allele and two primers (3+4) amplifying a 710 bp fragment for 
the mutant (-/-) allele. The heterozygous (+/-) animals amplify both fragments. (Bb) Northern analysis. Poly A+ 
mRNA was prepared from wild type and NCP1-LacZ mice and processed for Northen blotting. A 3’ cDNA fragment 
was used for hybridization which detected a 6.2 kb transcript in the wild type (+/+) mice. This transcript was not 
detected in the NCP1-lacZ (-/-) mutants indicating disruption of the NCP1 gene. (Bc) NCP1 expression. The wild 
type (+/+) animals showed a predominant protein band migrating at 190 kDa which was not detected from 
homozygous (-/-) animals demonstrating the loss of the NCP1 protein in NCP1-lacZ mice. (C) -Galactosidase 
expression. 30µm sagital sections of the cerebellum from P3 (Ca,b), P10 (Cc,d) and P20 (Ce,f) NCP1-lacZ animals 
were stained in X-gal solution. -Gal activity is seen in the Purkinje neurons through all postnatal developmental 
stages. In addition, the -gal activity is also present in the granular layer neurons. -Gal activity is not seen in the 
molecular layer (Cf) at P20. Wild type animals did not reveal any -gal activity (not shown). (ML, molecular layer; 
PL, Purkinje neuron layer; GL, inner granular layer; WM, white matter).
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The following data indicate that the NCP1-lacZ mutation is a null mutation. First, the 
NCP1 transcript is truncated as the coding sequence at exon 17 is disrupted. This was 
confirmed by Northern analysis using a cDNA probe that is downstream of the insertion site. 
No NCP1 transcript was detected in the homozygous NCP1-lacZ mice as compared to the 
wild type (Fig. 1Bb). The NCP1 protein was not detected in whole brain and sciatic nerve 
homogenates from homozygous mutant mice by Western blot analysis using two independent 
anti-sera generated to the C-terminal domain of NCP1; the same antisera revealed the 190 
kDa NCP1 proteins in wild type tissue (Fig. 1Bc). The severe motor coordination defects 
displayed by NCP1 mice (Bhat et al., 2001) prompted us to analyze the expression of NCP1-
lacZ in the cerebellum. To assess the expression pattern of the NCP1-lacZ, -galactosidase 
(-Gal) protein activity was localized in situ. The cerebella were dissected from NCP1-lacZ 
mice at P3, P10 and P20. As shown in Fig. 1Ca-c, -Gal activity was seen in Purkinje cell 
layer and inner granular layer throughout postnatal development. -Gal activity was strong in 
the Purkinje neurons and relatively low in the inner granular layer at all stages examined 
(Fig. 1C). Taken together, these data show that we have generated NCP1-lacZ mutant mice 
that lack the NCP1 protein and that -Gal activity in situ can be used to monitor the 
spatiotemporal expression of the NCP1 gene throughout development.
2 - Ataxia and Motor Deficits in AGJ Defective NCP1 and CGT Mutants
Strong ß-Gal activity in the Purkinje cells indicates that NCP1 plays an important role 
in cerebellar function throughout the life span of the animal. This idea is further implied by 
the severe neurological phenotype that is prominent in both the NCP1 and the NCP1-lacZ
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mutant mice. For the current study, NCP1 mutant mice were analyzed and wherever 
necessary, the phenotypes observed were confirmed in NCP1-lacZ mutant mice (data not 
shown). Starting at post-natal day 11 (P11), the mice display hypomotility, movement 
associated tremor, severely impaired control and coordination of movement and a wide based 
gait suggestive of cerebellar defect (Altman and Bayer, 1997; Palay and Chan Palay, 1974). 
As shown in Fig 2A, NCP1 mutant mice lack control and coordination of movement, which 
is demonstrated by frequent falls during normal walking and by an impaired righting 
response. 
Figure. 2. Motor Coordination and Cerebellar Morphology in NCP1 and CGT Mutants. (A) Visual appearance 
of a P20 NCP1 mutant (-/-) and a wild type littermate (+/+). (B) Latencies of wild type (n=11) and NCP1 
mutant (n=7) mice to fall from an accelerating rotarod. NCP1 mutants are unable to balance and walk forward 
on the rotating rod, and fall off quickly (* p<.05, post-hoc test following repeated measures ANOVA). (C) 
Overall cerebellar morphology in the wild type, NCP1 and CGT mutants show no apparent differences. Insets in 
(C) shows magnified views of the cerebellar layers with no obvious defects in neuronal migration. (ML, 
molecular layer; PCL, Purkinje neuron layer; IGL, inner granular layer; WM, white matter).
Additionally, while wild type mice extend their hind limbs and digits in response to 
being suspended by their tail, NCP1 mutants retract their hind feet and clench their digits 
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when similarly suspended. Furthermore, these mutants have an ataxic gait with a shuffling 
footprint pattern, a widened stance, and a lack of fore foot hind foot correspondence (data not 
shown). An accelerating rotarod was used to assess the ability of the surviving 3-month-old 
NCP1 mice to coordinate movement (Fig.2B). Wild type littermate control mice 
demonstrated normal motor coordination and balance, and exhibited significant improvement 
in performance over successive training trials. In contrast, the NCP1 mice were able to 
remain on the accelerating rod for only a few seconds, and their performance did not improve 
across successive training trials. Both cerebellar ataxia and peripheral deficits could 
contribute to these results. Measures of rearing and grip strength were similarly deficient in 
NCP1 versus wild type controls (data not shown).
Although these neurological deficits are consistent with cerebellar dysfunction, the 
precise mechanism that accounts for this phenotype remains unclear. Our previous findings 
have shown that NCP1 mutant mice display disrupted paranodal AGJs in the CNS (Bhat et 
al., 2001). Therefore based on our previous morphological observations combined with our 
current ß-Gal expression data, we postulate that the absence of NCP1, which results in the 
disruption of AGJs, is responsible for cerebellar dysfunction and the impaired motor 
coordination observed in the NCP1 mutants. To test this hypothesis, we carried out a series 
of experiments exploiting the NCP1 mutants that provide convincing evidence that cerebellar 
function is compromised in the absence of NCP1. Additionally, we have also analyzed the 
CGT mutant mice (Coetzee et al., 1996). The CGT null mice were chosen for this analysis 
since they also lack properly formed paranodal AGJs (Dupree et al., 1998). In addition, CGT 
mutants display a similar phenotype as the NCP1 mutants with regard to hypomotility, 
movement associated tremor, severely impaired control and coordination of movement and a 
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wide-based gait. In contrast to the NCP1 mice, the CGT mutants express normal levels of 
NCP1 but the distribution is altered and the genetic deficit in the CGT mice is in the glial cell 
whereas the genetic defect in the NCP1 mutants is in the neuron.
Since previous studies of the NCP1 and CGT mutants have not addressed cerebellar 
morphology, we first performed a detailed structural analysis of the cerebella of these mice. 
Using semi-thick sections (30µm) from P20 mice, we show that cerebellar morphology is not 
dramatically affected in NCP1 and CGT mutants as compared to wild type animals (Fig. 2C). 
The NCP1 and CGT mutants are generally smaller in size than their wild type littermates and 
have a smaller cerebellum. The cerebellar white matter tracts in the NCP1 mutants labeled 
darker with toluidine blue staining compared to the wild type and CGT mice. It is not clear 
whether these differences reflect changes in the lipid composition of the myelinated axons or 
some other aspects of the white matter in the NCP1 mutants. Moreover, the cerebellar layers 
in NCP1 and CGT mutants were indistinguishable from their wild type littermates. These 
data indicate that mutations in NCP1 and CGT do not affect gross cerebellar development 
and morphogenesis.
3 - NCP1 and CGT Mutant Purkinje Neuron Axons Develop Large Swellings
The expression of NCP1 in the cerebellum, the behavioral deficits displayed by NCP1 
and CGT mutant mice, and the lack of appreciable morphological abnormalities in their
cerebella, prompted us to analyze the cerebellar ultrastructure in more detail. A comparison 
of the -gal activity and the NCP1 protein expression showed an identical expression pattern, 
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however, most of the -gal activity (Fig. 1C) remains restricted to the neuronal cell bodies as 
it is not detected along the axons or dendrites (data not shown).
Figure 3 - Purkinje Neuron Axonal Swellings in NCP1 and CGT Mutants. A portion of wild type (A), 
NCP1 mutant (B) and CGT mutant (C) cerebellar white matter co-immunostained against NCP1 at 
paranodes (green, arrowheads) and calbindin (blue, axons). Red arrowheads point to paranodal regions of 
the non-Purkinje neuron axons. As expected, NCP1 is absent in (B). In CGT mutants, NCP1 does not show
normal paranodal localization (arrowheads in C); instead the protein is diffused in the axon (compare with 
A). Cerebellar folia from wild type (D), NCP1 mutant (E) and CGT mutant (F) co-immunostained against 
calbindin (green) and GFAP (blue). The cerebellar folial morphology in all three genotypes is 
indistinguishable, but signs of axonal swellings are clearly visible (arrowheads in E, F). At a higher 
magnification, wild type axons (G) show normal, axons with uniform caliber, whereas NCP1 (H) and CGT 
mutant axons (I) show a beaded appearance with many axonal swellings (arrowheads). Immunostaining 
against the mitochondrial protein cytochrome c (green) shows accumulation of mitochondria in the 
swellings in NCP1 (K, arrowheads) and CG mutants (L, arrowheads). Wild type axons did not show such 
cytochrome c accumulation in the axons (J, arrowhead). Immunostaining against phosphorylated 
neurofilaments (pNF, green) in wild type (M), NCP1 (N) and CGT (O) mutants showed that the axonal
swellings are enriched in pNF (arrowheads in N, O). Wild type axons did not show Pnf accumulation in the 
axons (M, arrowheads). Magnification bars: A-C, 100µm; D-F, 40 µm; G-1, 100µm; J-O, 200µm.
To determine precisely where NCP1 is localized in the cerebellum, wild type (Fig. 
3A), NCP1 (Fig. 3B) and CGT (Fig. 3C) mutant, tissues were immunostained with NCP1 
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antibodies to label paranodal regions and calbindin antibodies to label Purkinje neuron axons. 
The wild type Purkinje axons were NCP1-labeled in paranodal regions in the white matter 
(Fig. 3A green arrowheads). NCP1 also stains paranodal regions of myelinated axons not 
originating from the Purkinje neurons (e.g., mossy or climbing fibers, red arrowheads). The 
NCP1 staining was absent in the NCP1 mice (Fig. 3B). Interestingly, in the Purkinje axons of 
CGT mice, NCP1 immunoreactivity was not localized to the paranodal regions but rather 
diffusely distributed in the axons (Fig. 3C, arrowheads) indicating that paranodal region 
formation was compromised in the CGT mice (Dupree et al., 1999).
To analyze the organization of the Purkinje neuron layer, astrocytic and Bergmann 
glial processes, the cerebella from wild type (Fig. 3D), NCP1 (Fig. 3E) and CGT (Fig. 3F) 
mice were double stained with anti-calbindin (green) and anti-glial fibrillary acidic protein 
(GFAP, blue). Unexpectedly, from P10 onwards increasing numbers of focal axonal 
swellings were detected by calbindin immunoreactivity in both NCP1 and CGT mutants in 
the Purkinje neuron axons. These swellings were observed in the myelinated regions distal to 
the axon initial segment (arrowheads in Fig. 3E, F). Such axonal swellings are not observed 
in the Purkinje axons of wild type littermates (Fig. 3D). At a higher resolution, Purkinje 
axons in NCP1 (Fig. 3H) and CGT (Fig. 3I) mutant mice frequently display several 
consecutive swellings along the axons resembling beads on a string (arrowheads, compare 
with wild type in G). Some of these swellings reached 10-15 times the thickness of a normal 
myelinated axon. These data suggest that the loss of AGJs in both NCP1 and CGT mutants 
results in large swellings in the Purkinje neuron axons.
Disruptions in axonal transport are known to lead to swellings containing aggregates 
of cellular organelles and proteins that are normally transported along the axons, for 
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example, mitochondria and neurofilaments. To determine if mitochondria were accumulating 
in these swellings, we immunostained cerebella from wild type (Fig. 3J), NCP1 (Fig. 3K) and 
CGT (Fig. 3L) mutants with anti-cytochrome c antibodies, a marker for mitochondria. 
Cytochrome c immunoreactivity is enhanced in the swellings in NCP1 and CGT axons when 
compared to wild type axons (Fig. 3J-L, arrowheads). Similar axonal swellings have also 
been reported in PLP mutants, where the accumulation of mitochondria was attributed to 
impairment in fast axonal transport and associated with the accumulation of phosphorylated 
neurofilaments. We therefore determined the distribution of phosphorylated neurofilaments 
in NCP1 and CGT mutant Purkinje axons.
As shown in Fig. 3M-O, (arrowheads), the axonal swellings in NCP1 and CGT 
mutants also accumulate phosphorylated neurofilaments suggesting that axonal transport is 
impaired in NCP1 and CGT mutant axons.
4 - Cytoskeletal Disorganization at the Paranodal Regions in NCP1 and CGT Mutant 
Purkinje Axons
Since our immunocytochemical analysis revealed dramatic alterations in paranodal 
axolemma and in cytoskeletal organization, we decided to further analyze these abnormalities 
at the transmission electron microscopic (TEM) level. Axons from wild type mice display 
transverse septa, which link the paranodal myelin loops with axolemma (Fig. 4A, 
arrowheads). In both the NCP1 and CGT mutant mice, paranodal transverse septa are absent 
(Fig. 4B, C, arrowheads). 
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Figure 4 - Cytoskeletal Abnormalities in Purkinje Neuron Axons in NCP1 and CGT Mutants. (A) Wild type 
myelinated axons show paranodal AGJs with clearly visible transverse septa (arrowheads). (B) In NCP1 
mutants paranodal AGJ formation is abnormal and transverse septa are not formed (arrowheads). (C) In CGT 
mutants AGJs fail to form and no transverse septa are visible (arrowheads). (D) Wild type axons display a 
highly ordered distribution of microtubules (arrows) and neurofilaments (arrowheads) in the paranodal region. 
(E) Paranodal region from NCP1 mutants show axonal cytoskeletal proteins, neurofilaments and microtubules, 
losing their ordered distribution. The neurofilaments are demonstrating early signs of disorganization, which 
results in large axonal swellings. Several vesicles are visible along the microtubules (white arrowheads). (F) 
Another NCP1 mutant axon showing abnormal accumulation of mitochondria (M) in the 
71
paranodal/juxtaparanodal region. (G) Paranodal region of a CGT mutant axon also displays disorganization of 
both microtubules (arrows) and neurofilaments (arrowheads). Magnification bars: A-C = 0.25µm; D-G= 0.5µm.
Surprisingly, the NCP1 and CGT mutant axons also display severely disorganized and 
misoriented microtubules (arrows) and neurofilaments (arrowheads) (Fig. 4E and G), the 
major constituents of the axonal cytoskeleton. This disorganization of the cytoskeleton 
contrasts to that of the wild type axons, which display parallel arrays of microtubules 
(arrows) and neurofilaments (arrowheads) (Fig. 4D). In addition to cytoskeletal 
abnormalities, mitochondria (M) accumulated proximal to the paranodal region (Fig. 4F). 
Taken together, the ultrastructural analyses indicate that AGJ disruption in NCP1 and CGT 
mutant mice results in disorganized cytoskeleton and abnormal organelle accumulation 
specifically in the proximity of the paranodal junctional regions.
5 - Cytoskeletal Disorganization, Organelle Transport Defects and Axonal degeneration 
in NCP1 and CGT Mutants
The combination of abnormal accumulation of mitochondria and phosphorylated 
neurofilaments and the cytoskeletal disorganization in mutant axons suggests that loss of 
NCP1 and CGT leads to impaired axonal transport. This may result in a build up of various 
cellular organelles and axonal swellings. To fully characterize the ultrastructural defects of 
the mutant axons in the paranodal region, we performed further TEM analysis (Fig. 5). In 
NCP1 (Fig. 5B) and CGT (Fig. 5C) mutant mice we find large intra-axonal accumulations of 
cytoskeletal proteins and organelles resulting in dramatically enlarged axon caliber as 
compared between wild type (A) and NCP1 and CGT mutants (B and C, respectively). The 
intra-axonal swellings frequently form within or close to the paranodal region where 
axolemmal-cytoskeletal interactions have been lost (see arrows in A, B, C). 
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Figure 5 - Organelle Accumulation and Axonal Degeneration in NCP1 and CGT Mutants. (A) A sagital section 
of a wild type axon through the paranodal region (arrows) showing normal axonal diameter and cytoskeletal 
organization. (B) An NCP1 mutant axon shows a large swelling at the paranodal region (arrows). Note the 
accumulation of mitochondria (arrowheads) and cytoskeletal disorganization. (C) A CGT mutant axon also 
shows accumulation of mitochondria (arrowheads). Note the axon diameter disparity between wild type and 
mutants. (D-E) In NCP1 mutant axons, the most abundant components of the swellings are mitochondria and 
SER. Accumulation of SER results in membrane lattices which fill most of the swellings (arrowheads). (F) The 
CGT mutant axonal swellings also develop SER membrane lattices as in NCP1 mutants (arrowheads). (G-H)
NCP1 mutant axons in the process of degeneration showing vacuolation (arrowheads). (I) A CGT mutant axon 
in an early stage of degeneration displays electron dense bodies (arrowheads), which are a common feature 
associated with axonal decay and disorganized cytoskeleton. Arrow points to a normal myelinated axon. 
Magnification bars: A-F = 2 µm; G-I = 1µm.
In addition, the most frequent components of the axonal swellings are mitochondria 
(arrowheads in B, C) and smooth endoplasmic reticulum (SER) (NCP1, D, E; CGT, F, 
arrowheads). Accumulating SER is so extreme that it forms a lattice filling most of the 
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mutant axons (Fig. 5D, E, F, arrowheads). The accumulation of SER in cerebellar Purkinje 
cells has been proposed to correspond to a terminal stage of axonal degeneration (Palay and 
Chan-Palay, 1974). As postnatal development continues, the size of the axonal swelling 
increases and axonal degeneration becomes more prominent, as evidenced by vacuolation 
and fragmentation of the axonal cytoskeleton in both NCP1 (Fig. 5G, H, arrowheads) and 
CGT (I, arrowheads). A normal diameter myelinated axon is seen next to a degenerating axon 
in the CGT mutants (I, black arrow). This axonal degeneration is consistent with impaired 
axonal transport resulting from cytoskeletal disorganization and organelle accumulation 
(Griffiths et al., 1998; Rhyu et al., 1999; Rosenfeld and Freidrich, 1983).
6 - A Molecular Link Between Paranodal AGJs and Axonal Cytoskeleton
The paranodal regions flank the nodes of Ranvier in myelinated axons. It is at the 
paranodes that the axolemma and the lateral loops of the myelin sheath maintain their closest 
apposition to establish the paranodal AGJs (Bhat, 2003a; Pedraza et al., 2001; Popko, 2003; 
Salzer, 2003)The cytoskeletal disorganization seen in the NCP1 mutants suggests that NCP1 
might play a critical role in linking paranodal AGJs with the axonal cytoskeletal network. We 
therefore carried out immunoprecipitation experiments using anti-NCP1 antibodies on 
cerebellar lysates obtained from wild type, NCP1 and CGT mutants. Consistent with previous 
studies, these experiments revealed the presence of CONT and a brain specific isoform of 
actin/spectrin binding protein, band 4.1B (Denisenko-Nehrbass et al., 2003). The band 4.1 
proteins bind to erythrocyte glycophorin and filamentous (F) actin/spectrin to link the cortical 
membranes with the cytoskeleton (Workman and Low, 1998). Interestingly, we identified 
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two additional cytoskeletal proteins in our immunoprecipitates: actin and axon specific 
neuronal spectrin, fodrin or II spectrin (240 kDa) (Fig. 6A, +/+ panel) (Hirokawa et al., 
1983; Zagon et al., 1986). The presence of II spectrin in NCP1 immunoprecipitates was 
detected by a fodrin antibody and further confirmed by II spectrin specific antibodies (data 
not shown). Brain specific II spectrin has been reported to localize to myelinated axons in 
the mouse cerebellum (Zagon et al., 1986), however, its precise localization to the paranodal 
regions has not been established (see below). As negative control, none of these proteins 
were immunoprecipitated from NCP1 mutant lysates (Fig. 6A, NCP1-/- panel). Since NCP1 
protein was diffusely distributed in CGT mutant axons, we analyzed the NCP1-
immunoprecipitates from CGT mutants, which revealed the presence of the same proteins as 
in the wild type (Fig. 6A, CGT-/- panel). These data suggest that in the absence of AGJs in 
CGT mutant mice, the axonal proteins still form a biochemical complex, but are not properly 
targeted to paranodal junctions. Thus, the biochemical experiments indicate a molecular link 
between NCP1 at the paranodal AGJs and 4.1B/actin/ II spectrin of axonal cytoskeleton.
To establish whether these proteins are present or enriched at the paranodal junctions, 
we examined the sub-cellular localization of these proteins by immunocytochemistry. As 
shown in Fig. 6B, NCP1 (arrowheads) and CN localize to the paranodes, while 4.1B localizes 
to both paranodes and juxtaparanodes in the wild type cerebellum (Fig. 6B, left column). 
Interestingly, fodrin/ II spectrin, which is expressed throughout the axon, is highly enriched 
at the paranodal junctions, in agreement with our biochemical observations. Immunostaining 
using anti-actin antibodies, which is expressed both by glia and axons, showed a modest 
enrichment around the paranodal area in the wild type axons (Fig. 6B, left column). The 
paranodal localization of these proteins was also analyzed in NCP1 and CGT mice (Fig. 6B, 
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middle and right columns, respectively). All the proteins are diffusely present in the axons 
and are not enriched at the paranodes except for NCP1, which is absent in NCP1 mutants. 
The immunostaining data from CGT mutants raise an interesting possibility that the 
mere presence of NCP1 in the axons is not sufficient to establish or stabilize paranodal AGJs,
rather it is the proper localization of NCP1 at the paranodes that is critical for the normal 
organization of the axonal cytoskeleton in the paranodal region. These results further 
highlight the fact that glial contribution is equally important for the organization of the 
paranodal domains. To demonstrate that NCP1 colocalizes with fodrin/ II spectrin and actin 
at the paranodal junctions, we carried out double immunostaining. As shown in Fig. 6C, E 
(arrowheads), NCP1 and fodrin/ II spectrin colocalize at the paranodes, indicating that 
fodrin/ II spectrin is enriched at the paranodal junctions. Similarly, immunostaining with 
NCP1 and actin antibodies showed some regions of colocalization in the paranodal area (Fig. 
6D, arrowheads), with expression of actin in the axons and the glial cells. 
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Figure 6 - AGJs at the Paranodes are Linked to Axonal Cytoskeleton. (A) NCP1-associated 
protein complex immunoprecipitated with anti-NCP1 antibodies from wild type (+/+), NCP1 
and CGT mutant cerebellar lysates (Lys). (B) Immunostaining of wild type Purkinje axons 
using NCP1, CONT, 4.1B, fodrin and actin antibodies. (C) Co-immunostaining of the wild 
type Purkinje axons with NCP1 (Ca) and fodrin (Cb) antibodies shows that fodrin colocalizes 
with NCP1 at the AGJs (Cc, arrowheads). (D) Co-immunostaining with NCP1 (Da) and actin 
(Db) antibodies shows areas of overlap at the paranodal regions (Dc, arrowheads). (E) Co-
immunostaining of the wild type Purkinje axons with NCP1 (Ea) and II spectrin specific 
antibodies (Eb) shows that II spectrin colocalizes with NCP1 at the paranodes (Ec, 
arrowheads). (F) Analysis of the steady levels of relevant axonal and myelin proteins in wild 
type, NCP1 and CGT mutants. (G) Sucrose density gradient centrifugation of the AGJ-
associated proteins from wild type and NCP1 mutant cerebellar lysates.
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Taken together, the biochemical and immunohistochemical data indicate that 
NCP1/4.1B/actin/ II spectrin form a biochemical complex which localizes to the paranodal 
junctions, and that loss of NCP1 or mistargeting of the NCP1/4.1B/actin/ II spectrin 
complex (e.g., in CGT mutants) results in a similar phenotype. To determine whether the 
altered distribution of paranodal proteins in NCP1 and CGT mutants is associated with 
reduced steady state protein levels, we analyzed the expression of these proteins in P20 wild 
type, NCP1 and CGT mutant cerebella.
 As shown in Fig. 6F, the levels of axonal cytoskeletal proteins 4.1B, fodrin/ II 
spectrin and actin did not show any significant differences among genotypes. Interestingly, 
CONT, which interacts with NCP1 at paranodes, shows a higher apparent molecular weight 
in NCP1 and CGT mutants when compared to wild type. The reason for this apparent size 
shift is presently not clear (Gollan et al., 2003). In contrast, glial proteins NF155 and MAG, 
which localize to the paranodal region on the myelin side, both showed reduced their levels 
in NCP1 and CGT mutants, indicating that disruption of AGJs causes glial components of 
these junctions to be down-regulated or degraded. Most importantly, the short form of MAG 
(S-MAG), a hallmark of myelin maturation, seems to be specifically down regulated in both 
NCP1 and CGT mice (arrowheads). Previous studies in CGT mice have reported altered 
expression of MAG isoforms (Coetzee et al., 1998). These observations raise the possibility 
that disruption of AGJs in NCP1 and CGT mutants leads to changes in the levels of specific 
components of the paranodal junctions perhaps due to alteration in a signal transduction 
involving proper axon-glial interactions (Coetzee et al., 1998; Rios et al., 2003).
We hypothesized that loss of paranodal AGJs in NCP1 mutants might reflect a 
disruption of protein complexes containing NCP1, and that such changes might be reflected 
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in buoyant density in sucrose gradients. As shown in Figure 6G, CONT complexes shift 
towards a higher density when compared to wild type. This shift in buoyant density suggests 
that CONT may be assembled into different protein complexes in NCP1 mutants than in wild 
type. In contrast, band 4.1B and fodrin/ II spectrin did not reveal any significant shift in 
their distribution. It is possible that any changes in the paranodal 4.1B and fodrin/ II 
spectrin complexes have been masked by non-paranodal protein complexes, as these proteins 
are also expressed outside the paranodal region. Glial NF155 and MAG did not reveal any 
significant shift in their distribution, but again showed significantly reduced levels when 
compared to wild type (Fig. 6G). These sedimentation experiments suggest that loss of NCP1 
affects the biochemical nature of the paranodal NCP1-associated protein complexes. Taken 
together, the biochemical experiments indicate that NCP1 links paranodal AGJs to axonal 
cytoskeleton through 4.1B and II spectrin; and that loss (NCP1 mutants) or mislocalization 
(CGT mutants) of NCP1 results in the disruption of AGJs and destabilization of the axonal 
cytoskeleton around the paranodal region. We propose that these events lead to axonal 
transport defects at and around the paranodal regions, causing a massive build up of 
mitochondria, SER and other transport cargo, which ultimately leads to degeneration of 
Purkinje neuron axons and severe motor deficits.
DISCUSSION
In the present study we have characterized two mouse mutants, NCP1 and CGT,
which both display severe ataxia and motor coordination defects. We show that disruption of 
paranodal AGJs leads to cytoskeletal disorganization and degeneration of Purkinje neuron 
axons in the cerebellum. We also provide molecular evidence that AGJs are linked to axonal 
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cytoskeleton. Our data show that AGJs are not only essential for the organization of the 
molecular domains in the myelinated axons (Bhat et al., 2001), but also for the stability of the 
nodal/paranodal axonal cytoskeleton to allow normal axonal transport. Our studies may be 
relevant to understanding the role of various components of AGJs in human demyelinating 
diseases, axonopathies, and ataxia.
1 - NCP1 and CGT Mutant Mice Display Severe Motor Deficits
In the absence of NCP1 and CGT, mice exhibit tremors, paresis, and severe ataxia. 
These neurologic defects reflect the function of NCP1 and CGT in the nervous system and 
resemble neurologic defects displayed by CN mutant mice (Berglund et al., 1999). CN, a 
paranodal junction protein, interacts with NCP1 and is required for the cell surface 
expression of NCP1 (Boyle et al., 2001; Faivre-Sarrailh et al., 2000). CN mutant mice have 
striking defects in cerebellar development and CN is expressed by several types of cerebellar 
neurons and has been proposed to play a role in mediating neurite outgrowth and neuronal 
interactions (Faivre-Sarrailh and Rougon, 1997). In addition, CN mutants also display axonal 
swellings similar to NCP1 and CGT mutants (Berglund et al., 1999). It is thus conceivable 
that these mutations impair a common mechanism in cerebellar function which leads to 
severe ataxia in addition to other neuronal defects. 
Although the overall cerebellar development of NCP1, CGT and CN mutants is not 
severely affected, the ataxia, wide-based gait, and tremor of these mice reflect defects of 
cerebellar function stemming from abnormalities of the paranodal region. CN mutant mice 
are likely to exhibit more widespread defects than NCP1 and CGT mutant mice in view of 
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the extrajunctional expression of this protein at central nodes of Ranvier, and also due to 
defects in the orientation of the granular neuron parallel fibers (Berglund et al., 1999). These 
defects seem specific to CN mutants as we did not observe any parallel fiber orientation 
defects in NCP1 and CGT mutants (data not shown). These observations suggest that CN has 
additional functions which are independent of NCP1 and paranodal AGJs.
2 - Defective AGJs Lead to Cerebellar Dysfunction
The two mouse mutants studied in this work present defective AGJs caused by the 
ablation of either axonal (NCP1) or glial (CGT) proteins. It is generally accepted that 
defective motor coordination is an important sign of cerebellar dysfunction. We show here 
that NCP1 mutants display severe motor impairment in a rotarod test, which has been 
successfully used as indicative of cerebellar lesions in mouse mutants (Pellegrino and 
Altman, 1979). The common phenotype of ataxia and deficits in motor coordination suggest 
that disruption of AGJs lead to impairment of cerebellar functions. Although, at low 
magnification, NCP1 and CGT mutants show cerebellar morphology that is qualitatively 
indistinguishable from wild type littermates, our immunohistochemistry results at higher 
magnification revealed that all these mutants have swellings in Purkinje neuron axons in the 
cerebellum. 
Axonal swellings have been observed in neuropathies induced by neurotoxic 
chemicals (Valentine et al., 1997), genetic ablation or expression of mutated genes in 
transgenic mice (Ferreirinha et al., 2004; Griffiths et al., 1998) and neurodegenerative 
diseases such as amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease, Wallerian 
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degeneration, Alzheimer’s disease and cerebrospinal ataxia (Brownlees et al., 2002; Collard 
et al., 1995; Stokin et al., 2005; Zoghbi and Orr, 2004). In all these situations the 
development of swellings has been proposed to indicate the early signs of axonal transport 
impairments. We found that the swellings in Purkinje axons of NCP1 and CGT mice present 
aggregates of mitochondria, SER and neurofilaments. In cultured neurons, the physical 
constriction of the axonal transport in single axons leads to the development of axonal 
swellings that accumulate disorganized bundles of neurofilaments. 
We detected a strong enrichment of phosphorylated neurofilaments in the axonal 
swellings in our mutants. Besides its significance as an indicator of disrupted axonal 
transport, these data may also be interpreted as defects in the intrinsic properties of the 
cytoskeleton of myelinated axons. The bundling of neurofilaments along myelinated axons 
shows a well defined architecture and, while the bundles of neurofilaments are spaced along 
the internodes, they are highly packed at the nodes of Ranvier. The phosphorylation of 
neurofilaments also modulates the interfilament spacing and it is thought to be part of the 
signaling for the myelin-dependent expansion of axonal caliber at the internodes (reviewed in 
Cleveland, 1996; Salzer, 2003). Although interactions between axon and glia are known to 
strongly regulate the axonal caliber, the mechanisms responsible for this regulation are not 
fully understood. 
Our results raise the possibility that AGJs might participate in glial signaling to 
trigger stabilization and/or reorganization of axonal cytoskeleton at least in Purkinje neurons. 
This idea is strengthened by our TEM data showing that Purkinje axons in NCP1 and CGT 
mutants present disorganized arrays of microtubules and neurofilaments. It is pertinent to 
highlight that the defects on axon-glial interactions of the mutants seems to be limited to the 
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paranodal AGJs and at present there is no evidence for obvious abnormal interactions along 
the internodes.. It has been previously shown that NCP1 and CGT mice also have disrupted 
AGJs in the peripheral nerves (Bhat et al., 2001; Dupree et al., 1999). We did not observe 
axonal swellings in the sciatic nerves of NCP1 and CGT mutant mice. These phenotypic 
differences suggest that there may be inherent differences in the cytoskeletal organization 
and or mechanisms of axonal transport. On the other hand peripheral nerves may take longer 
time to develop axonal swellings or have an inbuilt compensatory mechanism to prevent the 
formation of the axonal swellings. A better understanding of the differences in the molecular 
architecture of the peripheral and central paranodal/nodal regions may be required to resolve 
some of these differences. It would be interesting to analyze the peripheral nerves of much 
older mutants which may provide some clues whether they develop peripheral axon 
swellings.
3 - AGJs Stabilize Axonal Cytoskeleton at Nodal/Paranodal Regions
The molecular interactions between myelinating glial cells and axons are central in 
establishing highly specialized micro domains with specific protein components along the 
length of the axon (Bhat, 2003a; Pedraza et al., 2001; Popko, 2003; Salzer, 2003). 
Perturbations due to mutations in myelin or axonal components result in various types of 
neuropathies often identified as reductions in the speed of the propagation of action 
potentials. In addition, several myelin diseases cause axonal damage, leading to loss of axons 
and an irreversible functional impairment (Bjartmar et al., 2003; de Waegh et al., 1992; 
Martini, 2001). A link has been suggested between axonal degeneration, axonal swellings 
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and the organization of nodes of Ranvier. The ultrastructure of injured axons showed that 
axonal fragmentation occurred more often at the nodal/paranodal regions (Maxwell et al., 
1993). After axonal injury, it was observed that damaged axons showed the presence of 
dilations of the nodes of Ranvier, which were named nodal blebs (Gennarelli et al., 1993). 
Similarly, the axonal swellings or nodal blebs we observed in  NCP1 and CGT mutants are 
characterized by cytoskeleton disorganization and accumulation of amorphous material. 
These different lines of evidence strongly suggest that axonal regions at the node and 
paranode may be more susceptible to cytoskeleton disorganization given the tight 
interactions with the overlaying myelin loops and presence of the AGJs. Thus, NCP1 is 
necessary for the formation of paranodal domain and for the proper organization of the 
cytoskeleton around the nodes of Ranvier. Most importantly, our data on the CGT mutants 
show that not only the absence of NCP1 in the axons but also its mislocalization lead to 
cytoskeletal disorganization and axonal swellings further highlighting the glial contribution 
and precise localization of NCP1 in the organization of the AGJs.
4 - NCP1 Recruits a Cytoskeleton-linked Paranodal Complex
Since NCP1 is the only AGJ protein known to project a cytoplasmic domain through the 
axolemma, it is possible that this protein establishes a link between AGJs and the axonal 
cytoskeleton. Through a series of biochemical and immunohistochemical experiments, we 
demonstrate that NCP1 forms a complex with actin and two actin-binding proteins: 4.1B and 
II spectrin, which are members of families of proteins known to associate with actin and 
transmembrane proteins and to modulate the shape of cytoskeleton-linked membranes. Our 
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data from CGT mutants show that NCP1 retains the ability to recruit this complex despite its 
failure to organize the paranodal region in these animals. Taken together, the results 
presented in this work show that NCP1 recruits a protein complex at the axonal side of the 
paranodes, through which it links the AGJs to the axonal cytoskeleton. We have identified 
the core of this paranodal complex as actin, 4.1B and   II spectrin. It would be interesting to 
determine how and when II spectrin gets enriched at the paranodes and whether similar 
mechanisms are involved in the nodal and paranodal domain organization (Poliak and Peles, 
2003). We also show that NCP1 is able to recruit this complex even though it is unable to 
localize at the paranodes, i.e. in CGT mutants. However, the formation of a mislocalized 
complex does not prevent Purkinje axons from displaying disorganized cytoskeleton, 
developing axonal swellings or from undergoing axonal degeneration.
We have schematized a model (Fig. 7) in which AGJs might be stabilizing the 
cytoskeleton at the paranodal region. As previously proposed, in the wild type, NCP1 
localizes at the paranodes, where its extracellular domain binds to CONT on the axonal side 
and the NCP1/CONT complex binds to NF155 on the glial side (Charles et al., 2002; Gollan 
et al., 2003). In addition, our data show that through the cytoplasmic domain, NCP1 forms a 
complex with 4.1B, actin and II spectrin and we speculate that this complex might be linked 
to microtubules in this region (Fig. 7A). We have previously shown that in the absence of 
NCP1, CONT does not localize to the paranodes, and in this study we show that the complex 
of 4.1B, actin and II spectrin fails to link with the AGJs leading to disorganization of the 
microtubules near the paranodal region (Fig.7B). Furthermore, cortical actin filaments, 
microtubules and neurofilaments are interlinked by members of the plakin cytoskeletal linker 
family, which provides stability for axonal cytoskeleton at and outside the paranodal regions 
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(Garcia et al., 2003; Svitkina et al., 1996; Yang et al., 1996). Future studies aimed at 
determining the molecular mechanisms that link the actin/spectrin-AGJ complex to the 
microtubules and axonal cytoskeleton may provide new insights into how these interactions 
coordinate the organization of the paranodal domain in the myelinated axons. 
Figure 8 - A Schematic Model of the Paranodal AGJs and Axonal Cytoskeleton in 
Wild type and NCP1 Mutants. (A) At the wild type paranodes, axonal NCP1/CONT 
interacts in trans with glial NF155 to establish AGJs. NCP1 links to the axonal 
cytoskeletal network through band 4.1B, actin and fodrin/ II spectrin, which in turn 
are linked to microtubules and neurofilaments. These molecular interactions stabilize 
paranodal AGJs and the underlying axonal cytoskeleton. (B) In NCP1 mutants, loss 
of NCP1 results in disruption of paranodal AGJs between myelin loops and 
axolemma and mislocalization of NF155. The axonal cytoskeleton fails to link with 
axolemma resulting in cytoskeletal disorganization at and around the paranodal 
region.
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In summary, we provide evidence that AGJs are linked to the axonal cytoskeleton 
through NCP1, which recruits an actin-binding protein complex. The physiological relevance 
of this link is highlighted by the disorganization of the axonal cytoskeleton promoted by the 
absence of NCP1 or mislocalization of NCP1-associated protein complex in NCP1 or CGT 
mutants, respectively. Furthermore, the loss of axons is a common feature in hereditary 
myelin disorders and neuropathies and the mechanisms of pathogenesis of axon loss in these 
disorders are not yet known. The current study raises an interesting possibility that the 
pathogenesis resulting from various myelin disorders may actually be linked to compromised 
AGJs leading to cytoskeletal disorganization, axonal neurodegeneration and severe motor 
deficits.
EXPERIMENTAL PROCEDURES
1 - NCP1-lacZ Targeting Vector and NCP1-lacZ Knock-in Mice
A mouse 129Sv/Ev genomic library in FIX II (Stratagene) was screened and 
overlapping genomic DNA phage clones were isolated to establish a contiguous map of the 
NCP1 locus. Based on the cDNA and genomic sequences in the mouse sequence data base  
exon-intron sequences were established and a targeting construct was designed with a 4.5 kb 
EcoRI-SmaI fragment as the 5’ homology arm and a 2 kb SmaI-SmaI fragment served as a 
3’homolgy arm flanked downstream by thymidine kinase, as a negative selection marker. A 
lacZ-pgk-neo cassette was inserted into exon 17 at SmaI site with lacZ serving as the gene for 
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-galactosidase and pgk-neo for positive selection. The linearized targeting vector was 
electroporated into embryonic stem (ES) cells and standard cell culture and molecular 
biological procedures were used to confirm the targeting event in the NCP1 locus. The 
targeted ES cells were used to obtain NCP1-lacZ homozygous mice using procedures 
described previously (Bhat et al., 2001).
2 - Staining for -Galactosidase Activity
Mice at different postnatal ages were perfused with 4% paraformaldehyde and the 
cerebella were removed and cut into 30µm sections using a Leica Vibratome. Appropriate 
sections were rinsed several times in PBS and stained at 37oC in dark for variable times with 
-Gal staining solution [100 mM K3Fe(CN)6, 5 mM K4Fe(CN)6, 40 mg/ml 5-bromo-4-
chloro-3-indolyl--D-galactopyranoside (X-gal) and 2 mM MgCl2 in PBS]. The sections 
were briefly rinsed in PBS and photographed by a digital camera and processed by Adobe 
Photoshop.
3 - Rotarod Testing
Mice were tested on an accelerating rotarod (Ugo Basile, Comerio VA, Italy) to 
assess motor coordination. First session, animals were given three trials with 45 seconds 
between each trial. Two additional trials were given 48 hours later. Revolutions per minute 
(rpm) were set at an initial value of 3, with progressive increase to a maximum of 30 rpm 
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across 3 minutes (the max. trial length). Measures were taken for latency to fall from the top 
of the rotating barrel.
4 - Antibodies, Immunofluorescence and Western Blot Analysis
The primary antibodies used were anti- NCP1 guinea pig polyclonal antibodies (Bhat 
et  al., 2001), rabbit anti-calbindin (Sigma), rabbit anti-GFAP (Chemicon), mouse  anti-
cytochrome C (M. Deshmukh, University of North Carolina), mouse anti-phosphorylated 
neurofilaments (Sternberger monoclonals), anti-CONT (J. Salzer, NYU, NY; S. Harroch, 
Pasteur Institute, France), anti-4.1B (ProteinExpress, Japan; P. Gascard, Lawrence Berkely 
Lab, CA), rabbit anti-fodrin (R. Cheney, University of North Carolina), rabbit anti- II 
spectrin (S. Goodman, University of Texas, Dallas), mouse anti-actin (Chemicon) mouse 
anti-MAG (Chemicon), NF155 (M. Bhat, unpublished; A. Gow, Wayne State University), 
and mouse anti--tubulin (Chemicon). The secondary antibodies conjugated to rhodamine or 
fluorescein, were obtained from Jackson Laboratories. Immunofluorescence and Western 
blot analyses were carried as previously described (Bhat et al., 2001).
5 - Transmission Electron Microscopy
Wild type, NCP1 and CGT mutant mice were deeply anesthetized and transcardially 
perfused with Millonig’s buffer solution containing 4% paraformaldehyde and 2.5% 
glutaraldehyde (pH 7.3). Following the perfusion, the whole animal was post-fixed for 2 
weeks at 4oC in the same fixation solution. Following an overnight incubation in Millonig’s 
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buffer, cerebellar tissue from each animal was  postfixed for 1 hour in cacodylate buffered 
1% osmium tetroxide. The tissue was then rinsed, dehydrated in increasing concentrations of 
cold ethanol, and infiltrated and embedded in PolyBed (Polysciences). One µm and 90 
nanometer sections were cut and stained with toluidine blue or a combination of uranyl 
acetate and lead citrate, respectively. The one µm thick sections were analyzed with a Nikon 
Eclipse 800 and the thin sections were analyzed using a Zeiss EM 10CA. To produce digital 
images, EM negatives were scanned using a Microtek ScanMaker 5900. EM figures were 
assembled using Adobe Photoshop.
6 - Immunoprecipitation
Cerebella from wild type and mutants were dissected and homogenized in 10ml of ice 
cold buffer containing 50mM Tris-HCl (pH7.6), 3mM MgCl2, 320mM sucrose and protease 
inhibitors using a glass homogenizer. The homogenates were centrifuged at 1000 x g for 15 
minutes at 4oC. The supernatants were centrifuged again at 100, 000 x g for 2 hours at 4oC. 
The membrane pellets were extracted for 30 minutes on ice in buffer containing 50mM Tris-
HCl (pH 7.6), 2% sucrose monolaurate, 0.1% sodium deoxycholate and protease inhibitors. 
The solubilized pellets were centrifuged again at 100, 000 x g for 2 hours at 4oC. The 
supernatants were used for the immunoprecipitation. The Protein A beads (100µl) were pre-
incubated with 8µl of NCP1 antibody for 3 hours and washed three times with phosphate 
buffered saline (PBS). The NCP1-Protein A beads were added to 1.5ml of the solubilized 
membrane fraction and incubated overnight at 4oC. The beads were washed four times with 
50mM Tris-HCl, (pH7.6) for 10 min each. The protein complexes bound to the beads were 
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eluted in 150 µl of 100mM glycine-HCl, pH 2.5. 20 µl of the samples from each genotype 
were separated on  SDSPAGE for immunoblotting with respective antibodies.
7 - Sucrose Density Gradient Centrifugation
Cerebella were dissected and homogenized in 10mM Tris-HCl, pH 7.4 containing 
100mM NaCl, 10mM EDTA, 1mM PMSF, 0.5% Triton X-100 with protease inhibitors 
followed by centrifugation at 100,000 x g for 20 min at 4oC. After protein estimation, 2 
milligram (mg) of total protein from each genotype was layered on a 10-45% continuous 
sucrose gradient followed by centrifugation at 100,000 x g for 20 hours at 4oC. 250µL 
fractions were collected from the top and appropriate amounts were processed for 
immunoblotting as described above.
CHAPTER IV
Genetic Epistasis between NCP1 and CGT: Phenotypic Analysis of NCP1/CGT
Double Mutants
ABSTRACT
Axo-glial junctions are essential for the organization of molecular domains in the 
myelinated fibers. They are dependent on a complex of proteins that are interlinked and act in 
conjunction to organize various molecular domains around the node of Ranvier. Two of these 
proteins, namely NCP1 and CGT are required directly and indirectly for axo-glial junction 
formation. Generation of NCP1 as well as CGT mutant mice has been shown to have 
disrupted axo-glial junctions. Interestingly NCP1 is a protein that is expressed on the axonal 
membrane of axo-glial junctions, whereas CGT is an enzyme expressed on the overlying 
glial cell. For this study we generated NCP1/CGT double mutant mice. Immunohistological 
as well as ultrastructural analysis showed that double mutants lack axo-glial junctions and 
develop swellings in their Purkinje cell axons,  which accumulate organelles, suggesting an 
impairment of axonal transport consistent with the phenotypes observed in both NCP1 and 
CGT mutant mice. Our main goal in this study was to determine if the simultaneous removal
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of these genes enhanced, suppressed or maintained the axonal degeneration phenotype. This 
would give clues to whether the phenotypes observed in single mutants follow a common 
pathway or are distinct events that could potentially utilize independent mechanisms. 
INTRODUCTION
Myelinated axons contain regularly spaced unmyelinated gaps referred as Nodes of 
Ranvier and are critical for the proper function of the central and peripheral nervous system 
(Morell et al., 1994). The structure and function of this very specialized region is highly 
dependent on the interaction between the axon and the overlying Schwann cell or 
oligodendrocytes in the peripheral or central nervous system respectively. In addition 
paranodal junctions are formed adjacent to the node of Ranvier (Einherber et al., 1997).  
Structurally, these interactions establish the spacing of adjacent myelin segments and 
ultimately determine the position and length of the nodal gaps as well as the distribution of 
the underlying channel complexes. 
Several mutations of key proteins have been shown to disrupt axo-glial interactions. 
These interactions are essential for the proper development, establishment and maintenance 
of myelinated fiber domains as well as their conductivities. The bi-directional signal between 
the neuron axons and the overlying glial cell must be under precise regulation for the survival 
of the cell. Proteins affecting axo-glial interactions therefore include proteins arising from the 
axonal membrane as well as proteins from the myelin sheath. Examples of these proteins 
include Contactin (CN), a glycosyl phosphatidylinositol (GPI) anchored protein that interacts 
in cis with NCP1. Mice deficient in CN display disruption of paranodal axo-glial junctions, 
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tremor and ataxia (Boyle, et al., 2001). A second key protein, NCP1 localizes to paranodal
septate junctions (Bhat et al., 2001; Boyle et al. 2001; Peles et al. 1997). Genetic ablation of
NCP1 in mice showed that the mutant mice are viable with ataxia, motor deficits and have a 
dramatic reduction in nerve conduction velocity as was observed in the CGT mutants (Bhat et 
al., 2001). At the ultrastructural level, the mutant paranodes show aberrant organization of
axo-glial interactions, loss of septate junctions and eversion of myelin loops away from the 
axonal surface (Bhat et al., 2001). In addition, the strict separation between Na+ channels at
the node and K+ channels at the juxtaparanode is abolished (Bhat et al., 2001). These studies 
have demonstrated a critical role for NCP1 in the development and maintenance of paranodal 
axo-glial junctions. 
Two of the major components of the myelin sheath are galactocerebroside (GalC) and 
sulfatide (sulfated form of Galc) (Morell et al., 1994). Their role in myelin is still unclear but 
previous studies have suggested that these lipids stabilize membranes. Membranes containing 
Galc or sulfatide are highly ordered and extremely thermostable when compared with 
membranes rich in phospholipids (Koynova and Caffrey, 1995), suggesting that lipids 
contribute to the remarkable stability of myelin and that they may play a role in cell-cell 
interactions (Coetzee et al., 1998).
Ceramide galactosyltransferase (CGT) is a 541 KDa microsomal enzyme that 
catalyzes the transfer of galactose from UDP-galactose to ceramide. These animals are 
unable to synthesize both Galc and their downstream byproduct sulfatide (Bosio et al., 1996; 
Coetzee et al., 1996), but are able to form myelin with an apparently normal ultrastructure. 
The CGT mutant mice exhibit a severe behavioral phenotype characterized by tremoring, 
ataxia and paralysis of their hind legs. Ultrastructural analysis has shown that the behavioral 
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phenotype observed is mainly due to a disruption of axo-glial junctions (Dupree et al., 1998).
How the loss of CGT results in paranodal abnormalities is not clear. The idea that myelin 
galactolipids interact directly with the glial paranodal components, or may be required for 
their proper transport or localization, remains a strong possibility.
NCP1 and CGT mutant mice display severe ataxia and motor coordination defects 
commonly associated with cerebellar dysfunctions. In the current study we generated 
NCP1/CGT double mutant mice and our results clearly showed that these mutant mice lack 
axo-glial junctions, they develop swellings, accumulate organelles and have motor 
coordination problems all consistent with the phenotypes observed in both NCP1 and CGT
mutant mice. Our main goal in this study was to determine if the simultaneous removal of 
these genes enhanced, suppressed or maintained the axonal degeneration phenotype. This 
would give clues to whether the phenotypes observed in single mutants follow a common 
pathway or are distinct events that could potentially utilize independent mechanisms. 
RESULTS
1 - Generation of NCP1/CGT double mutants
In order to determine if the observed phenotypes in NCP1 and CGT mutant mice 
share a common pathway we generated  NCP1/CGT double mutant mice using traditional 
Mendelian crossing strategies. The initial matings were between a heterozygous CGT  with a 
heterozygous NCP1 animal. The result of this cross generates several genotypes from which 
a double heterozygous NCP1/CGT was selected and paired with an animal of opposite sex 
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but same genotype. The mating of two double heterozygous mice (Figure 1) produced a 
progeny with sixteen probable genotypes. Four of these genotypes were double heterozygous 
which were used to maintain the stocks (Figure 1 – yellow squares). The double NCP1/CGT 
homozygous mutants were born at the expected Mendelian frequency of 1:16. This presents a 
potential problem due to the low frequency of double mutants born. In most cases the 
progeny of a double heterozygous cross did not produce any double homozygous mutant 
mice. 
Figure 1 – Punett square to generate the NCP1/CGT double mutant 
mice. Genetic crosses between a male and a female double heterozygous for 
NCP1 and CGT (blue squares). The Mendelian ratio to obtain a double 
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homozygous mutant mouse is 1/16 (red square). Yellow squares denote the 
double heterozygous mice that are used to maintain the stocks. 
These mice display an identical phenotype as that of the NCP1 and CGT mutant mice 
generated previously (Bhat et al., 2001, Dupree et al., 1998) with no obvious behavioral 
difference that would stand out. The NCP1/CGT double mutation was confirmed with PCR 
using four sets of primers from which two were designed to detect the NCP1 null mutation 
(Bhat et al., 2001) and the other two for the CGT null mutation (Popko et al., 1998 – Figure 
2).
Figure 2 – Genotyping by PCR. PCR of NCP1 and CGT mice using two sets of primers against wild 
type sequences to amplify a 578bp and a 500 bp fragment respectively and one set against neo 
sequence to amplify a 530bp and a 300bp fragment respectively. The Heterozygous animals amplify 
both fragments.
2 - NCP1/CGT double Mutants develop axonal swellings in Purkinje neurons 
Immunofluorescence analysis of wild-type, NCP1, CGT and NCP1;CGT double 
mutants using calbindin staining of the Purkinje neurons demonstrated large 
numbers of focal axonal swellings in all three mutant samples at postnatal day 20 (Figure 3 
B-D). These swellings were not observed in the Purkinje axons of wild type littermates 
(Figure 3A). Interestingly, in many cases, Purkinje cell axons  frequently display several
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 consecutive swellings on the axon resembling beads on a string (blue arrowheads), some of 
them reaching 10-15 times the thickness of a normal myelinated axon. These data suggest 
that the loss of AGJs in all three NCP1, CGT and NCP1/CGT double mutants results in the 
development of swellings in the Purkinje neuron axons. 
Figure 3 – NCP1/CGT double mutants develop Purkinje neuron axonal swellings. Immunohistochemical 
staining of wild-type (A), NCP1 mutant (B), CGT mutant (C) and NCP1/CGT double mutant (D) Purkinje cell 
axons using calbindin antibody. White arrowheads denote individual axonal swellings while blue arrowheads 
denote axonal swellings in a tandem.
Previous data has shown that disruption of axonal transport has a direct link in the 
generation of axonal swellings, and that these swellings contain aggregates of cellular 
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organelles and proteins such as mitochondria and neuronal intermediate filaments that are 
usually transported along the axons in normal conditions. One such report was that of the 
PLP mutants in which accumulation of mitochondria and phosphorylated neurofilaments was 
attributed to the impairment of fast and slow axonal transport respectively (Griffiths et al. 
1998). 
To determine if neurofilaments  were accumulating in these swellings, we 
immunostained cerebella from wild type, NCP1, CGT  and NCP1/CGT double mutants with 
anti-phosphorylated medium neurofilament antibody. As shown in Figure 4A-D 
(arrowheads), the axonal swellings in all three mutants accumulate phosphorylated 
neurofilaments, suggesting that axonal transport is impaired in all three NCP1, CGT and 
NCP1/CGT double mutant axons. 
Figure 4 – NCP1/CGT double mutants accumulate phosphorylated neurofilaments in their axonal 
swellings. Immunohistochemical staining of wild-type (A), NCP1 mutant (B), CGT mutant (C) and NCP1/CGT
double mutant (D) Purkinje cell axons using calbindin (red), and phosphorylated medium weight neurofilament 
(pNF). Arrowheads denote overlapping staining between pNF and Calb.
3 - Increased Axonal Degeneration in NCP1/ CGT Double Mutants
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The similarity in the Purkinje neuron axonal phenotypes displayed by NCP1 and CGT 
single mutants suggested that both genes are involved in paranode formation/stabilization. 
Therefore, we wanted to determine if the simultaneous removal of these genes enhanced the 
axonal degeneration phenotype. 
A qualitative assessment of the cerebellar granular cell layer of the NCP1/CGT 
double mutants indicates a dramatic reduction in the total number of axons, and particularly 
of myelinated axons, when compared to wild type littermates (Fig. 5 A, B, arrowheads).
Additionally as shown in Fig. 5C, wild type myelinated axons maintain a myelin sheath with 
normal thickness and morphology, whereas the NCP1/CGT double mutant axons display a 
thin myelin sheath, and in some cases there are completely unmyelinated axons (Figure 5 D-
1,2,3). Presently, we have not determined whether the absence of myelin is the result of 
demyelination or if myelin formation is inhibited in these mice.
As presented in Chapter 3, where NCP1 and CGT mutant mice showed prominent 
axonal swellings, NCP1/CGT double mutant mice also displayed these accumulations. In 
order to investigate the ultrastructure of these swellings we performed transmission electron 
microscopy (TEM) of longitudinal sections of the Purkinje axons. Consistent with previous 
work, our TEM data show that axons from wild type mice display normal axon thickness 
(Figure 6A,C arrows) whereas in the double mutant mice the axonal calibers reached up to 
ten times the normal axonal thickness (Figure 6C,D).
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Figure 5 – Myelination and axonal numbers is affected in NCP1/CGT double mutant mice. Electron 
micrographs of  transverse axons in wild-type (A,C) and NCP1/CGT double mutants (B,D) of cerebellar granule 
cell layer (A-B) and white matter tracts (C-D). Arrowheads denote axons. Arrows in D denote an axon 
undergoing demyelination.
We detected large axonal accumulations of organelles resulting in dramatically 
enlarged axon caliber as compared to wild type. In addition, the most frequent components of 
the axonal swellings are mitochondria and smooth endoplasmic reticulum (SER). The 
accumulation of SER is so extreme that it forms a lattice filling most of the mutant axon (Fig. 
6D, asterisk). As postnatal development continues, the size of the axonal swelling increases 
and axonal degeneration becomes more prominent, as evidenced by vacuolation and 
fragmentation of the axonal cytoskeleton (Figure 6C). Taken together, the ultrastructural 
analyses indicate that AGJ disruption in NCP1/CGT  double mutant mice results in 
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disorganized cytoskeleton and abnormal organelle accumulation and suggests that NCP1 and 
CGT play important roles in the organization of the paranodal AGJs from the axonal and 
glial side, respectively. Additionally the absence of myelin may result from secondary effects 
on oligodendrocyte function or impaired axo-glial signal transduction and signs indicative of 
axonal degeneration including mitochondrial accumulation and prominent vacuolation (Fig. 
6B,D).
Figure 6. Axonal Pathology is Enhanced in NCP1/CGT Double Mutants (A) A P20 wild type axon from the 
granular layer and a swollen axon from the NCP1/CGT double mutant (B), also from the granular cell layer. 
Note the mutant axon has thin myelin (arrow) and prominently displays signs of degeneration including large
vacuoles and electron dense bodies. (C) A wild type myelinated axon (arrow) revealing a normal complement 
of axonal content. Note the caliber of the wild type axon as compared to the unmyelinated, swollen axon in (D), 
which is very common in the NCP1/CGT double mutant mice.  Magnification bars: A-D = 1µm; E, F = 2µm.
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4 - AGJ disruption and cerebellar dysfunction 
We have previously demonstrated that NCP1 mutant mice display disrupted 
paranodal AGJs in the central nervous system (CNS) (Bhat et al., 2001). We therefore asked 
whether disruption of AGJs could be responsible for a cerebellar dysfunction that would lead 
to the impaired motor coordination observed in the NCP1 mutants. To test this hypothesis we 
analyzed NCP1 mice in parallel with CGT and the CGT/NCP1 double mutant mice. CGT 
mice show disruptions of AGJs due to impairment of lipid biosynthesis in myelinating glia 
(Coetzee et al., 1996). One would expect that if cerebellar defects are caused by disruptions 
in AGJs, the phenotype should be reproduced in mutants with disrupted AGJs, regardless of 
whether the causal mutation takes place in the glia (CGT) or neurons (NCP1) or in both 
(NCP1/CGT). In fact, all three mutants display a similar phenotype with regard to 
hypomotility, movement associated tremor, severely impaired control and coordination of 
movement and a wide-based gait (Dupree et al. 1998; Bhat et al., 2001). 
We first tested whether the cerebellar circuitry was disrupted in all mutants. The 
motor impairments and ataxia are readily detected in all three mutants as early as P15, 
suggesting that any circuitry defect responsible for this phenotype must take place before 
P15. The migration of granule cells and subsequent synaptogenesis take place in mouse 
cerebellum during the second week after birth and are complete by P21. We used 
transmission electron microscopy (TEM) to analyze the ultrastructure of the synaptic 
input of parallel fibers to Purkinje dendrites in the molecular layer of NCP1, CGT and 
NCP1/CGT double mutants at P20. The synapses in the molecular layer of the NCP1, CGT
and NCP1/CGT double mutants (Figure 7B-D) presented all the key ultrastructural 
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components of asymmetric synapses observed in the wild type (Figure 7A). For example, the 
presynaptic terminal of parallel fibers contained numerous spherical vesicles, the 
postsynaptic dendritic spines of Purkinje neurons frequently contained SER, and the electron-
dense band (active zone) between the terminal and the dendritic spine is asymmetric, 
consistent with the excitatory nature of the input (Figure 7A-D). 
To further determine whether the mutations affect the synaptic density in the 
molecular layer, we quantified the number of synapses in the molecular layer of these mice 
(Fig. 7E). Our results show that the mutations did not significantly affect the number of 
synapses per µm2 when compared to the wild type. We analyzed the deep cerebellar nuclei of 
cerebellar sections of P20 mutants and found that the Purkinje axons contact their appropriate 
postsynaptic targets in this region. Taken together, these results suggest that disruptions in 
the circuitry of Purkinje neurons in the cerebellum are not the underlying cause of the ataxia 
observed in NCP1 and CGT mutants. 
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Figure 7 - NCP1/CGT double mutants do not display aberrant synaptic density in the molecular layer. 
Analysis of electron micrographs from the molecular layer of wild-type (A), NCP1 (B), CGT (C) and 
NCP1/CGT double mutants (D) at P20 reveals synapses with all the key ultrastructural components (synapses 
are marked in red). (E) Synaptic density is not significantly affected in the molecular layer of NCP1, CGT and
NCP1/CGT double mutant mice when compared to the wild type. Counting of synaptic density was based on 
the counting of 250-300 synapses corresponding to 10 images for each animal and at least 3 mice per genotype. 
Magnification bar: 0.5µm.
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DISCUSSION
In this study we have analyzed three lines of mutant mice, NCP1, CGT, and 
NCP1/CGT. All these mice display severe ataxia and motor coordination defects. We show 
that disruption deletion of both NCP1 and CGT genes leads to accumulation of axonal 
swellings and degeneration of Purkinje neuron axons in the cerebellum, consistent with the 
phenotype observed in NCP1 and CGT mutant mice. We also provide additional evidence 
that deletion of both genes disrupts myelin formation. Our data suggests that deletion of both 
NCP1 and CGT does not suppress or enhance the phenotypes observed in individual NCP1
and CGT mutants. Hence a common pathway that links both the glial cell and the underlying 
axon must exist and be responsible for the maintenance and development of axo-glial 
junctions. 
1 - Two faces of AGJs: glial and neuronal 
The three mouse lines studied in this work present defective AGJs caused by very 
different mutations. CGT mice present genetic defects in glial cells, whereas the genetic 
defect in the NCP1 mutants is in the neurons. The double mutants NCP1/CGT present a 
genetic deficit coming from both ends, the glial as well as the axonal side. NCP1 is a key 
component of AGJs at the axonal side and the disruption of AGJs in NCP1 mutants is due to 
the absence of this protein in the axons. In contrast to the NCP1 mice, the CGT mutants 
express normal levels of NCP1 but the localization at the AGJs is disrupted. CGT does not 
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participate directly in AGJ formation but its activity is necessary for the segregation of lipid 
microdomains necessary for the clustering of NF155, the glial binding partner of the axonal 
paranodal complex (Charles et al., 2002; Schafer et al., 2004). Most importantly, one would 
not expect CGT mutation to affect NCP1 function that is not related to AGJ formation, as the 
absence of CGT is hypothesized to affect the clustering of the NF155-based glial complex 
which is the binding partner for the NCP1/CONT-based axonal complex in AGJs. 
CGT mutant mice have been previously shown to have hypomyelinated as well as 
demyelinated axonal fibers in their spinal cords (Popko et al., 1998). Here we show that the 
NCP1/CGT double mutant mice contain demyelinated as well as hypomyelinated fibers as 
previously shown but are prominent in cerebellar Purkinje cell axons. On the other hand 
NCP1 mutant mice do not show any demyelinating or hypomyelinating defects suggesting 
that the myelination defects observed are due to the lack of the CGT enzyme. Thus 
demyelination or hypomyelination do not share a common pathway with NCP1 mutant mice 
since they are specific to the CGT mutants.
2 - Axonal swellings and axonal degeneration 
Axonal swellings have been described for many years now. One of the earliest studies 
was done on the Quaking mice (Friedrich, 1974).  These mice showed axonal enlargements 
that contained arrayed lattices later to be identified as smooth endoplasmatic reticulum 
(SER), they also had accumulated mitochondria and cell debris.
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Since then many reports on axonal swellings have been published and have shown to 
be linked to neurodegenerative diseases such as amyotrophic lateral sclerosis, Charcot-
Marie-Tooth disease, cerebrospinal ataxia, and others (Brownlees et al., 2002; Collard et al., 
1995; Stokin et al., 2005; Zoghbi and Orr, 2004). In most cases but not all, axonal swellings 
have been linked to be a late sign of axonal transport impairment. It is still not known 
whether the transport motors themselves are a direct cause of the swellings, but we do know 
that a disorganized cytoskeleton does impair transport by disrupting neurofilaments and 
microtubular arrays, which are used as guides for motor proteins to carry their cargo (Garcia-
Fresco et al., under review). These swellings have been shown to contain membranous 
organelles such as mitochondria and SER, which have been proposed to correspond to a 
terminal stage of axonal degeneration (Palay and Chan-Palay, 1974). Asides from 
mitochondria and SER we found that neurofilaments are highly enriched in axonal swellings. 
Neurofilaments are transported by what is known as slow axonal transport. NCP1, CGT, and 
NCP1/CGT double mutant mice have shown to accumulate large quantities of 
phosphorylated neurofilaments in the axonal swellings, which provide further evidence that 
axonal transport is impaired. 
3 - AGJs and relevance to human diseases
Human diseases such as multiple sclerosis (MS) are broadly known to cause axonal 
degeneration and demyelination, but the mechanisms that lead to axonal degeneration 
remains largely unclear. Recently, Wolswijk and Balesar analyzed a number of human brains 
affected by MS and found that NCP1 is diffused along the axons of these samples (Wolswijk 
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and Balesar, 2003). The authors suggest that the aberrant location of NCP1 is an early sign of 
impending myelin loss in MS. Interestingly, this study also reports that NCP1 positive 
regions on some myelinated axons presented increased axonal caliber near the lesion edges 
(Wolswijk and Balesar, 2003). Although MS is a human disease, we show in this work that 
three different mouse models for AGJs disruption present axonal swellings close to the 
putative paranodal region and that the paranodal complex and/or its components are diffused 
in these axons. 
4 - NCP1/CGT a Common Pathway
In the current study we raised the question whether simultaneous removal of NCP1
and CGT genes enhanced, suppressed or maintained the axonal degeneration phenotype so 
that it would give us clues whether the phenotypes observed in their individual mutants 
follow a common pathway or they utilize distinct mechanisms. We have concluded that in all 
a common mechanism is present that leads to the ataxic events, the swellings and the 
disruption of axo-glial junctions. Despite the common phenotypes shared each individual 
gene mutation does have an effect of its own, for instance CGT mutants have been shown to 
have demyelinated as well as hypomyelinated fibers whereas NCP1 mutant mice do not show 
any signs of demyelination (Popko et al., 1998; Bhat et al., 2001). Our NCP1/CGT double 
mutants however show a cerebellar demyelinating phenotype consistent with that of the CGT
mutant mice, suggesting that a common signaling pathway that controls myelination is not 
shared by both proteins.
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EXPERIMENTAL PROCEDURES
1 - Antibodies, Immunofluorescence and Western Blot Analysis
The primary antibodies used were rabbit anti-calbindin (Sigma C-2724) and mouse 
anti phosphorylated neurofilaments (Sternberger monoclonals SMI-31). The secondary 
antibodies conjugated to rhodamine or fluorescein, were obtained from Jackson Laboratories. 
Confocal images we were captured on a Zeiss Axioplan2 microscope with a BioRad 
Radiance 2000 scanning system. 
2 - Transmission Electron Microscopy
Wild type, NCP1, CGT and NCP1/CGT double mutant mice were deeply anesthetized 
and transcardially perfused with Millonig’s buffer solution containing 4% paraformaldehyde 
and 2.5% glutaraldehyde (pH 7.3). Following the perfusion, the whole animal was post-fixed 
for 2 weeks at 4oC in the same fixation solution. Following an overnight incubation in 
Millonig’s buffer, cerebellar tissue from each animal was postfixed for 1 hour in cacodylate 
buffered 1% osmium tetroxide. The tissue was then rinsed, dehydrated in increasing 
concentrations of cold ethanol, and infiltrated and embedded in PolyBed (Polysciences). One 
µm and 90 nanometer sections were cut and stained with toluidine blue or a combination of 
uranyl acetate and lead citrate, respectively. The one µm thick sections were analyzed with a 
Nikon Eclipse 800 and the thin sections were analyzed using a Zeiss EM 10CA. To produce 
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digital images, EM negatives were scanned using a Microtek ScanMaker 5900. EM figures 
were assembled using Adobe Photoshop.
3 - Synapse quantification 
The quantitative analyses used electron micrographs taken from corresponding 
regions in the molecular layer of wild type, CGT, NCP1 and NCP1/CGT mice at P20. We 
analyzed 10 images of each animal and a minimum of 3 mice per genotype (2 mice for the 
double mutants), summing a total of 250-300 synapses per genotype. Synapses between 
parallel fibers and Purkinje dendrites are excitatory and consequently asymmetric. We 
included a qualitative component in our analysis by counting only synapses that 
ultrastructurally qualified as asymmetric and displayed well-defined active zone, with a 
minimum extension of 150 nm. That might lead to sub estimation of the total number of 
synapses in the molecular layer in our quantification but it would detect gross defects in 
ultrastructural morphology of these synapses.
CHAPTER V
Gene Expression Profiling in NCP1 Mutant Cerebellum
ABSTRACT
Identification of mRNAs that have restricted expression patterns in the brain 
represents powerful tools with which to characterize and manipulate the nervous system. 
Here we utilized a strategy with microarray technology based on Affymetrix arrays, to 
identify mRNA transcripts in NCP1 mutant mice that showed fold changes when compared 
to its wild-type counterpart. The gene expression profiles were compared between cerebella 
of 10 day old NCP1 mutant and wild-type mice. Analysis of the total 22,244 genes was 
carried using three distinct methods and a total of 446 genes were found to be expressed 
differentially (up or down regulated). Among all the differentially expressed genes 15 genes 
represented a 50-100% fold increase or decrease in their levels of expression. 8 out of the 15 
genes were consistent in all three methods used for analysis. 
These studies suggest  that NCP1 protein might be required not only for proper axo-
glial junction formation and maintenance but also may directly or indirectly affect normal 
neuronal cell function. 
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INTRODUCTION
In recent years, DNA microarray technology has gained increasing popularity for 
gene expression studies (Greenberg 2001). Using these methods one can detect and quantify 
differential expression of thousands of genes simultaneously under almost identical 
experimental conditions. There are several different advantages of these studies one of them 
being that many molecular pathways can be investigated globally since most if not all the 
genes involved will be present in the analysis. This type of approach has initially been 
demonstrated in cancer research (Soriano et al 2000) and its use is growing in many different 
areas including those related to nervous function and disease (Jin et al. 2001; Raghavenrdra 
et al. 2002; Tang et al. 2002; Lu et al, 2003).
For our studies we used Affymetrix GeneChip microarrays to investigate the 
differential expression of genes in mutant mice lacking NCP1 protein. The model system we 
used was the mouse cerebellum for two main reasons: - NCP1 mutant mice develop 
cerebellar ataxia thus it would be interesting to see what gene products suffer changes in their 
expression levels when compared to controls; this could give us clues to whether lack of 
NCP1 has only an effect in the generation of axo-glial junctions or it can also cause 
secondary effects that affect the overall cerebellar function. 
The mammalian cerebellum is a system that has been used as a model to investigate 
many fundamental neurobiological processes ranging from development to information 
processing (Ito, 1984; Sotelo, 2004). It is a relatively large structure composed of highly 
ordered layers which makes it easy for study. Its development and cytoarchitecture are well
characterized as well as neuronal cell markers so that it makes it easy to identify neuronal 
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cell types (Ziai et al, 2002; Nordquist et al,, 1988; Oberdick et al., 1988). Finally the 
cerebellum, more so than any other brain region, many spontaneous and induced mutations 
have been identified in mice that affect the structure and function of the cerebellum (Sidman 
et al., 1962; Sidman et al, 1970; Quackenbush, 2001; Mullen et al., 1976; Mariani et al., 
1977; Landis et al., 1975). As some of these mutations lead to degeneration of specific 
neuronal populations, it provides an opportunity to identify differences between cell 
populations between normal mice and mice lacking a specific protein. 
The cerebellum possesses eight types of neurons: Purkinje, granule, lugaro, stellate, 
basquet, Golgi, brush and candelabrum cell (Mariani et al., 1977; Mugnaini 1994; Ito 1984). 
By far the most relevant cell in the cerebellum is the Purkinje cell, which provide the sole 
output of the cerebellar cortex and are the pivotal element around which the cerebellar circuit 
is organized (Ito, 1987). The main connections of the Purkinje cells come from parallel fibers 
which are the axonal extensions of granule cells, the most abundant cell in the cerebellum. 
Purkinje neurons also receive extracellular inputs from climbing fibers as well as inhibitory 
imputs from stellate and basket cells. Purkinje cells are considered to be the primary site for 
information processing in the cerebellum and all that information is channeled out to the 
brain via the deep cerebellar nuclei (Ito, 1987). The information conveyed by the cerebellum 
is mainly responsible for motor coordination, motor tone and equilibrium (Ito, 1987). Thus 
any mutations affecting directly or indirectly Purkinje cells frequently result in tremors and 
ataxic behavior (Sidman, et al., 1970; Sidman, 1983).
These behavioral traits are useful then to identify genes that underlie the phenotypes 
observed. Recently we have generated a mutant mouse model in which the NCP1 gene was 
removed (Bhat et al., 2001). The mice expressed a behavioral phenotype characterized by 
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tremors and ataxia by early adulthood. NCP1 is a transmembrane protein and is localized to 
paranodal junctions. It dimerizes with contactin protein and together they form a complex to 
keep the paranodal myelin loops attached to the axonal cytoskeleton. The behavioral deficit 
observed in NCP1 mutant mice affords the opportunity to identify gene products that are 
preferentially or selectively expressed in cerebellar cell populations. 
Here we describe the use of Affymetrix microarray technology, combined with a 
bioinformatics analysis approach to identify new transcripts that are enriched in the 
cerebellum and might be up or down regulated when a wild-type mouse strain is compared to 
a mutant one. 
RESULTS
For the Gene chips arrays we used Affymetrix Mouse Genome 430A 2.0 Arrays 
(Table A). These chips contain over 22,000 probe sets representing transcripts and variants 
from over 14,000 well characterized mouse genes that can be used to explore mechanisms 
behind biological and disease process. The sequences used in the design of these arrays were 
selected from GeneBank and refseq. Oligonucleotide probes complementary to each 
corresponding sequence are synthesized in situ  on the array. There are eleven pairs of 
oligonucleotide probes that are used to measure the level of transcription of each sequence 
represented on the GeneChip array (www.Affymetrix.com).
Table A - GeneChip Mouse Genome 430A 2.0 Array Specifications
Number of probes set >22.000
Feature Size 11µm
Oligonucleotide probe length 25-mer
Probe pair sequences 11
Control sequences included GAPDH, -Actin, Transferrin receptor, Pyruvate carboxylase
Detection sensitivity 1:100.000
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1 - Gene Expression Profiling
Affymetrix has designed new algorithms for monitoring GeneChip expression data. 
These statistical algorithms, were designed to accommodate the typical distribution of data 
found in microarray experiments. The new statistical algorithms employ standard statistical 
techniques and are optimized to accommodate advancements in array and probe selection 
technology. They provide accurate, high-quality analysis for GeneChip array data.
The analysis process begins by obtaining data in the form of flat files that were 
generated by the scanning software used to analyze the Affymetrix chips. Raw data usually 
refers to the gene or spot intensity values in the scanned files. Once the software recognizes 
the raw data, it applies standard normalizations which are appropriate for our expression 
analysis. These normalizations then enable us to distinguish between real (biological) 
variations in gene expression levels and variations due to the measurement process. 
Normalizing also scales the data to allow us to compare relative gene expression levels. 
There are many different ways to normalize the data, and although Affymetrix chips are pre 
normalized they may not meet the standards of our software normalization requirements. One 
most common normalization method is called Per-chip normalization, which control for chip-
wide variations in intensity. These variations may be due to inconsistent washing, 
inconsistent sample preparation, or other microarray imperfection. For our  studies we 
performed per-chip normalizations normalizing to a median or percentile, which allows us to 
divide all of the measurements on each chip by a specified percentile value, which in our 
case was 50%.
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We also normalized our data to a median, which accounts for the difference in 
detection efficiency between spots and it lets us compare relative change in gene expression 
levels. Finally we performed per-gene normalizations, just like per-chip normalization, each 
measurement was divided by the 50.0th percentile of all measurements in that sample. The 
per-gene normalizations were also normalized to a median using the same cutoff values (10) 
as those for per-chip normalizations.
Figure 1 – Scatter plots of Raw and Normalized data of the 22.244 genes obtained after the initial gene spring 
analysis comparing wild-type and mutant gene chips.
Figure 1 show scatter plots of the raw data before normalization and after 
normalization of the 22.244 genes analyzed.  Note the change in distribution of the spots 
after the data has been normalized. All viable spots concentrate in one area according to the 
parameters set by the normalization standards.  The green lines represent fold changes of the 
gene values. The middle green line represents a neutral value, which represents no absolute 
fold change whereas the other two lines represent absolute fold changes above 1.2 or 20%, as 
established in the filtering parameters. 
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For our studies we used three analysis methods that use separate algorithms for the 
selection of significant gene fold-change values: GeneSpring, GC-RMA and GC-RMA-
GEM. GeneSpring utilizes an algorithm known as MAS 5.0. The Signal algorithm 
implemented in MAS 5.0 is very robust against corrupted data and the results remain well-
correlated even when as much as 20% of the data is corrupt. Naturally, additional noise never 
improves the quality of the data, and so does degrade the results, but robustness provides a 
safety net against corrupted data completely destroying the utility of an array. The second 
method, GC-RMA  (Robust Microarray Analysis) depends on the Guanine-Cytosine content 
present on the array probes. This algorithm is usually chosen for its much improved 
performance in reporting low- and high-level expression over the other methods as well as its 
dynamic range for single probe sets. Finally, the third method GC-RMA-GEM utilizes the 
same algorithm as GC-RMA but it has added to it a Global Error Model (GEM), which 
performs chip estimations based on the variation between the chips. Although it is not 
extremely accurate it is a good system for a general estimation.
We used a total of 5 arrays. Two represented the wild-type cerebellum of p10 mice 
whereas the other three were used for p10 NCP1 mutant mice. A total of 22,244 genes were 
analyzed in our chips. All arrays were compared to each other using the three methods 
described above. From the 22,244 genes we obtained a total of 550 genes that were 
significant (Figure 2). We performed two filters for the selection of the genes: 1 – genes had 
to have an expression signal greater than 53 and less than 32,200 in all 5 chips. 2- Genes 
selected from the knock out samples that have normalized data values greater or less than 
those from the wild type samples by a factor of 1.2 fold. That is any gene that is up regulated 
or down regulated 20% from its wild-type control.  
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Figure 2 –  Venn Diagram of the comparison of the three analysis methods used in this study.
From the 550 genes obtained by our filtering methods, 255 genes were from 
GeneSpring, 186 from GC-RMA-GEM and 109 from the GC-RMA algorithm (Figure 2). 
Only 12 genes were consistently up or down regulated in all three methods as shown in the 
figure in red where all three circles overlap. When comparing two methods at the same time, 
GeneSpring did not seem to be consistent with the other two methods. It only had 7 and 4 
gene in common (Figure 2 – yellow and green)  which represented a 2.74 and a 1.56% of 
genes, thus a very low overlap. When comparing the CG-RMA and GC-RMA-GEM 
methods, the overlapping genes represented a total of 63 and 37% respectively. Based on this 
we decided to use the GC-RMA gene list for our selection. 
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2 - NCP1 Mutant Mice Affect Indirectly Other Gene Functions
Table 2 lists the 109 genes obtained with the GC-RMA algorithm after filtering. 109 
genes represent a large number of genes to work with. We decided to filter genes even 
further by only analyzing genes that were 50% up or down regulated. That is their fold 
change value had to be -1.5 < X > 1.5 where X represents fold change. As noted in table 2, 
genes that fell in that category are underlined in yellow. Table 2 also shows one underlined 
gene (ID: 1437180_at) in blue, which represents an unknown gene product normally referred 
to as RIKEN cDNA. A total of 15 genes were selected (table 3) and chosen for a more 
detailed analysis. Note that from those 15 genes 8 of them were present in all 3 analysis 
methods which had an absolute fold change greater than 50% (Figure 1- red ; Table 4). From 
the 15 genes obtained in the GC-RMA algorithm, 14 of them were down regulated and only 
one, UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase was up regulated.
________________________________________________________________________
GENE ID GENE SYMBOL GENE TITLE FOLD CHANGE
1435035_at Rg9mtd2 RNA (guanine-9-) methyltransferase domain containing 2 1.178879310
1424443_at Tm6sf1 Transmembrane 6 superfamily member 1 -1.471095571
1421192_a_at Itsn1 Intersectin 1 (SH3 domain protein 1A) -1.690156600
1456057_x_at 1110006I15Rik RIKEN cDNA 1110006I15 gene -1.171907757
1428751_at Pacrg Park2 co-regulated 1.076680672
1450105_at A disintegrin and metalloprotease domain 10 -1.260975610
1418295_s_at Dgat1 Diacylglycerol O-acyltransferase 1 1.419908467
1430125_s_at Pqlc1 PQ loop repeat containing 1 -1.141201264
1426326_at Zfp91 Mus musculus Balb/c zinc finger protein PZF (Pzf) mRNA, 
complete cds.
-1.396273292
1439441_x_at Lats2 Large tumor suppressor 2 -1.459887006
1427016_at 4932438A13Rik RIKEN cDNA 4932438A13 gene -1.172413793
1439380_x_at Gtl2 BB093563 RIKEN full-length enriched 1.425925926
1415963_at Hnrph2 Heterogeneous nuclear ribonucleoprotein H2 -1.443699732
1438759_x_at AU046270 Mouse sixteen-cell-embryo cDNA Mus musculus -1.256890849
1418629_a_at KH domain containing, RNA binding -1.098018770
1436834_x_at Mdh1 Malate dehydrogenase 1, NAD (soluble) -1.407676349
1437223_s_at Xbp1 X-box binding protein 1 -1.180598555
1421025_at Agpat1 1-acylglycerol-3-phosphate O-acyltransferase 1 1.075365579
1454807_a_at Snx12 Sorting nexin 12 -1.110062893
1423599_a_at Pdcl unnamed protein product; phosducin-like (MGD|MGI:1914716 -1.305429864
1422697_s_at Jumonji, AT rich interactive domain 2 -1.274099884
1416725_at Tcf4 Transcription factor 4 -1.142640364
1437205_at DNA segment, Chr 8, ERATO Doi 325, expressed 1.181923523
1436152_a_at Hbxip Hepatitis B virus x interacting protein -1.361963190
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GENE ID                      GENE SYMBOL              GENE TITLE                                                                                                                  FOLD CHANGE
1457588_at Vlcp Valosin containing protein 1.261388286
1417781_at Lass4 Longevity assurance homolog 4 (S. cerevisiae) 1.356790123
1420950_at  Znrf1 Zinc and ring finger 1 1.218241042
1426795_at Ptprs protein tyrosine phosphatase, receptor type, S 1.253065775
1417963_at Pltp Phospholipid transfer protein -1.310796074
1452359_at AA536743 Expressed sequence AA536743 -1.243272336
1418772_at BC016423 cDNA sequence BC016423 -1.390742734
1448941_at B4galt2 UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, 
polypeptide 2
1.742566510
1449111_a_at Grb2 Growth factor receptor bound protein 2 -1.073921971
1432394_a_at Aatf  apoptosis antagonizing transcription factor -1.422037422
1419814_s_at S100a1 S100 calcium binding protein A1 1.330891331
1416041_at Sgk Serum/glucocorticoid regulated kinase -1.645728643
1438637_x_at Sf3b2 Splicing factor 3b, subunit 2 -1.257328990
1424672_at Dxml1 RIKEN cDNA C630007L23 gene ( Dmx-like 1) -1.456193353
1452207_at -1.207674944
1437180_at 6530403A03Rik RIKEN cDNA 6530403A03 gene 1.623298033
1448704_s_at H47 Histocompatibility 47 -1.253863135
1433574_at Cdc37l1 Cell division cycle 37 homolog (S. cerevisiae)-like 1 1.385650224
1434369_a_at Cryab Crystallin, alpha B -1.399638118
1455824_x_at Itm1 Intergral membrane protein 1 -1.466173362
1426021_a_at Cdc7 Cell division cycle 7 (S. cerevisiae) 1.306432749
1448733_at Bmi1 B lymphoma Mo-MLV insertion region 1 -1.083333333
1460562_at Eftud1 Elongation factor Tu GTP binding domain containing 1 -1.169546436
1424544_at Nrbp2 Nuclear receptor binding protein 2 1.312633833
1425280_at Leng1 Leukocyte receptor cluster (LRC) member 1 -1.065458207
1434342_at S100bp S100 protein, beta polypeptide, neural -1.614798694
1421096_at Trpc1 Transient receptor potential cation channel, subfamily C, 
member 1
-1.074413863
1421252_a_at Mef2a Myocyte enhancer factor 2A -1.200227531
1417101_at Hspa2 Heat shock protein 2 -1.295047418
1452031_at Slc1a3
Solute carrier family 1 (glial high affinity glutamate 
transporter), member 3 -1.541755889
1419114_at 5430428G01Rik RIKEN cDNA 5430428G01 gene -1.104568528
1453030_at Rnf184 Ring finger protein 184 -1.159763314
1426544_a_at Ttc14 Tetratricopeptide repeat domain 14 1.496462264
1449423_at Mast1 Microtubule associated serine/threonine kinase 1 1.091571280
1431464_a_at Pmm2 unnamed protein product; phosphomannomutase 2 -1.462184874
1451004_at Acvr2a Activin receptor IIA 1.134570766
1439432_x_at Morf4l2 Mortality factor 4 like 2 -1.242524917
1451388_a_at Atp11b ATPase, Class VI, type 11B 1.457073761
1416886_at Nuclear DNA binding protein -1.035425101
1448916_at Mafg V-maf musculoaponeurotic fibrosarcoma oncogene family, 
protein G (avian)
1.184210526
1451132_at Pbxip1 Pre-B-cell leukemia transcription factor interacting protein 1 1.068852459
1418271_at Bhlhb5 Basic helix-loop-helix domain containing, class B5 -1.483803553
1434697_at 1110001P04Rik RIKEN cDNA 1110001P04 gene -1.482479784
1451499_at Cadps2 Ca2+-dependent activator protein for secretion 2 -1.083249749
1437526_x_at Hnrpr Heterogeneous nuclear ribonucleoprotein R mRNA, mRNA 
sequence.
-1.342741935
1427482_a_at Car8 Carbonic anhydrase 8 -1.522371365
1416164_at  Fbln5 Fibulin 5 -1.315614618
1419057_at Slc5a1
Solute carrier family 5 (sodium/glucose cotransporter), 
member 1 -1.882562278
1424859_at Homer3 Homer homolog 3 (Drosophila) -1.508792497
1435327_at AW112037 Expressed sequence AW112037 -1.405291005
1417456_at Gnpat Glyceronephosphate O-acyltransferase -1.206709957
1449014_at Lactb Lactamase, beta -1.549479167
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GENE ID                      GENE SYMBOL              GENE TITLE                                                                                                                  FOLD CHANGE
_______________________________________________________________________
TABLE 2 – Gene list obtained using the GC-RMA algorithm. A total of 109 genes were obtained after 
the applying filters in the selection criteria. Yellow denotes genes that have absolute fold changes of 50% 
or above. Blue represent an unknown gene product also above 50% fold change. 
GENE ID GENE 
SYMBOL
GENE TITLE
FOLD CHANGE
1448941_at B4galt2 UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2  1.742566510
1424859_at Homer3 Homer homolog 3 (Drosophila) -1.508792497
1427482_a_at Car8 Carbonic anhydrase 8 -1.522371365
1452031_at Slc1a3 Solute carrier family 1 (glial high affinity glutamate transporter), -1.541755889
1449014_at Lactb Lactamase, beta -1.549479167
1450632_at RasA Ras homolog gene family, member A -1.592517695
1434342_at S100bp S100 protein, beta polypeptide, neural -1.614798694
1426047_a_at Ptprr Protein tyrosine phosphatase, receptor type -1.629200463
1416041_at Sgk Serum/glucocorticoid regulated kinase -1.645728643
1433906_at Abh Aspartate-beta-hydroxylase -1.652654867
1451331_at Ppp1r1b Protein phatase 1, regulatory (inhibitor) subunit 1B -1.666666667
1421192_a_at Itsn1 Intersectin 1 (SH3 domain protein 1A) -1.690156600
1451089_a_at Arcn1 Archain 1 -1.826985854
1419057_at Slc5a1 Solute carrier family 5 (sodium/glucose cotransporter), member 1 -1.882562278
1424114_s_at Lamb1-1 Laminin B1 subunit 1 -1.892307692
TABLE 3 – 15 selected genes from the GC-RMA algorithm organized by fold change values.
1454974_at Ntn1 Netrin 1 -1.174746336
1435228_at BC023829 CDNA sequence BC023829 -1.349336057
1439450_x_at A230046K03Rik RIKEN cDNA A230046K03 gene -1.183718372
1448343_a_at Nbr1 Neighbor of Brca1 gene 1 -1.169133192
1451519_at Rnf2 Ring finger protein 2 -1.288194444
1418135_at Aff1 AF4/FMR2 family, member 1 -1.266279070
1427068_x_at 4933439F18Rik RIKEN cDNA 4933439F18 gene -1.290456432
1416976_at Stam2 Signal transducing adaptor molecule (SH3 domain) -1.289473684
1431765_a_at Rps2 Ribosomal protein S2 1.229143493
1422824_s_at Eps8 Epidermal growth factor receptor pathway substrate 8 -1.393640351
1422044_at Ndst1 N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1 1.347174164
1451684_a_at Bicd1 Bicaudal D homolog 1 (Drosophila) -1.293922652
1416733_at Msk1 Muskelin 1, intracellular mediator containing kelch motifs -1.171974522
1427730_a_at Zfp148 Zinc finger protein 148 -1.280092593
1455214_at Mitf Microphthalmia-associated transcription factor -1.116407982
1425149_a_at Pdcl Phosducin-like -1.408983452
1451089_a_at Arcn1 Archain 1 -1.826985854
1426047_a_at Ptprr Protein tyrosine phosphatase, receptor type, R -1.629200463
1426952_at Arhgap18 Rho GTPase activating protein 18 -1.329809725
1426955_at Col18a1 Procollagen, type XVIII, alpha 1 -1.485714286
1424114_s_at Lamb1-1 Laminin B1 subunit 1 -1.892307692
1434883_at Mtdh Metadherin -1.041439477
1460004_x_at Stx6 Syntaxin 6 -1.270299145
1425497_a_at Prpf4b PRP4 pre-mRNA processing factor 4 homolog B (yeast) 1.107332625
1454796_at D5Ertd40e Expressed sequence AI562086 -1.270132518
1439444_x_at 1110014C03Rik Similar to Histone deacetylase 1 (HD1) -1.124724062
1451331_at Ppp1r1b Protein phosphatase 1, regulatory (inhibitor) subunit 1B -1.666666667
1423408_a_at 2500003M10Rik RIKEN cDNA 2500003M10 gene -1.224561404
1433906_at Abh Aspartate-beta-hydroxylase -1.652654867
1450632_at RasA Ras homolog gene family, member A -1.592517695
1435725_x_at Rpl12 Large tumor suppressor 2 1.259171598
1437719_x_at A230046K03Rik RIKEN cDNA A230046K03 gene -1.247925311
1425296_a_at Rgs3 Regulator of G-protein signaling 3 -1.342792281
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TABLE 4 – 12 overlapping genes using all three algorithms. Yellow denotes the genes that are above the 
absolute 50% fold change which are also part of the 15 genes selected from the GC-RMA algorithm.
We performed a hierarchical cluster heat map to see the relative expression of the 15 
selected genes comparing all five chips (Figure 3). The color intensities shown in the figure 
represent the fold change form each individual genes. The relative change is compared to the 
wild-type samples which are represented in the two left columns. The more red the blocks 
are,  the more relative overexpression they represent. On the other hand,  the other end of the 
spectrum is a green color which represents an under expressed gene. Yellow is the mean 
average between red and green and represents an unchanged value. Although some of the 
samples are represented by yellow when all 5 samples are averaged together the fold change 
was significant enough to pass the filtering parameters.
GENE ID GENE SYMBOL GENE TITLE FOLD CHANGE
1417781_at Lass4 Longevity assurance homolog 4 (S. cerevisiae) 1.3567901
1422697_s_at Jmd2 Jumonji, AT rich interactive domain 2 -1.2740998
1422824_s_at Eps8 Epidermal growth factor receptor pathway substrate 8 -1.3936407
1426955_at Col18a1 Procollagen, type XVIII, alpha 1 -1.4857142
1427482_a_at Car8 Carbonic anhydrase 8 *** -1.5223713
1452031_at Slc1a3 Solute carrier family 1 (glial high affinityg Glutamate transporter), 
member 3  ***
-1.5417558
1450632_at RasA Ras homolog gene family, member A *** -1.5925176
1426047_a_at Ptprr Protein tyrosine phosphatase, receptor type *** -1.6292004
1416041_at Sgk Serum/glucocorticoid regulated kinase  *** -1.6457286
1433906_at Abh Aspartate-beta-hydroxylase *** -1.6526548
1451331_at Ppp1r1b Protein phosphatase 1, regulatory (inhibitor) subunit 1B *** -1.6666666
1421192_a_at Itsn1 Intersectin 1 (SH3 domain protein 1A)  *** -1.6901566
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Figure 3 – Hierarchical clustering heat map of the 15 selected genes by GC-RMA method. The 
color intensities represent the fold change of the genes. The reddish colors represent a higher 
expression. First two columns in A correspond to wild-type samples and other three to NCP1 mutant 
mice. B is an expansion of A.
We then performed a scatter plot of the 15 genes selected with the GC-RMA method 
after a 50% fold change filter. This allows us to have a more exact and quantitative 
measurements. As mentioned above there is only one gene over expressed above 50% 
(figure 4- point 1) whereas the rest are all under expressed 50%. Note that the closer the spots 
are to the green lines the less fold change it represents. Point 15 in the figure represents
laminin B1 gene which is almost 100% fold change.  In this case the scatter plot represents 
the genes that were up or down regulated an absolute value of 1.5 or 50%.
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These results suggest then that lack of NCP1 protein, not only is required for axo-
glial junction formation but might have a secondary effect in many cellular processes as 
demonstrated by the fold change shown by the GeneSpring analysis. 
Figure 4 – Scatter plot of the 15 selected GC-RMA genes.  Points 1 and 15 represent both ends of the 
scale. Point 1 is the only up regulated gene and point 15 is the gene most down regulated. 
DISCUSSION
We describe here a high throughput microarray-based strategy to identify candidate 
transcripts that are affected by the loss of NCP1 proteins. These genes could serve a potential 
role in cerebellar function. The approach used takes advantage of the availability of the 
NCP1 mutant mice, which serves as an excellent model to compare gene expression with 
wild-type samples. This allowed us to identify 15 potential candidate genes that were for the 
most part down regulated. Conceptually the same strategy could be applied to other mutant 
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strains of mutant mice that share a similar phenotype such as CGT or Contactin mutants 
(Dupree et al. 1998; Boyle et al. 2001). Both share the similar behavioral as well as structural 
phenotypes. The contactin mutant has an extended cerebellar phenotype, in which parallel 
fibers from the granule cell layer are inverted and granule cells have defective claws which 
ultimately lead to defective synaptic connectivity. This way Contactin mutant make an ideal 
candidate for gene expression profiling experiments that could help identify new candidate 
genes that affect cerebellar function.  
From the 15 genes identified by the Affymetrix chip analysis, it is evident that more 
than 50% of the proteins are involved directly and/or indirectly in signaling transduction 
pathways. The rest of the proteins are randomly involved in mechanisms of transport 
(glutamate transporter, Na/glucose co transporter), structural cell integrity (Laminin 1) and 
posttranslational modifications (UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase).  All 
of the genes identified here are known, based on available databases with the exception of 
one gene (RIKEN cDNA 6530403A03), which is underlined in blue on table 2. It would be 
noteworthy to identify the gene sequence using today’s available gene banks since it could 
represent a potential new gene candidate whose function might be downstream of the axo-
glial junctions.
We must keep in mind that only one time point (p10) was selected for the gene 
expression profile study. We initially rationalized that analyzing mice at an early stage would 
give us more opportunity to find early development genes that could be regulated by axo-
glial junctions.  On the other hand, by p10 mutant NCP1 mice as well as wild-type mice do 
not show significant differences in their development nor their behavior. Additional studies 
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need to be carried out to address the role of NCP1 and axo-glial junctions in signal 
transduction pathways or posttranslational modifications. 
Despite this fact, we were able to identify two proteins which are interesting and will 
be pursued for further experiments. These proteins are the solute carrier family 1 glutamate 
transporter and most importantly intersectin 1. A brief description of their functions, 
implications and their potential relevance to axo-glial junctions is detailed below. 
1 - Carrier family 1 glutamate transporter
L-Glutamate is a major excitatory neurotransmitter in the mammalian central nervous 
system (CNS) that contribute not only to fast synaptic neurotransmission, but also to complex 
physiological processes like memory, learning, plasticity, and neuronal cell death 
(Dingledine et al., 1999; Ozawa et al., 1998). Glutamate activates ionotropic glutamate 
receptors for fast excitatory neurotransmission and metabotropic receptors for slower 
modulatory affects on transmission (Balcar, 2002).
The solute carrier family 1 (SLC1) is composed of five high affinity glutamate 
transporters each of which exhibits distinct functional properties. Glutamate transporters 
mediate the transport of L-Glu, L-Asp and D-Asp, accompanied by the cotransport of 3 Na+ 
and 1 H+, and the countertransport of 1 K. One of the main functions of glutamate 
transporters is protect neurons against glutamate excitotoxicity in the central nervous system 
(CNS). The regulation and manipulation of their function is a critical issue in the 
pathogenesis and treatment of CNS disorders involving glutamate excitotoxicity. Loss of 
function of the glial glutamate transporter GLT1, a transporter mainly expressed in glial 
127
cells, has been implicated in the pathogenesis of amyotrophic lateral sclerosis (ALS), 
resulting in damage of adjacent motor neurons. 
ALS is a progressive neurological disorder characterized by degeneration of upper 
and lower motor neurons. A decrease in the glutamate transporter activity due to the 
reduction of GLT1 has been reported in patients with ALS (Rothstein et al., 1994, 1995).
This suggests that GLT1 reduction is a direct cause for ALS. Our results are in concordance 
with the results observed in patients with ALS, which is a reduction of glutamate transporter 
expression. Based on our Affymetrix data, this protein is reduced over 50% in the mutants. It 
would then be interesting to see whether NCP1 alone is the major cause for the behavioral 
phenotypes observed or if the lack of glutamate transporters is an indirect cause that 
contributes to the phenotypes of the NCP1 mutant mice. Regardless of the cause, glutamate 
seems to be an interesting candidate for study in our knock-out mice.
2 - Intersectin 1
Intersectin (ITSN) proteins are present predominantly in the nervous system with 
lower expression elsewhere (Guipponi et al., 1998; Okamoto et al., 1999; Sengar et al., 
1999). It is a multifunctional adaptor protein and has been isolated by a number of groups 
based on its ability to bind proline-rich peptides (Yamabhai et al., 1998), to form a complex 
with dynamin (Roos and Kelly, 1998) and SNAP-23/25  (Okamoto et al., 1999). 
The domain structure of ITSN suggests that this protein may act as a scaffolding or 
adaptor protein that regulates various biochemical pathways. It consists of two amino-
terminal Eps15 homology domains (EH), a central coiled-coil domain (CC) and five tandem 
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Src homology 3 domains (SH3). SH3 domains recognize Pro-rich sequences within target 
proteins and are present in a variety of cytoskeletal and signaling proteins such as NCP1 
(Mayer and Eck, 1995, Bhat et al. 2001). It is therefore interesting to test whether NCP1 
protein has a direct link between ITSN1 via it SH3 domain. Our laboratory as well as other 
research groups is interested in identifying an SH3 domain containing protein that could 
potentially bind to NCP1 and participate in a signaling mechanism. ITSN1 seem to be an 
ideal candidate for this task. Our Affymetrix data shows that the mRNA is down regulated 
70%. One plausible explanation for this could arise from the fact that axo-glial junctions may 
regulate the expression of ITSN1. Future experiments to address the how the loss of NCP1 
affects the expression of ITSN1 are needed in order to better understand the role of axo-glial 
junctions. 
We have not validated the expression of the identified genes, it would now be 
necessary to carry out further experiments that use quantitative RT-PCR techniques to 
confirm or validate the results obtained by the GC-RMA microarray analysis. This will then 
provide us clues about the role of NCP1 or axo-glial junctions in signal transduction 
pathways. 
EXPERIMENTAL PROCEDURES
1 - Brain Tissue Collection and RNA Isolation
P10 wild-type and mutant mice were anesthetized deeply and cerebellums were harvested for 
analysis. Total RNA extraction was performed using TRIzol Regent according to the 
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manufacturer’s instructions (Invitrogen, CA). Samples were homogenized in TRIzol Reagent 
for 30 seconds. After mixing with chloroform, samples were centrifuged for 15 minutes at 
12.000xg at 4Cº. For RNA precipitation, isopropanol was added to the aqueous phase. This 
precipitation mix was then centrifuged for 10 minutes at 12.000xg at 4Cº. The RNA pellet 
was washed once with cold 75% ethanol and air dried for 10 minutes. Total RNA was 
resuspended in RNase-free water. One cerebellum yielded about 10-20µg RNA, sufficient for 
1 array. We used a total of 5 cerebellums. 2 wild-type and 3 mutants.
2 - Microarray hybridization and Analysis
Affymetrix CEL. Files were uploaded to GeneSpring software for analysis by the 
GCRMA method. The samples were filtered with control gene values less than 53 in 2 out of 
5 samples based on the cross gene error model (GEM) estimation. A second filter was 
applied using genes with an absolute value of 1.2 or 20% fold change when comparing wild-
types and knock outs. A Welch t-test was then applied and the value for p-value cutoff was 
0.05. A significance analysis of microarray (SAM) was carried following the filters for the 
two-class unpaired case assuming unequal variances with delta = 0.5, q-value = 0.06. All 
genes with the fold change greater or less than 1.5 between the wild type and knockout 
groups in the resulting list by Welch t-test were then selected as well as those by the SAM 
analysis. Global normalization was applied. Relative change in expression between two 
samples is given as a fold change value, negative values representing a decrease in 
expression in the experimental compared to the baseline sample. Candidate genes were 
retained if they showed at least a 1.5 fold difference in expression levels.
CHAPTER 6
CONCLUSIONS
Myelination, a process carried out by Schwann cells and oligodendrocytes in the PNS 
and CNS respectively, is an area which remains of great interest. It is a highly regulated 
process which ensures an efficient and rapid propagation of action potentials. The 
coordinated differentiation of the axon and its myelinating cell requires a bi-directional axo-
glial communication by signaling mechanisms. Signal arising from the axon will then 
regulate the survival, proliferation and the differentiation of Schwann cells. On the other 
hand, reciprocal signals from glial cells will affect the cytoskeleton and are required for the 
axon to survive. As a result the myelinated fibers develop structural features that allow them 
to maximize the conduction potentials. One such feature is the differentiation of myelinated 
fibers into distinct molecular functional domains. Of particular interest are the paranodal 
junctions. In the past few years rapid progress has been made in identifying the molecular 
constituents of these axo-glial junctions but their functions remain to be characterized.
Novel functions of axo-glial junctions in cellular physiology and diseases are 
emerging. On this section, a brief discussion is provided on the evolutionary importance of 
axo-glial junctions, and would like to address the role of paranodal junctions in signaling. 
Finally, I will highlight the role that paranodal junctions play in neuronal axonopathies and 
myelinating diseases.
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1 - Axo-Glial Junctions: from Flies to Humans
To highlight the importance of paranodal axo-glial junctions it is important to 
understand its conservation throughout evolution. Recent advances in the composition of 
axo-glial junctions indicate that insect septate junctions, share several structural and 
functional components with the vertebrate paranodal junctions. This suggests that both 
junctions evolved from a common ancestral precursor, and those invertebrate septate 
junctions were ahead from paranodal junctions in the evolutionary tree (Hortsch and 
Margolis, 2003). 
Two recently published articles provide evidence that the function and its molecular 
composition are evolutionary conserved when compared to paranodal vertebrate junctions 
(Genova and Fehon, 2003; Schulte et al., 2003). In these studies they identify new proteins 
that are required for a functional paracellular barrier in Drosophila. The findings are of great 
importance since it provides a better understanding of the function and structure of septate 
junctions as well as leading to a better understanding of axo-glial interactions in the 
vertebrate system. 
Having junctions is crucial throughout the entire organism. Epithelial cells in 
particular control and maintain distinct extracellular environments. This is mainly achieved 
by the formation of a paracellular diffusion barrier, which is a tight seal formed between 
epithelial cells that regulate solute flow between adjacent cells. This seal provides a barrier to 
help maintain the ionic concentration across the junction and in vertebrates is commonly 
referred to as tight junction. They are found throughout the organism in many tissues 
132
including intestines, kidneys and the bladder (Firth, 2002). The importance of a paracellular 
barrier is demonstrated in diseases that involve the blood brain barrier, in which disruption of 
the barrier is associated with many central nervous system diseases, including Alzheimer’s 
and multiple sclerosis (Huber et al., 2001). 
In vertebrate systems the epithelia form tight junctions to provide a barrier between 
the apical and the basolateral surfaces of the epithelium. Interestingly, invertebrate system 
achieves this function via its septate junctions, which in the Drosophila nervous system are 
located between two perineurial glial cells. Ultrastructurally, septate junctions are 
characterized by regions in the apical-lateral membranes of epithelial cells. These regions 
contain an electron dense material, or septa that appear in large numbers and are arranged 
equidistantly giving the junction a ladder like structure. 
Genetic analysis of Drosophila proteins has identified several components of the 
septate junctions. These proteins include adhesive membrane and intracellular linker 
proteins, similar to those found in vertebrate paranodal junctions, therefore suggesting that 
they are evolutionary related. Apparently, at some evolutionary time-point after the 
separation of chordates from the arthropod lineage, claudin based tight junctions replaced 
septate junctions as the ion seals in vertebrate epithelia and the septate-like junctions became 
more specialized evolving into what is known today as the paranodal axo-glial junction. 
The first two septate junction proteins identified were coracle (COR) and neurexin IV 
(NRX; Baumgartner et al., 1996; Ward et al., 1998). The coracle gene encodes for a 
Drosophila homologue of mammalian protein 4.1B, a cytoskeletal protein that links the 
paranodal junction to the cytoskeleton (chapter 3). NRX  is a protein member of the neurexin 
family and is homologous to the vertebrate NCP1 (figure 1B). NRX binds to COR via its 
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conserved 4.1 binding domain, the same way NCP1 binds to 4.1b in the vertebrate system. In 
embryos mutants for either COR or NRX the membranes of adjacent cells maintain their 
uniform spacing but the septae are lost, and the embryos fail to hatch. Asides from these 
three proteins, septate junctions have yet two other homologous proteins to paranodal 
junctions: Drosophila contactin (DCN) and neuroglian (NRG) which are homologous to CN 
and NF155 respectively (Genova and Fehon, 2003; Faivre-Sarraliah et al., 2004). Just like 
paranodal junctions in which all three proteins, CN - NCP1 and NF155, form a complex in 
septate junctions DCN, NRX and NRG do the same (figure 1A). There is one difference and 
that is that NRG is not exclusively enriched in septate junctions, it is also highly expressed in 
other areas outside of septate junctions, suggesting that asides from being essential to septate 
junctions it might also be required to perform other cellular functions. A fourth cell adhesion 
molecule, fasciclin III (FASIII), has also been found in septate junctions but no homologue 
has been reported in vertebrate paranodal junctions. Although it is expressed there, it is 
unclear how FASIII might interact with other septate junction proteins.
Asides from COR there are other cytoskeletal proteins that are involved in the 
formation of septate junctions. Two of these proteins belong to the PDZ family, namely discs 
large (DLG) and scribble (SCB). Both these proteins are enriched in septate junctions and are 
suggested to be linked to the NRX complex via their PDZ domains. Their structure suggests 
a role as adaptor proteins and perhaps is used to bring together signaling proteins (Tepass et 
al. 2001; Bilder et al. 2000). There are also two more proteins found to interact in septate
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Figure 1 – Comparison between invertebrate and vertebrate axo-glial junctions a conservation 
throughout evolution. Schematic representation of a Drosophila septate junction (A) and a vertebrate 
paranodal junction (B). 
junctions that have been coimmunoprecipitated with NRG, NRX and COR, indicating that 
they are part of a larger multimolecular protein complex. These proteins are two subunits of 
the Na+/K+ ATPase, the  and the  subunit, which in Drosophila it consist of two genes for 
the   (atp and CG17923) and three genes for the  (nrv1, 2 and 3).  Loss of the  or NRV2, 
leads to septate junction disruption (Paul et al., 2003). 
Although both, the vertebrate and the invertebrate system share slight differences in 
their protein composition, the bulk of axo-glial junctions have been conserved. We also can’t 
discard the possibility that these differences are only temporary. It might just be a matter of 
time to find each and every protein that has a role in septate/paranodal junctions. 
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2 - Axo-Glial Junctions throughout the Nervous System
One interesting question that many research groups focus on is: are axo-glial 
junctions consistent throughout the nervous system? The first reaction to this question would 
be yes, in the general scheme of things, axo-glial junctions are highly conserved. They are 
composed by NCP1 and CN which interact in cis and together with NF155, they form a 
trans-paranodal complex. This is true for all paranodal axo-glial junctions so far studied, but 
the question lies deeper, in that: are all paranodal junctions identical? Do CNS and PNS 
paranodal junctions share the same characteristics or there are differences between them? To 
answer these questions we must not look at paranodal junctions as a whole but dissect out 
every player out there that plays a role regulating, maintaining or forming these junctions. 
First I want to briefly mention the proteins that make the bulk of axo-glial junctions 
that thus far have been consistent in every system in the nervous system, whether it is CNS or 
PNS. As mentioned earlier, NCP1 and CN are the main key players located on the axonal 
side at paranodal axo-glial junctions; removal of either of these proteins disrupts axo-glial 
junctions in both CNS and PNS. The third key player is a splice isoform of the neurofascin 
gene: neurofascin 155 (NF155). Until recently there little evidence of NF155’s role in axo-
glial junctions, since most the data presented was based on speculations. Dr. Brophy and his 
team have now generated a neurofascin mutant, in which both splice isoforms namely NF155 
(paranodal) and NF186 (nodal) were knocked out (Sherman et al., 2005). The resulting 
mutant did not form neither paranodal junctions nor nodal complexes.  They also 
transgenically expressed NF155 into the myelinating glia of the knock out mice and they 
were able to rescue the paranodal axo-glial complex (Sherman et al., 2005). This then 
corroborates the previous speculations of NF155 and its role in paranodal junctions, leaving 
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it clear that NF155 is as much needed as is NCP1 and CN proteins for the formation of 
paranodes.  
These three proteins share a common feature, which is they all have an extracellular 
domain in which they interact with each other. This leaves then the intracellular domain to 
interact with remaining proteins. CN is a GPI anchor protein with no intracellular domain, 
thus no partner has been identified at paranodal junctions other than NCP1. Of course one 
may argue that the lipid microdomains or rafts associated with CN and NCP1 are interacting 
biological partners, but that is beyond the scope of this discussion. This leaves NCP1 and 
NF155, both of which contain and intracellular domain, to act as a link between the tripartite 
complex and the internal structures of the cell. Unfortunately, no interacting partner with 
NF155 has been found yet; whereas for NCP1 protein 4.1B has been identified as a paranodal 
cytoskeletal protein that interacts with its intracellular domain in both CNS and PNS. 
Based on the data presented in chapter 3, it is evident now that two new members of 
the paranodal junctions have been identified in sciatic nerve fibers and Purkinje cell axons, 
namely actin and spectrin. Although not every myelinated tract in the nervous system was 
tested to see whether all six members of paranodal junctions are present, one can speculate 
that it would be the case based on the results observed in both CNS and PNS systems. Most 
differences observed in myelinated fibers whether it is paranodal junctions, nodal domains, 
signaling mechanisms or protein trafficking, there are usually slight changes when comparing 
fibers in the PNS or the CNS. Thus when looking at paranodal junctions, having all six 
proteins expressed in both CNS and PNS, makes it easier to make such assumptions, but 
remember: it is not absolute!
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This brings me then to an earlier question: Are paranodal junctions identical? Take 
for instance Nogo A. It was recently shown that it is an oligondendroglial component which 
congregates and interacts with the NCP1/CN complex at paranodal junctions in the CNS and 
not PNS (Nie et al., 2003). Originally Nogo A together with its receptor Nogo-66 was found 
to form a complex with P75 neurotrophin receptor which leads to the activation of Rho (Hunt 
et al., 2003; Yiu and He, 2003). It is clear now that Nogo-A plays differential roles in the 
nervous system. What is the role of Nogo-A? Nie and others not only shown that NCP1 and 
Nogo-A interact with each other but they also interact with Kv potassium channels early in 
paranodal development, before potassium channels are localized to the Juxtaparanodal 
junctions (Nie et al., 2003). This then suggests that Nogo-A might play a role in modulating 
the axo-glial junction architecture and possible potassium channel localization. 
To determine the importance of Nogo-A at paranodal axo-glial junctions it would be 
interesting to use Nogo-A knock-out models to see whether these junctions suffer any 
consequences as it shows when NCP1 is missing. It would also be interesting, and now that 
the models are available, to determine the Nogo-A expression in NCP1, CN and NF155 
mutants. Nogo-A could potentially be a binding partner for NF155 on the glial side as is CN 
with NCP1. 
CD9, a member of the tetraspanin family, has been shown to be at paranodal 
junctions (Ishibashi, et al., 2004). CD9 is concentrated in the paranode as myelination 
proceeds, but CD9 clusters become diffuse, associated with disruption of the paranode, in 
cerebroside sulfotransferase-deficient mice (CST). They also show that ablation of CD9 in 
mutant mice disrupt junctional attachment at the paranode and alter the paranodal 
components NCP1 and NF155. This then suggested that CD9 is a myelin protein important 
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for the formation of paranodal junctions and that plays a role in the formation of compact 
myelin in the PNS. In contrary to Nogo-A where it is expressed in CNS paranodal junctions, 
CD9 is present only in PNS nerve fibers, which then highlights once again the diversity of 
paranodal junctions throughout the nervous system. 
Myelin and lymphocyte protein (MAL) is yet another protein that serves as an 
example to further stress out the fact that paranodal junctions are not one hundred percent 
consistent throughout the nervous system. In this case the protein is not directly involved 
with the paranodal junction machinery; instead it affects paranodal junctions indirectly. MAL 
is a tetraspan raft-associated proteolipid protein that is mainly expressed in oligodendrocytes 
and Schwann cells.
It was recently shown that genetic ablation of the mal  gene resulted in paranodal 
abnormalities similar to those observed in CN, NCP1 and CGT mutants (Schaeren-Wiemers 
et al., 2004).  This suggested that MAL is required for the maintenance of axon-glial 
interactions in the CNS and not PNS, likely by controlling the trafficking and/or sorting of 
NF155 and other membrane components in oligodendrocytes. This could be due to 
compensatory mechanisms of another yet unknown raft-associated proteolipid protein, which 
might replace the functional role of MAL, or known basic structural differences between 
myelinated PNS and CNS nerve fibers (Salzer, 2003). Regardless of the cause MAL is only 
required in the CNS. This example again supports the idea that microenvironments whether it 
is the paranodal junction itself or its surrounding areas can have a differential effect in 
distinct areas of the nervous system in this particular case MAL is a protein expressed in 
CNS (not PNS) glial cells and has a role in the maintenance of axo-glial junctions. 
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As a final example, paranodal junctions not only are distinct in their structural 
components as clearly stated with the Nogo-A protein but there could be also differences in 
their functions throughout the nervous system. Take for example a well studied system that is 
the clustering of voltage gated sodium channels. During development, Nav1.2 first appears in 
the predicted nodes during myelination, and Nav1.6 replaces it in the mature nodes. This 
switch seems to have a physiological relevance to action potential conduction in myelinated 
nerves. Suzuki and others examined the influence of the paranodal junction on switching of 
sodium channel subunits using the sulfatide-deficient mouse (Suzuki et al., 2004). CGT 
mutants displayed disruption of paranodal axo-glial junctions and altered nodal lengths and 
channel distributions. The initial switching of Nav1.2 to Nav1.6 occurred in the mutant optic 
nerves. However, such subtype abnormality was not observed in the sciatic nerve, where
paranodal disruption was observed. Thus, the paranodal junction significantly influences the 
retention of Nav1.6 in the node, which is followed by disorganization of nodal structures. 
However, its importance may differ between the central and peripheral nervous system.
Taken all together all, it is now evident that there are subtle changes caused by critical 
players that have a role in establishing, maintaining and regulating axo-glial paranodal 
junctions. This answers our question regarding the consistency of paranodal axo-glial 
junctions throughout the nervous system. There are differences amongst axo-glial junctions 
that make them variable through out the nervous system. Perhaps one way that myelinated 
fibers cope with this, is through compensatory mechanisms that involve proteins yet to be 
discovered. It is in our major interest to find these members in order to have a better 
understanding of the molecular machinery that underlies axo-glial junctions. 
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3 - Axo-Glial Junctions and Signaling
During myelination, a myelinating cell wraps around an axon to elaborate a myelin 
sheath, therefore allowing the establishment of a rapid, saltatory conduction of action 
potentials along the axon. In PNS, myelination is achieved by Schwann cells whereas 
oligodendrocytes are the myelinating cells in the central nervous system (CNS). There is an 
active zone of communication between the myelinating glia with the underlying axon. This 
tight interaction implies reciprocal signaling between the oligodendrocytes (or the Schwann 
cells) and the axons to be myelinated.
Throughout the myelinated fiber there are distinct domains where axo-glial 
communication is established. These include the internode, the juxtaparanode, the paranode 
and the node of Ranvier. As stated in chapter I there are clear molecular complexes that are 
clustered in these specific regions and are in active communication with the overlying glial 
cell. Take for instance the internodal region. This region has no direct contact with the
overlying glial cell. The space between glia and neuron is much greater than that observed at 
paranodes. Nevertheless, there is a very active communication between both cells, and one of 
these signaling cascades is responsible for the regulation of the axonal caliber of the neuron 
axon. 
This cascade of events involves myelin associated glycoprotein (MAG). It was found 
to be implicated in an “outside-in” signaling cascade that mediates radial growth Garcia et 
al., 2003). During myelination MAG is redistributed to membrane domains juxtaposed to 
axonal regions timing that is consistent with the initial wave of radial growth (Trapp et al., 
1989). P75 was recently identified as a probable receptor for MAG (Wang et al., 2002; 
141
Yamashita et al., 2002) which occurs in association with  neuronal gangliosides GT1b and 
GD1a (Vyas et al., 2002). Activation of the P75 receptor causes three type II MAGE family 
members to be activated which interact with p75: NRAGE, necdin and MAGE-H1 
(Tcherpakov et al. 2002; Salehi et al., 2000). The recruitment of the three proteins together 
with the P75 receptor forms a cytoplasmic surface that recruits signal transduction molecules 
including ERK1/2 which phosphorylates NF-M.
As mentioned in chapter III, neurofilaments are the major cause for establishing 
axonal diameter. Several lines of evidence suggest that neurofilament phosphorylation is 
essential for proper axonal diameter and that phosphorylation is regulated by myelinating 
glial cells (Yin et al., 1998). Loss of functional P75 receptor either through antibody 
inhibition or through gene deletion inhibits the accumulation of MAG and the formation of 
mature myelin internodes, and reduces the number of myelinated axons in adult nerves 
(Cosgaya et al. 2002). Here we depict a clear example of a signaling cascade that regulates a 
myelinating event and is a result of an interaction between the neurons and their ensheathing 
glial cells.  
Keeping this model in mind one can look for similar models throughout the 
myelinated fiber. One such popular candidate, the paranodal junction, has been thought to be 
involved in signaling for almost a decade now. Although such signaling cascades have not 
been established, our group as well as others have been looking for a putative intracellular 
partner of NCP1.
As mentioned earlier (chapters I and V), NCP1 bears an SH3 binding domain on its 
cytoplasmic tail. SH3 domains have long been implicated in binding proteins that participate 
in signaling cascades. One such group of proteins is the Src family proteins (Pawson 1995)
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which include Fyn and Lyn kinases. These two kinases have been shown to interact with 
contactin and have been isolated from lipid rafts (Olive et al., 1995; Umemori et al., 1999). 
They have also been implicated in signaling cascades involving myelin associated 
glycoprotein (MAG) at internodal regions (Garcia et al. 2003). It is therefore not hard to 
place NCP1 as a strong candidate for a signaling cascade complex.
Another interesting way to look at signaling complexes is through microdomains, that 
is domains within domains. We all understand that the paranodal junction is considered a 
domain of a myelinated fiber. But within the paranodal junctions there are microdomains, 
which generally involve lipid rafts, characterized by their high density of glycosphingolipids 
and cholesterol. The preponderance of saturated hydrocarbon chains in cell sphingolipids 
allows for cholesterol to be tightly intercalated giving the lipid raft a more compact 
characteristic as compared to the phospholipids in their surroundings which give the 
membrane a more liquid like property (Brown and London, 1998b). This then gives the lipid 
rafts a unique property that distinguishes them from the rest of the membrane components, 
not only for their lipid/cholesterol contents but also by their protein contents. This then 
generates a microenvironment within the paranodal environ with unique properties so that it 
constitutes its own domain. 
A number of proteins have been reported to be enriched in lipid rafts, most of which 
are modified postranslationally at the Golgi level, where the lipid rafts assemble. These 
modifications which some of them include, glycosylphosphatidylinositol (GPI) anchor, 
palmitolation and acylation are in some cases essential and provides the protein the ability to 
be tightly packed into an ordered lipid environment (Brown and London, 1998a; Arni, et al. 
1998; zhang, et al. 1998; Melkonian, et al. 1999; Moffett, et al. 2000). 
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Lipid Rafts seem to have two main functions. First they seem to act as protein carriers 
to target them to their proper locations and second they play a very important role in signal 
transduction. One way of doing this is by concentrating proteins that participate in signaling 
events in the lipid microenvironment. This allows them to interact with specific proteins 
within the lipid raft and excludes them from proteins and lipids in their surroundings (Brown 
and London, 1998a). 
The importance of rafts for the assembly of signaling platforms during 
oligodendrocytes differentiation has been also demonstrated previously for the interaction of 
integrins with the PDGFa receptor, the activation of fyn kinase by interaction with N-
CAM120 and CN and the segregation of NgR (Baron et al., 2003; Kramer et al., 1999; Vyas 
et al. 2001; Yu et al., 2004),
Except for Nogo-A, and perhaps contactin, paranodal proteins have not been involved 
in signaling cascades. Despite this, they have been implicated in  lipid raft assemblies, 
including NF155, CN, and NCP1 (Maier, et al. 2005; Popko, 2000; Olive, et al. 1995;
Simons, et al. 1997; Schaeren-Wiemers, et al. 2004; Schafer, et al. 2004; Kramer, et al. 
1999). Maier, et al. has recently shown that the association of NF155 to lipid rafts is required 
for its proper partitioning in the formation of paranodal junctions (Maier, et al. 2005). To 
confirm this even further, NF155 is absent from paranodal loops,  and fail to fractionate in 
lipid fractions CGT -/- mice indicating that indeed raft assembly might be essential for 
NF155 to localize properly at paranodal junctions (Menon, et al. 2003; Schafer, et al. 2004). 
It is tempting to speculate that NF155 becomes part of such signaling platforms during 
oligodendrocyte development. Thus, raft association of NF155 may be important for its
interaction with other proteins. On the same line of experiments, NCP1, Contactin (CN), and 
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Ncam 120, were also isolated in low density fractions as well (Kramer, et al. 1997; Schaeren-
Wiemers, et al. 2004). 
Taken together the information presented here, NCP1 protein and perhaps also 
NF155, seem to be two key candidates able to participate either directly or indirectly in 
signaling mechanisms. 
4 – Axo-glial Junctions and Neuropathies
There is increasing evidence suggesting that disturbances of the axonal domain 
organization and function are an important source of neurological disorders (see Poliak and 
Peles, 2003 for review). Disorders can arise from mislocalized channels, improper domain 
formation, defects of the axonal cytoarchitecture or from a miscommunication between the 
axon and the overlaying glial cell (Bhat et al., 2001; Boyle et al., 2001; Boiko et al., 2001; 
Boiko et al., 2003; Tait et al., 2000; Rasband et al., 1999a-b; Rasband et al., 2003; Lambert et 
al., 1997; Ishibashi et al., 2002; Ishibashi et al., 2003; Dupree et al., 1998, Dupree et al., 
1999; Poliak et al., 2001;  Poliak et al., 2003; Rosenbluth et al., 2003; Traka et al., 2002; 
Gollan et al., 2002; Rios et al., 2003; Honke et al., 2003; Mathis et al., 2001; Vabnick and 
Shrager 1998). Although communication between neuron and glial cells is essential, loss of 
myelin does not have an immediate detrimental effect as observed in some demyelinating 
diseases (Mathis et al, 2001; Vabnick and Shrager 1998). Several mutant mice form normal 
myelin during development, as time goes by, axo-glial communication is truncated resulting 
in the death of the axon. Some of these mutants include MAG, PLP, CGT, and NCP1 (Yin et 
al., 1998; Griffiths et al. 1998; Dupree et al., 1998; Garcia-Fresco et al., 2005).
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Amongst the most common axonopathies is multiple sclerosis (MS). It was 
discovered over one hundred years ago (1868) by Dr. Charcot. Although considered an 
autoimmune disease, MS is now beginning to fall into the field of axo-glial neuropathies 
(Arroyo et al., 2002; Mathis et al., 2001; Wolswijk and Balesar 2003). Evidence for this 
came from studies of MS patient’s myelinated fibers. MS axons have aberrant Na+ channel 
isoform switching as seen in NCP1 mutant mice and paranodal markers are lost earlier than 
nodal markers following demyelination (Rios et al., 2003; Kearney et al., 2002; Arroyo et al., 
2002; Mathis et al., 2001; Wolswijk and Balesar 2003). These results suggest that paranodes 
can be a potential target for pathogenic mechanisms that lead to dispersion of the node and 
paranodal markers. 
Another feature of MS nerve fibers is the abnormalities observed in the 
phosphorylation of neurofilaments (Trapp et al., 1998). Neurofilaments, the intermediate 
filaments of axons, are a major component of the axonal cytoskeleton. One of the main 
functions of neurofilaments is to control axonal caliber, which is crucial since the speed of 
conductivity of an impulse down the axon is proportional to the axonal caliber. Tampering 
with the neurofilament network has been shown to cause deficits in axonal transport and 
caliber of myelinated fibers, leading to axonal accumulations (axonal swellings) and 
degeneration (Griffiths et al., 1998; Popko 2003). Axonal swellings have been shown in a 
number of myelin deficient mice such as CGT, CST, CN, Jimpy, and PLP (Jenkins et al., 
2002; Griffiths et al., 1998; Boyle et al., 2001; Dupree et al., 1998; Honke et al., 2002). 
The precise mechanism of how neurofilaments accumulate is not known, one 
possibility arises from the work on NCP1 mutant mice (chapter III) which suggest that a 
disrupted axonal cytoskeleton affects the axonal transport leading to neurofilament 
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accumulation. Interestingly a disruption of axonal neurofilaments is an early pathological 
feature seen in many diseases including amyotropic lateral sclerosis, multiple sclerosis, 
Charcot Marie tooth disease, and Parkinson’s disease. This then suggest that neurofilaments 
are an important requirement of the neuronal cytoskeleton, since they interact with other 
elements in their surroundings that are involved in transport and cytoarchitecture integrity. 
Remyelination is a potential treatment for demyelinating diseases such as MS. This 
process requires new axo-glial interactions to be formed by differentiating oligodendrocytic 
cell (Maier et al., 2005). NF155, a glial paranodal marker, is important for the establishment 
of paranodal junctions. It has been previously shown that NF155 is recruited to paranodal 
junctions via lipid rafts (Schafer et al.. 2004; Maier et al., 2005), which are required for glial 
cell development and hence myelination. This was corroborated in CGT mutant mice where 
action potentials along the axon as well as paranodal junctions are perturbed (Dupree et al., 
1998; Ishibashi et al., 2002). Intriguingly, NF155, which is normally highly enriched in 
paranodal myelin fractions, is completely absent from paranodes of CGT mutant mice, 
indicating that raft assembly might be critical for its accumulation in paranodes (Menon et 
al., 2003).
NF155 could then play a potential role in myelination. Using a mouse model for MS, 
namely the experimental allergic encephalomyelinitis (EAE) mice, Maier and others showed 
that although the expression of NF155 was not altered, it was greatly enhanced in lesion 
sites. The results suggest that the association of NF155 to microdomains in the
oligodendrocyte membrane is required for its participation in intermolecular interactions, 
which are important for myelination and/or myelin integrity.
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This then concludes my four years of work as a graduate student. Hopefully I have 
clearly emphasized the importance of axo-glial interactions and how their integrity is 
dependent on the survival of neuronal cells. These junctions are critical and having 
deficiencies leads to several well known axonal neuropathies. If we look back in the last five 
years, a tremendous effort has been made to advance the field of paranodal/septate junctions. 
I am confident that our knowledge and understanding of the mechanisms involved in axo-
glial junctions will continue to grow and will hopefully will help us develop better methods 
for treating diseases such as MS, CMT or ALS.
148
REFERENCES
Adlkofer K., Martini R., Aguzzi A., Zielasek J., Toyka K., Suter U. 1995. Hypermyelination 
and demyelinating peripheral neuropathy in Pmp22-deficient mice. Nature Genetics. 11: 
274-280.
Alberts B., Bray D., Lewis J., Raff M., Roberts K., and Watson J. (1994). “Molecular 
Biology of the Cell”. Garland Publishing, New York and London.
Altevogt, B., Kleopa, K., Postma, F., Scherer, S., and Paiul, D. (2002). Connexin29 is 
uniquely distributed within myelinated glial cells of the central and peripheral nervous 
systems. J. of Neuroscience. 22: 6458- 6470.
Altman, J., and Bayer, S. A. (1997). Development of the Cerebellar System: in relation to
its evolution, structure and functions (CRC Press, Inc.).
Andres, K, (1965). Über die Feinstruktur besonderer Einrichtungen in markhaltigen 
Nervenfasern des Kleinhirns der Ratte. Z. Zellforsch. Mikrosk. Anat. 65: 701–712. 
Arbuthnott E., Boyd I., and Kalu K. 1980. Ultrastructural dimensions of myelinated 
peripheral nerve fibers in the cat and their relation to conduction velocity. Journal of 
Physiology. 308: 125-157.
Arni, S., Keilbaugh, S., Ostermeyer, A., and Brown, D. (1998). Association of GAP-43 with 
detergent-resistant membranes requires two palmitolated cysteine residues. J. of Biological 
Chemistry. 273: 28478-28495.
Arroyo, E., Xu, Y., Zhou, L., Messing, A., Peles, E., Chiu, S., and Scherer, S. (1999). 
Myelinating Schwann cells determine the internodal localization of Kv1.1, Kv1.2, Kvbeta2, 
and Caspr. J. of Neurocytology. 28: 333- 347.
Arroyo, E., Xu, T., Grinspan, J. Lambert, S. Levinson, S. Brophy, P., Peles, E. and Scherer, 
S. (2002). Genetic dysmyelination alters the molecular architecture of the nodal region. J. of 
Neuroscience. 22: 1726-1737.
Baba, H., Akita, H., Ishibashi, T., Inoue, Y., Nakahira, K., and Ikenaka, K. (1999). 
Completion of myelin compaction, but not the attachment of oligodendroglial processes 
triggers K(+) channel clustering. J. of Neuroscience Research. 58: 752-764.
Balcar V. (2002). Molecular pharmacology of the Na+-dependent transport of acidic amino 
acids in the mammalian central nervous system. Biological Pharmaceutical Bulletin. 25: 
291–301.
Baumgartner, S., Littleton, J., Broadie, K., Bhat, M., Harbecke, R., Lengyel, J., Chiquet-
Ehrismann, R., Prokop, A. and Bellen, H., (1996). A Drosophila neurexin is required for 
septate junction and blood-nerve barrier formation and function. Cell 87: 1059–1068.
149
Bellen, H., Lu, Y., Beckstead, R. and Bhat, M., (1998). Neurexin IV, caspr and paranodin—
novel members of the neurexin family: encounters of axons and glia. Trends Neuroscience.
21: 444–449.
Bennett, V. and Lambert, S., (1999). Physiological roles of axonal ankyrins in survival of 
premyelinated axons and localization of voltage-gated sodium channels. J. Neurocytol. 28:
303–318. 
Berghs, S., Ferracci, F., Maksimove, E., Gleason, S., Butler, M., De Camilli, P., and 
Solimena, M. (2000). BetaIV spectrin, a new spectrin localized at the axon initial segments 
and nodes of Ranvier in the central and peripheral system. J. of Cell Biology. 151: 985-1002.
Berglund, E., Murai, K., Fredette, B., Sekerkova, G., Marturano, B., Weber, L., Mugnaini, E. 
and Ranscht, B., (1999). Ataxia and abnormal cerebellar microorganization in mice with 
ablated contactin gene expression. Neuron 24: 739–750. 
Bergmann, W. and Lindner, E., (1964). Über den Feinbau des Nebennierenmarkes des Igels 
(Erinaceus europaeus L). Z. Zellforsch. Mikrosk. Anat. 64: 868–912. 
Bhat, M., Philp, A., Glover, D. and Bellen, H., (1996). Chromatid segregation at anaphase 
requires the barren product, a novel chromosome-associated protein that interacts with 
topoisomerase II. Cell 87: 1103–1114. 
Bhat, M. A. (2003a). Molecular organization of axo-glial junctions. Current Opinion in 
Neurobiology. 13: 552-559.
Bhat, M. A. (2003b). Myelin Biology and Disorders. In, R. A. Lazzarini, ed. (Elsevier
Academic Press).
Bhat, M., Izaddoost, S., Lu, Y., Cho, K., Choi, K. and Bellen, H., (1999). Discs Lost, a novel 
multi-PDZ domain protein, establishes and maintains epithelial polarity. Cell 96: 833–845.
Bhat, M., Rios, J., Lu, Y., Garcia-Fresco, G., Ching, W., St Martin, M., Li, J., Einheber, S., 
Chesler, M., Rosenbluth, J., Salzer, J., and Bellen, H. (2001). Axon-glia interactions and the 
domain organization of myelinated axons requires neurexin IV/Caspr/Paranodin. Neuron. 30: 
369-383.
Bjartmar, C., Karlsson, B., and Hildebrand, C. (1994). Cellular and extracellular components 
at nodes of Ranvier in rat white matter. Brain Research. 667: 111-114.
Bjartmar, C., Wujek, J., and Trapp, B. (2003). Axonal loss in the pathology of MS 
consequences for understanding the progressive phase of the disease. Journal of 
Neuroscience. 206: 165-171.
Black, J., and Waxman, S. (1988). The perinodal astrocyte. Glia. 1: 169-183.
150
Blakemore W. (1969). Schmidt-Lantermann incisures in the central nervous system. Journal 
of Ultrastructure Research. 29: 496 -498.
Boiko, T., Rasband, M., Levinson, S., Caldwell, J., Mandel, G., Trimmer, J., and Mathews, 
G. (2001). Compact myelin dictates the differential targeting of two sodium channel isoforms 
in the same axon. Neuron. 30: 91 -104.
Boiko, T., Van Wart, A., Caldwell, J., Levinson, S., Trimmer, J., and Matthews, G. (2003). 
Functional specialization of the axon initial segment by isoform-specific sodium channel 
targeting.  J of Neuroscience. 23: 2306- 2313.
Bosio, A., Binczek, E. and Stoffel, W. (1996). Functional breakdown of the lipid bilayer of 
the myelin membrane in central and peripheral nervous system by disrupted 
galactocerebrosides synthesis. Proc. Natural Academy of Science. 93: 13280-13285.
Bosio, A., Bussow, H., Adam, J. and Stoffel, W., (1998). Galactosphingolipids and axon-
glial interaction in myelin of the central nervous system. Cell Tissue Res. 292: 199–210.
Boyle, M., Berglund, E., Murai, K., Weber, L., Peles, E., and Ranscht, B. (2001). Contactin 
orchestrates assembly of the septate-like junctions at the paranode in myelinated peripheral 
nerve. (2001). Neuron. 30: 385-397.
Bretscher, A., Edwards, K., and Fehon, R. (2002). ERM proteins and merlin: integrators at 
the cell cortex. Nature Review of Molecular Cell Biology. 3: 586-599.
Brown, D.,  and London, E. (1998). Functions of lipid rafts in biological membranes. Annual 
Review of Cell and Developmental Biology. 14: 111-136. 
Brown, D.,  and London, E. (1998). Structure and origin of ordered lipid domains in 
biological membranes. J. of Membrane Biology. 164: 103-114. 
Brownlees, J., Ackerley, S., Grierson, A., Jacobsen, N., Shea, K., Anderton, B., Leigh, P., 
Shaw, C., and Miller, C. (2002). Charcot-Marie-Tooth disease neurofilament mutations 
disrupt neurofilament assembly and axonal transport. Human Molecular Genetics. 11: 2837-
2844.
Bunge, M.; Bunge R. and Pappas, G. (1962). Electron microscopic demonstration of 
connections between glia and myelin sheaths in the developing mammalian nervous system.. 
Journal of Cell Biology. 12: 448 -453. 
Bunge, R., Bunge, M. and Bates, M., (1989). Movements of the Schwann cell nucleus 
implicate progression of the inner (axon-related) Schwann cell process during myelination. J. 
Cell Biol. 109: 273–284. 
151
Butt, A., Kiff, J., Hubbard, P., and Berry, M. 2002. Synantocytes: new functions for novel 
NG2 expressing glia. J. Neurocytology. 31: 551-565.
Cajal, R. y (1888a). Nota sobre la estructura de los tubos nerviosos del lobulo cerebral 
electrico del torpedo. Revista Trimestral de Histologia Normal y Patologia. 1: 49-55.
Cajal, R. y (1888b). Estructura de los centros nerviosos de las aves.  Revista Trimestral de 
Histologia Normal y Patologia. 1: 1-10.
Cajal, R. y (1889a). Contribucion al studio de la estructura de la medulla espinal. Revista 
Trimestral de Histologia Normal y Patologia. 1: 1-79.
Cajal, R. y (1889b). Sobre las fibras nerviosas de la capa granulose del cerebelo. Revista 
Trimestral de Histologia Normal y Patologia. 1: 107-118.
Cajal, R. y (1920a). Algunas consideraciones sobre la mesoglia de Robertson y Rio Hortega. 
Trabajo de Laboratori de Investigacion Biologica. 18: 109-127.
Cajal, R. y (1920b). Una modificacion del metodo de Bielschowsky para la impregnacion de 
la neuroglia comun y mesoglia y algunos consejos acerca de la tecnica del oro-sublimado. 
Trabajo de Laboratori de Investigacion Biologica. 18: 129-141.
Caldwell, J., Schaller, K., Lasher, R., Peles, E., and Levinson, S. (2000).  Sodium channel 
Nav1.6 is localized at nodes of Ranvier, dendrites, and synapses. Proc. Natural Academy of 
Sciences. 97: 5616-5620.
Carey D., Eldridge C., Cornbrooks C., Timpl R., and Bunge R. 1983. Biosynthesis of type IV 
collagen by cultured rat Schwann cells. Journal of Cell Biology. 97: 473-479.
Catterall, W. (2000). From ionic currents to molecular mechanisms: the structure and 
function of voltage gated sodium channels. Neuron. 26: 13-25.
Charles, P., Tait, S., Faivre-Sarrailh, C., Barbin, G., Gunn-Moore, F., Denisenko-   Nehrbass, 
N., Guennoc, A., Girault, J., Brophy, P., and Lubetzki, C. (2002). Neurofascin is a glial 
receptor for the paranodin/Caspr-contactin axonal complex at the axoglial junction. Current 
Biology. 12: 217- 220.
Ching, W., Zanazzi, G., Levinson, S., and Salzer, J. (1999). Clustering of neuronal sodium 
channels requires contact with myelinating Schwann cells. J. of Neurocytology. 28: 295-301. 
Cleveland, D. (1996). Neuronal growth and death: order and disorder in the axoplasm.
Cell 84: 663-666.
Coetzee, T., Dupree, J., and Popko, B. (1998). Demyelination and alteredexpression of 
myelin-associated glycoprotein isoforms in the central nervous system of galactolipid-
deficient mice. J. of Neuroscience. 54: 613-622.
152
Coetzee, T., Fujita, N., Dupree, J., Shi, R., Blight, A., Suzuki, K., Suzuki, K., and Popko, B. 
(1996). Myelination in the absence of galactocerebroside and sulfatide: normal structure with 
abnormal function and regional instability. Cel.l 86: 209-219.
Collard, J., Cote, F., and Julien, J. (1995). Defective axonal transport in a transgenic
mouse model of amyotrophic lateral sclerosis. Nature. 375: 61-64.
Collinson, J., Marshall, D., Gillespie, C. and Brophy, P., (1998). Transient expression of 
neurofascin by oligodendrocytes at the onset of myelinogenesis: implications for mechanisms 
of axon-glial interaction. Glia 23: 11–23.
Cosgaya J., Chan J., and Shooter E. (2002). The neurotrophin receptor p75NTR as a positive 
modulator of myelination. Science.  298: 1245-1248.
Davis, J.Q., Lambert, S. and Bennett, V., (1996). Molecular composition of the node of 
Ranvier: identification of ankyrin-binding cell adhesion molecules neurofascin (mucin+/third 
FNIII domain-) and NrCAM at nodal axon segments. J. Cell Biol. 135: 1355–1367.
Denisenko-Nehrbass, N., Oguieveskaia, K., Goutebroze, L., Galvez, T., Yamakawa, H., 
Ohara, O., Carnaud, M., and Girault, J. (2003). Protein 4.1B associates with both 
caspr/paranodin and caspr2 at paranodes and juxtaparanodes of myelinated fibers. European 
J. of Neuroscience. 17: 411-416.
de Waegh S., Lee V., and Brady ST. 1992. Local modulation of neurofilament 
phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells.
Cell. 68: 451-463.
Devaux, J., Kleopa, K., Cooper, E., Bennett, V., and Scherer, S. (2003). Anatomical and 
physiological evidence of KNCQ2 subunits at PNS and CNS nodes. Neuroscience. 28: 368.
Devaux, J., Alcaraz, G., Grinspan, J., Bennett, V., Joho, R., Crest, M., and Scherer, S. (2003). 
Kv1.3b is a novel component of CNS nodes. J. of Neuroscience. 23: 4509-4518.
Dieters, O. (1865). “Unterschungen Uber Gehirn und Ruckenmark des Menschen und der 
Saugethiere”. (M. Schultze, ed.) Vieweg, Braunschweig, pp. 318.
Dingledine R., Borges K., Bowie D., and Traynelis S. (1999). The glutamate receptor ion 
channels. Pharmacological Reviews. 51: 7 – 61.
Duncan I., Hammang J., and Trapp B. 1987. Abnormal compact myelin in the myelin-
deficient rat: absence of proteolipid protein correlates with a defect in the intraperiod line. 
Procedures Nat. Academy of Sciences. 84: 6287-6291.
153
Dupree, J., Coetzee, T., Blight, A., Suzuki, K., and Popko, B. (1998). Myelin galactolipids 
are essential for proper node of Ranvier formation in the CNS. J. of Neuroscience. 18: 1642-
1649.
Dupree, J., Coetzee, T., Suzuki, K., and Popko, B. (1998). Myelin abnormalities in mice 
deficient in galactocerebroside and sulfatide. Journal of Neurocytology. 27: 649-659.
Dupree, J., Girault, J., and Popko, B. (1999). Axo-glial interactions regulate the localization 
of axonal paranodal proteins. J. Cell Biology. 147: 1145-1152.
Dupree, J. and Popko, B., (1999). Genetic dissection of myelin galactolipid function. J. 
Neurocytol. 28: 271–279.
Einheber, S., Zanazzi, G., Ching, W., Scherer, S., Milner, T., Peles, E., and Salzer, J. (1997). 
The axonal membrane protein Caspr, a homologue of neurexin IV, is a component of the 
septate-like paranodal junctions that assemble during myelination. J. Cell Biology. 139: 
1495-1506. 
Elder G., Friedrich V Jr., Bosco P., Kang C., Gourov A., Tu P., Lee V., and Lazzarini R. 
(1998). Absence of the mid-sized neurofilament subunit decreases axonal calibers, levels of 
light neurofilament (NF-L), and neurofilament content. Journal of Cell Biology. 141: 727-
739.
Elder G., Friedrich V Jr, Chu K., and Lazzarini R. 2001. Schwann cells and oligodendrocytes 
read distinct signals in establishing myelin sheath thickness. Journal of Neuroscience 
Research. 65: 493 -499.
Faivre-Sarrailh, C. and Rougon, G., (1997). Axonal molecules of the immunoglobulin 
superfamily bearing a GPI anchor: their role in controlling neurite outgrowth. Mol. Cell. 
Neurosci. 9: 109–115. 
Faivre-Sarrailh, C., Gauthier, F., Denisenko-Nehrbass, N., Le Bivic, A., Rougon, G., and 
Girault, J. (2000). The glycosylphosphatidyl inositol-anchored adhesion molecule 
F3/contactin is required for surface transport of paranodin/contactin-associated protein 
(caspr).  J. of Cell Biology. 149: 491-502. 
Faivre-Sarrailh, C., Banerjee, S., Li, J., Hortsch, M., Laval, M., and Bhat, M. (2004).
Drosophila contactin, a homolog of vertebrate contactin, is required for septate junction
organization and paracellular barrier function. Development. 131: 4931-4942.
Fanarraga M., Griffiths I., Zhao M., and Duncan I. 1998. Oligodendrocytes are not inherently 
programmed to myelinate a specific size of axon. Journal of Comparative Neurology. 399: 
94-100.
Ferreirinha, F., Quattrini, A., Pirozzi, M., Valsecchi, V., Dina, G., Broccoli, V., Auricchio, 
A., Piemonte, F., Tozzi, G., Gaeta, L., (2004). Axonal degeneration in paraplegin-deficient 
154
mice is associated with abnormal mitochondria and impairment of axonal transport. Journal 
of Clinical Investigations. 113: 231-242.
Fjell, J., Hjelmstrom, P., Hormuzdiar, W., Melenkovic, M., Agleico, F., Tyrell, L., Waxman, 
S., and Black, J. (2000). Localization of the tetrodotoxin-resistant sodium channel NaN in 
nocireceptors. Neuroreports. 11: 199- 202. 
Garcia, M., Lobsiger, C., Shah,, S., Deerinck, T., Crum, J., Young, D., Ward, C., Crawford, 
T., Gotow, T., Uchiyama, Y., Ellisman, M., Clcutt, N., and Cleveland, D. (2003). NF-M is an 
essential target for the myelin-directed “outside-in” signaling cascade that mediates radial 
axonal growth. J. Cell Biology. 163: 1011-1020.
Garcia-Fresco, G.,  Sousa, A.,  Pillai, A.,  Moy, S., Crawley, J.,  Tessarollo, L., Dupree, J.,  
and Bhat, M. 2005. Disruption of axo-glial junctions causes cytoskeletal disorganization and 
degeneration of Purkinje neuron axons. PNAS. Submitted December 2005.
Garver, T., Ren, Q., Tuvia, S. and Bennett, V. (1997). Tyrosine phosphorylation at a site 
highly conserved in the L1 family of cell adhesion molecules abolishes ankryn binding and 
increases lateral mobility of neurofascin. J. Cell Biology. 137: 703-714.
Gatto, C., Walker, B., and Lambert, S. (2003). Local ERM activation and dynamic growth 
cones at Schwann cell tips implicated in efficient formation of nodes of Ranvier. J. Cell 
Biology. 162: 489-498.
Gennarelli, T., Tipperman, R., Maxwell, W., Graham, D., Adams, J., and Irvine, A. (1993). 
Traumatic damage to the nodal axolemma: an early, secondary injury. Acta Neurochir. Suppl. 
(Wien). 57: 49-52.
Genova, J., Fehon, G. 2003. Neuroglian, Gliotactin, and the Na+/K+ ATPase are essential for 
septate junction function in Drosophila. Journal of Cell Biology. 161: 979-989.
Giese K. Martini R. Lemke G. Soriano P. and Schachner M. 1992. Mouse P0 gene disruption 
leads to hypomyelination, abnormal expression of recognition molecules, and degeneration 
of myelin and axons. Cell. 61: 565 -576.
Guipponi M., Scott S., Hattori M., Ishii K., Sakaki Y., and Antonarakis S. (1998). Genomic 
structure, sequence, and refined mapping of the human intersectin gene (ITSN), which 
encompasses 250 kb on chromosome 21q22.1-->q22.2. Cytogenet Cell Genetics. 83: 218-20
Geren, B. (1954). The formation from the Schwann cell surface of myelin in the peripheral 
nerves of chick embryos. Expreimental Cell Research. 7: 558-562.
Goldin, A., Barchi, R., Caldwell, J., Hofmann, F., Howe, J., Hunter, J., Kallen, R., Mandel, 
G., Meisler, M., Netter, Y., Noda, M., Tankun, M., Waxman, S., Wood, J., and Catterall, W. 
(2000). Nomenclature of voltage gated sodium channels. Neuron. 28: 365- 368.
155
Goldin, A. (2001). Resurgence of sodium channel research. Annual Review of Physiology.
63: 871 -894.
Gollan, L., Sabanay, H., Poliak, S., Berglund, E., Ranscht, B., and Peles, E. (2002). Retention 
of a cell adhesion complex at the paranodal junction requires the cytoplasmic region of 
Caspr. J. Cell Biology. 157: 1247-1256.
Gollan, L., Salomon, D., Salzer, J., and Peles, E. (2003). Caspr regulates the processing of 
contactin and inhibits its binding to neurofascin. Journal of Cell Biology. 163: 1213-1218.
Greenberg S. (2001). DNA microarray gene expression analysis technology and its 
application to neurological disorders. Neurology. 57:755–761.
Greenfield S., Brostoff S., Eylar E., and Morell P. (1973). Protein composition of myelin of 
the peripheral nervous system. Journal of Neurochemistry. 20: 1207-1216.
Griffiths I,, Klugmann M,, Anderson T,, Yool D,, Thomson C,, Schwab M,, Schneider A,, 
Zimmermann F,, McCulloch M,, Nadon N,, and Nave K. (1998). Axonal swellings and 
degeneration in mice lacking the major proteolipid of myelin. Science. 280: 1610-1613.
Hirokawa, N., Cheney, R., and Willard, M. (1983). Location of a protein of the 
fodrinspectrin-TW260/240 family in the mouse intestinal brush border. Cell. 32: 953-965.
Hsieh S., Kidd G., Crawford T., Xu Z., Lin W., Trapp B., Cleveland D., and Griffin J. 
(1994). Regional modulation of neurofilament organization by myelination in normal axons. 
Journal of Neuroscience. 14: 6392 -6401.
Hoffman P., Cleveland D., Griffin J., Landes P., Cowan N., and Price D. (1987). 
Neurofilament gene expression: a major determinant of axonal caliber. Pocedures Natl 
Academy of Sciences. 84: 3472-3476.
Honke, K., Hirahara, Y., Dupree, J., Suzuki, K., Popko, B., Fukushima, K., Fukushima, J., 
Nagasawa, T., Yoshida, N., Wada, Y.,  and Taniguchi, N. (2002). Paranodal junction 
formation and spermatogenesis require sulfoglycolipids. Proc. Natural Acedemy of Sciences. 
99: 4227 -4232.
Hunt D., Coffin R., and Anderson P. (2003). The Nogo receptor, its ligands and axonal 
regeneration in the spinal cord; a review. Journal of Neurocytology. 31: 93–120.
Ichimura, T. and Ellisman, M. (1991). Three-dimensional fine structure of cytoskeletal-
membrane interactions at nodes of Ranvier. Journal of Neurocytology. 20: 667-681. 
Ishibashi T., Dupree, J., Ikenaka, K., Hirahara, Y., Honke, K., Peles, E., Popko, B., Suzuki, 
K., Nishino, H., and Baba, H. (2002). A myelin galactolipid, sulfatide, is essential for 
maintenance of ion channels on myelinated axon but not essential for initial cluster 
formation. J. of Neuroscience. 22:  6507-6514.
156
Ishibashi, T., Ikenaka, K., Shimizu, T., Kagawa, T., and Baba, H. (2003). Initiation of 
sodium channel clustering at the node of Ranvier in the mouse optic nerve. Neurochemical 
Research. 28: 117 -125.
Ishibashi T., Ding L., Ikenaka K., Inoue Y., Miyado K., Mekada E., Baba H. (2004).
Tetraspanin protein CD9 is a novel paranodal component regulating paranodal junctional 
formation. Journal of Neuroscience. 24: 96-102.
Ito M. (1984). The Cerebellum and Neural Control, Raven Press, New York, 1984, 580 
Ito M. (1987). Signal processing in cerebellar Purkinje cells, Physiol. Bohemoslov. 36: 203–
216.
Jacomy H., Zhu Q., Couillard-Despres S., Beaulieu J., and Julien J. (1999). Disruption of 
type IV intermediate filament network in mice lacking the neurofilament medium and heavy 
subunits. Journal of Neurochemistry. 73: 972-984.
Kaplan, M., Cho, M., Ullian, E., Isom, L., Levinson, S., and Barres, B. (2001). Differential 
control of clustering of the sodium channels Na(v) 1.2 and Na(v) 1.6 at developing CNS 
nodes of Ranvier. Neuron.  30: 105 -119. 
Jenkins, S., and Bennett, V. (2002). Developing nodes of Ranvier are defined by ankryn-G 
clustering and are independent of paranodal axoglial adhesions. Prec. Natural Academy of 
Science. 99: 2303-2308.
Jin K., Mao X., Eshoo M., Nagayama T., Minami M., Simon R., and Greenberg D. (2001). 
Microarray analysis of hippocampal gene expression in global cerebral ischemia. Annals of 
Neurology. 50:93–103.
Kazarinova-Noyes, K., Malhotra, J., McEdwen, D., Mattei, L., Berglund, E., Ranscht, B., 
Levinson, S., Schachner, M., Shrager, P., and Xiao, Z. (2001). Contactin associates with Na+ 
channels and increases their functional expression. J. of Neuroscience. 21: 7517-7525.
Kearney, J., Buchner, D., De Haan, G., Adamska, M., Levin, S., Furay, A., Albin, R., Jones, 
J., Montal, M., and Stevens, M. (2002). Molecular and pathological effects of a modifier 
gene on deficiency of the sodium channel Scn8a (Na9V)1.6).  Human Molecular Genetics.
11: 2765 -2775.
Kelm, S., Pelz, A., Schauer, R., Filbin, M., Tang, S., de Bellard, M., Schnaar, R., Mahoney, 
J., Hartnell, A., Bradfield, P., and Crocker, P. (1994). Sialoadhesin, myelin-associated 
glycoprotein and CD22 define a new family of sialic acid-dependent adhesion molecules of 
the immunoglobulin superfamily. Current Biology. 4: 965-972.
Klugmann, M., Schwab, M., Puhlhofer, A., Schneider, A., Zimmermann, F., Griffiths,
I. R., and Nave, K. A. (1997). Assembly of CNS myelin in the absence of proteolipid
157
protein. Neuron. 18: 59-70.
Koch, T., Brugger, T., Bach, A., Gennarini, G. and Trotter, J., (1997). Expression of the 
immunoglobulin superfamily cell adhesion molecule F3 by oligodendrocyte-lineage cells. 
Glia 19: 199–212. 
Kordeli, E., Lambert, S., and Bennett, V. (1995). AnkrynG. A new ankyrin gene with neural-
specific isoforms localized at the axonal initial segment and node of Ranvier. J. of Biological 
Chemistry. 270: 2352-2359.
Kramer E., Klein C., Koch T., Boytinck M., and Trotter J. (1999). Compartmentation of Fyn 
kinase with glycosylphosphatidylinositol-anchored molecules in oligodendrocytes facilitates 
kinase activation during myelination. Journal of Biological Chemistry. 274: 29042-29049.
Lambert, S., Davis, J., Bennett, V. (1997). Morphogenesis of the node of Ranvier;  co-
clusters of ankyrin and ankyrin-binding internal proteins define early developmental 
intermediates. J. of Neuroscience. 17: 7025-7036.
Landis S. (1975). Histochemical demonstration of mitochondrial dehydrogenases in 
developing normal and nervous mutant mouse Purkinje cells. Journal Histochemistry
Cytochemistry. 23: 136– 143.
Lappe-Siefke, C., Goebbels, S., Gravel, M., Nicksch, E., Lee, J., Braun, P., Griffiths, I., and 
Nave, K. (2003). Disruption of Cnp1 uncouples oligodendroglial functions in axonal support 
and myelination. Nature Genetics. 33: 366-374.
Lazzarini R., Griffin J., Lassman H., Nave K., Miller R., and Trapp B. (2004).  “Myelin 
Biology and Disorders”. Elsevier Academic Press. 
Lees M. and Brostoff S. 1984. Proteins of myelin. In “Myelin”, pp 197-224. Plenum Press, 
New York.
Lemaillet, G., Walker, B., and Lambert, S. (2003). Identification of a conserved ankyrin-
bindin motif in the family of sodium channels -subunits. J. of Biological Chemistry. 278: 
27333-27339.
Li, X., Lynn, B., Olson, C., Meier, C., Davidson, K., Yasumura, T., Rash, J., and Nagy, J.
(2002). Connexin29 expression, immunocytochemistry and freeze-fracture replica 
immunogold labelling (FRIL) in sciatic nerve. Euripean J. of Neuroscience. 16: 795-806.
Lu A., Tang Y., Ran R., Clark J., Aronow B., and Sharp F. (2003). Genomics of the 
periinfarction cortex after focal cerebral ischemia. Journal of Cerebral Blood Flow 
Metabolism. 23:786–810.
Maier, O., van der Heide, T., van Dam, A., Baron, W., de Vries, H., and Hoekstra, D. (2005).
Alteration of the extracellular matrix interferes with raft association of neurofascin in 
158
oligodendrocytes. Potential significance for multiple sclerosis? Molecular Cell Neuroscience. 
28: 390 -401.
Malhotra, J., Kazen-Gillepsie, K., Hortsch, M., and Isom, L. (2000). Sodium channel 
subunits mediate homophilic cell adhesion and recruit ankyrin to points of cell-cell contact. 
J. of Biological Chemistry. 275: 11383-11388.
Malhotra, J., Koopmann, M., Kazen-Gillespie, K., Fettman, N., Hortsch, M., and Isom, L. 
(2002). Structural requirements for interaction of sodium channel beta 1 subunits with 
ankyrin. J. of Biological Chemistry. 277: 26681-26688.
Marcus, J., Dupree, J., and Popko, B. (2002). Myelin associated glycoprotein and myelin 
galactolipids stsbilize developing axoglial interactions. J. Cell Biology. 156: 567-577.
Mariani J., Crepel F., Mikoshiba K., Changeux J., and Sotelo C. (1977).  Anatomical, 
physiological and biochemical studies of the cerebellum from Reeler mutant mouse, Philos. 
Trans. R. Soc. Lond., B Biol. Sci. 281: 1 – 28.
Marszalek J., Williamson T., Lee M., Xu Z., Hoffman P., Becher M., Crawford T., and 
Cleveland D. (1996). Neurofilament subunit NF-H modulates axonal diameter by selectively 
slowing neurofilament transport. Journal of Cell Biology. 135: 711-724. 
Martin, S., Levine, A., Chen, Z., Ughrin, Y., and Levine, J. (2001). Deposition of the NG2 
proteoglycan at nodes of Ranvier in the peripheral nervous system. J. of Neuroscience. 21: 
8119-8128.
Martini, R. (2001). The effect of myelinating Schwann cells on axons. Muscle Nerve. 24:
456-466.
Martini, R., Schachner, M., and Faissner, A. (1990). Enhanced expression of the extracellular 
matrix molecule J1/tenascin in the regenerating adult mouse sciatic nerve. J. Neurocytology. 
19: 601 -616.
Mathis, C., Denisenko-Nehrbass, N., Girault, J., and Borelli, E. (2001). Essential role of 
oligodendrocytes in the formation and maintenance of central nervous system nodal regions. 
Development. 128: 4881-4890.
Maxwell, W., Watt, C., Graham, D., and Gennarelli, T. (1993). Ultrastructural evidence of 
axonal shearing as a result of lateral acceleration of the head in non-human primates. Acta 
Neuropathol. (Berl). 86: 136-144.
Mayer J., Eck M. (1999). SH3 domains. Minding your p's and q's. Current Biology. 1:364-7. 
Melendez-Vasquez, C., Rios, J., Zanazzi, G., Lambert, S., Bretscher, A., and Salzer, J. 
(2001). Nodes of Ranvier form in association with ezrin-radixin-moesin (ERM)-positive 
Schwann cell processes. Proc. Natural Academy of Sciences. 98: 1235 -1240.
159
Melkonian, K., Ostermeyer, A., Chen, J., Roth, M., and Brown, D. (1999). Role of lipid 
modifications in targeting proteins to detergent-resistant membrane rafts. Many raft proteins 
are acylated, while few are prenylated. J. of Biological Chemistry. 274: 3910-1917.
Menegoz, M., Gaspar, P., Le Bert, M., Galvez, T., Burgaya, F., Palfrey, C., Ezan, P., Arnos, 
F., and Girault, J. (1997). Paranodin, a glycoprotein of neuronal paranodal membranes. 
Neuron. 19: 319- 331.
Menon, K., Rasband, M,, Taylor, C., Brophy, P., Bansal, R., and Pfeiffer, S. (2003). The 
myelin-axolemmal complex: biochemical dissection and the role of galactosphingolipids. J. 
of Neurochemistry. 87: 995 -1009
Miller, R, and da Silva P. (1977) Particle rosettes in the periaxiaxonal Schwann cell 
membrane and particle clusters in the axolema of rat sciatic nerve. Brain Research. 130: 135-
141.
Missler, M. and Südhof, T., (1998). Neurexins: three genes and 1001 products. Trends Genet.
14: 20–26.
Moffett, S., Brown, D., and Linder, M. (2000). Lipid-dependent targeting of G proteins into 
rafts. J. of Biological Chemistry. 275: 2191-2198.
Montag D, Giese KP, Bartsch U, Martini R, Lang Y, Bluthmann H, Karthigasan J, Kirschner 
DA, Wintergerst ES, Nave KA, Zielasek J., Toyka K., Lipp, H., and Schachner M. 1994. 
Mice deficient for the myelin-associated glycoprotein show subtle abnormalities in myelin. 
Neuron.  13: 229- 246.
Mugnaini E., and Floris A. (1994). The unipolar brush cell: a neglected neuron of the 
mammalian cerebellar cortex. Journal of Comparative Neurology. 339: 174– 180.
Mullen R., Eicher E., and Sidman R. (1976). Purkinje cell degeneration, a new neurological 
mutation in the mouse. Proceedures of the Natural  Academy of  Science. 73: 208– 212.
Nakagawa T., Chen J., Zhang Z., Kanai Y., and Hirokawa N. (1995). Two distinct functions 
of the carboxyl-terminal tail domain of NF-M upon neurofilament assembly: cross-bridge 
formation and longitudinal elongation of filaments. Journal of Cell Biology. 129: 411-429.
Nie D., Zhou Z., Ang B., Teng F., Xu G., Xiang T., Wang C.,  Zeng L., Takeda Y.,  Xu T., 
Ng Y., Faivre-Sarrailh C.,  Popko B.,  Ling E.,  Schachner M., Watanabe K., Pallen C., Tang
B., and Xiao Z. (2003). Nogo-A at CNS paranodes is a ligand of Caspr: possible regulation 
of K+ channel localization. EMBO Journal. 22: 5666–5678.
Nordquist D., Kozak C., and Orr H. (1988).  cDNA cloning and characterization of three 
genes uniquely expressed in cerebellum by Purkinje neurons. Journal of Neuroscience. 8:
4780–4789.
160
Norton W., and Poduslo S. 1973. Myelination in rat brain: method of myelin isolation. 
Journal of Neurochemistry. 21: 749 -757.
Oberdick J., Levinthal E., and Levinthal C. (1988). A Purkinje cell differentiation marker 
shows a partial DNA sequence homology to the cellular sis/PDGF2 gene. Neuron. 1: 367–
376.
Ohara, R., Yamakawa, H., Nakayama, M., and Ohara, O. (2000). Type II brain 4.1 
(4.1B/KIAA0987), a  member of the protein 4.1 family, is localized to neuronal paranodes. 
Molecular Brain Research. 85: 41 -52.
Okamoto M., Schoch S., Sudhof, T. (1999). EHSH1/intersectin, a protein that contains EH 
and SH3 domains and binds to dynamin and SNAP-25. A protein connection between 
exocytosis and endocytosis? Journal of Biological Chemistry. 274:18446-54.
Olive, S., Dubois, C., Schachner, M.,  and Rougon, G. (1995). The F3 neuronal 
glycosylphosphatidylinositol-linked molecule is localized to glycolipid-enriched membrane 
subdomains and interacts with L1 and fyn kinase in cerebellum. J. Neurochemistry. 65: 
2307-2317.
Oohashi, T., Hirakawa, S., Bekku, Y., Rauch, U., Zimmermann, D., Su, W., Ohtsuka, A., 
Murakami, T., and Ninomiya, Y. (2002). Bral1, a brain-specific link protein, colocalizing 
with the versican V2 isoform at the nodes of Ranvier in developing and adult mouse central 
nervous systems. Molecular Cell, Neuroscience. 19: 43-57.
Ozawa S., Kamiya H., and Tsuzuki T. (1998). Glutamate receptors in the mammalian central 
nervous system. Progress in  Neurobiology. 54: 581– 618.
Palay, S., and Chan-Palay, V. (1974). Cerebellar Cortex (New York, Springer-Verlag). 
Pedraza, L., Huang, J., and Colman, D. R. (2001). Organizing principles of the axoglial 
apparatus. Neuron. 30: 335-344.
Parra, M., Gascard, P., Walensky, L., Gimm, J., Blackshaw, S., Chan, N., Takakuwa, Y., 
Berger, T., Lee, G., Chasis, J., Snyder, S., Mohandas, N., and Conboy, J. (2000). Molecular 
and functional characterization of protein 4.1B, a novel member of the protein 4.1 family 
with high level, focal expression in brain.  J. of Biological Chemistry. 275: 3247-3255. 
Pawson, T. (1995). Protein modules and signaling networks. Nature. 373: 573-580
Pedraza L., Huang J., and Colman D. (2001). Organizing principles of the axoglial apparatus. 
Neuron. 30: 335- 344.
Peles, E., Nativ, M., Lustig, M., Grumet, M., Schilling, J., Martinez, R., Plowman, G., and 
Schlessinger, J. (1997). Identification of a novel contactin-associated transmembrane 
161
receptor with multiple domains implicated in protein-protein interactions. EMBO J. 16: 978-
988. 
Peles, E., and Salzer, J. (2000). Molecular domains of myelinated axons.  Current Opinion of 
Neurobiology. 10: 558- 565.
Pellegrino, L., and Altman, J. (1979). Effects of differential interference with postnatal 
cerebellar neurogenesis on motor performance, activity level, and maze learning of rats: 
developmental study. Journal of Comparative Physiological Psychology. 93: 1-33.
Poliak, S., Gollan, L., Martinez, R., Custer, A., Einheber, S., Salzer, J., Trimmer, J., Shrager, 
P., and Peles, E. (1999). Caspr2, a new member of the neuraxin superfamily, is localized at 
the juxtaparanodes of myelinated axons and associates with K+ channels. Neuron. 24: 1037 -
1047.
Poliak, S., Gollan, L., Salomon, D., Berglund, E., Ohara, R., Ranscht, B., and Peles, E. 
(2001). Localization of Caspr2 in myelinated nerves depends on axon-glia interactions and 
the generation of barriers along the axon. J. of Neuroscience. 21: 7568-7575. 
Poliak, S., Salomon, D., Elhanany, H., Sabanay, H., Kiernan, B., Pevny, L., Stewart, C., Xu,
X., Chiu, S., Shrager, P., Furley, A., Peles, E. (2003). Juxtaparanodal clustering of Shaker-
like K+ channels in myelinated axons depends on Caspr2 and TAG-1. J. of Cell Biology. 
162: 1149-1160. 
Poliak, S., and Peles, E. (2003). The local differentiation of myelinated axons at nodes of
Ranvier. Nature Reviews Neuroscience. 4: 968-980.
Popko, B. (2003). Myelin: not just a conduit for conduction. Nature Genetics. 33: 327 -328.
Privat A., Jacque C., Bourre J., Dupouey P., and Baumann N. 1979. Absence of the major 
dense line in myelin of the mutant mouse "shiverer". Neuroscience Letters. 12: 107-112.
Quackenbush J. (2001). Computational analysis of microarray data. Nature Reviews 
Genetics. 2: 418– 427.
Raghavendra Rao V., Bowen K., Dhodda V., Song G., Franklin J., Gavva N., and Dempsey 
R. (2002). Gene expression analysis of spontaneously hypertensive rat cerebral cortex 
following transient focal cerebral ischemia. Journal of Neurochemistry. 83:1072–1086.
Rao M., Houseweart M., Williamson T., Crawford T., Folmer J., and Cleveland D. (1998). 
Neurofilament-dependent radial growth of motor axons and axonal organization of 
neurofilaments does not require the neurofilament heavy subunit (NF-H) or its 
phosphorylation. Journal of Cell Biology. 143:171-181.
162
Rasband, M., Trimmer, J., Schwarz, T., Levinson, S., Ellisman, M., Schachner, M., Shrager,
P. (1998). Potassium channel distribution, clustering, and function in remyelinating rat axons. 
J. of Neuroscience. 18: 36-47.
Rasband, M., Peles, E., Trimmer, J., Levinson, S., Lux, S., Shrager, P. (1999). Dependence 
of nodal sodium channel clustering on paranodal axoglial contact in the developing CNS. J. 
of Neuroscience. 19: 7516 -7528. 
Rasband, M. Trimmer, J., Peles, E., Levinson, S., and Shrager, P. (1999). K+ channel 
distribution and clustering in developing and hypomyelinatied axons of the optic nerve. J. of 
Neurocytology. 28: 319- 331. 
Rasband, M, Kagawa, T., Park, E., Ikenaka, K., and Trimmer, J. (2003). Dysregulation of 
axonal sodium channel isoforms after adult-onset chronic demyelination. J. of Neuroscience 
Research. 73: 465 -470.
Rasband, M., Taylor, C., and Bensal, R. (2003). Paranodal transverse bands are required for 
maintenance but not initiation of the Nav1.6 sodium channel clustering in CNS optic nerve 
axons. Glia. 44: 173- 182. 
Rasband, M., Park, E., Zhen, D., Arbuckle, M., Poliak, S., Peles, E., Grant, S., and Trimmer, 
J. (2002). Clustering of neuronal potassium channels is independent of their interaction with 
PSD-95. J. of Cell Biology. 159: 663-672.
Ratcliffe, C., Qu, Y., McCormick, K., Tibbs, V., Dixon, J., Scheuer, T., and Catterall, W.
(2000). A sodium channel signaling complex modulation by associated receptor protein 
tyrosine phosphatase  . Nature Neuroscience. 3: 437-444.
Ratcliffe, C., Wetenbroek, R., Curtis, R., and Catterall, W. (2001). Sodium channel beta1 and 
beta3 subunits associate with neurofascin through their extracellular immunoglobulin 
domain. J. of Cell Biology. 154: 427-434.
Rhodes, K., Strassle, B., Monaghan, M., Bekele-Arcuri, Z., Matos, M., and Trimmer, J. 
(1997). Association and colocalization of the Kvbeta1 and Kvbeta2 beta-subunits with Kv1 
alpha-subunits in mammalian brain K+ channel complexes. J. of Neuroscience.17: 8246-
8258.
Rhyu, I., Abbott, L., Walker, D., and Sotelo, C. (1999). An ultrastructural study of granule 
cell/Purkinje cell synapses in tottering (tg/tg), leaner (tg(la)/tg(la)) and compound 
heterozygous tottering/leaner (tg/tg(la)) mice. Neuroscience. 90: 717-728.
Rieger, F., Daniloff, J., Pincon-Raymond, M., Crossin, K., Grumet, M., and Edelman, G. 
(1986). Neuronal cell adhesion molecules and cytotactin are colocalized at the node of 
Ranvier. J. of Cell Biology. 103: 379-391.
163
Rios, J., Melendez-Vasquez, C., Einheber, S., Lustig, M., Grumet, M., Peles, E., and Salzer, 
J. (2000). Contactin associated protein (caspr) and contactin form a complex that is targeted 
to the paranodal junctions during myelination.  Journal of Neuroscience.20: 8354-8364.
Rio Hortega, P. del (1921). La glia de escasas radiaciones (oligodendroglia). Boletin R. Soc. 
Esp. Hist. Nat. 21: 63- 92. 
Rio Hortega, P. del (1928). Tercera aportacion al conocimiento morfologico e interpretacion 
functional de la oligodendroglia. Mem. R. Soc. Esp. Hist. Nat. 14: 5-122.
Rios, J., Melendez-Vasquez, C., Einheber, S., Lustig, M., Grumet, M., Hemperly, J., Peles, 
E., and Salzer, J. (2000). Contactin-associated protein (Caspr) and contactin form a complex 
that is targeted to the paranodal junctions during myelination. Journal of Neuroscience. 20: 
8354-8364.
Rios, J., Rubin, M., St Martin, M., Downey, R., Einheber, S., Rosenbluth, J., Levinson, R., 
Bhat, M.,  and Salzer, J. (2003). Paranodal interactions regulate expression of sodium 
channel subtypes and provide a diffusion barrier for the node of Ranvier. J. of Neuroscience. 
23: 7001 -7011.
Robertson, J., (1957). The ultrastructure of nodes of Ranvier in frog nerve fibers. J. Physiol.
137: 8–9. 
Roos J., and Kelly R. (1998). Dap160, a neural-specific Eps15 homology and multiple SH3 
domain containing protein that interacts with Drosophila dynamin. Journal of Biological
Chemistry. 273: 19108-19119.
Rosenbluth, J. (1976). Intramembranous particle distribution at the node of Ranvier and 
adjacent axolema in myelinated axons of the frog brain. J. Neurocytology. 5: 731-745.
Rosenbluth, J. (1981). Axoglial junctions in the mouse mutant Shiverer. Brain Research. 
208: 283-297.
Rosenbluth, J. (1987). Abnormal axoglial junctions in the myelin-deficient rat mutant. J. of 
Neurocytology. 16: 497- 509.
Rosenbluth, J., (1995). Glial membranes and axoglial junctions. In: Kettenmann, H. and 
Ransom, B.R., Editors, 1995. Neuroglia, Oxford University Press, New York 613–633.pp 
Rosenbluth, J., Dupree, J., and Popko, B. (2003). Nodal sodium channel domainintegrity 
depends on the presence of transverse bands. Glia. 41: 318-325.
Rosenfeld, J., and Freidrich, V., Jr. (1983). Axonal swellings in jimpy mice: does lack of 
myelin cause neuronal abnormalities? Neuroscience. 10: 959-966.
164
Rothstein D., Martin L., Levey I., Dykes-Hoberg M.,  Jin L., Wu D., Nash N., Kuncl W. 
(1994). Localization of neuronal and glial glutamate transporters. Neuron. 13: 713– 725.
Rothstein D., Van Kammen M., Levey I., Martin J., and Kuncl W. (1995). Selective loss of 
glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann. Neurol. 38: 73–84.
Rudenko, G., Nguyen, T., Chelliah, Y., Sudhof, T. and Deisenhofer, J., (1999). The structure 
of the ligand-binding domain of neurexin Ibeta: regulation of LNS domain function by 
alternative splicing. Cell 99: 93–10.
Saito, F., Masaki, T., Kamakura, K., Anderson, L., Fujita, S., Fukuta-Ohi, H., Sunada, Y., 
Shimizu, T., and Matsumura, K. (1999). Characterization of the transmembrane molecular 
architecture of the dystroglycan complex in schwann cells. J. of Biological Chemistry. 274: 
8240-8246.
Salehi A., Roux P., Kubu C., Zeindler C., Bhakar A., Tannis L., Verdi J., and Barker P. 
(2000). NRAGE, a novel MAGE protein, interacts with the p75 neurotrophin receptor and 
facilitates nerve growth factor-dependent apoptosis. Neuron. 27: 279-288.
Salzer J., Holmes W., and Colman D. 1987. The amino acid sequences of the myelin-
associated glycoproteins: homology to the immunoglobulin gene superfamily. Journal of 
Cell Biology. 104: 957-965.
Salzer, J. L. (2003). Polarized domains of myelinated axons. Neuron. 40: 297-318.
Sanchez I., Hassinger L., Paskevich P., Shine H., and Nixon R. 1996. Oligodendroglia 
regulate the regional expansion of axon caliber and local accumulation of neurofilaments 
during development independently of myelin formation. Journal of Neuroscience. 16: 5095-
5105.
Schaeren-Wiemers N., Bonnet A., Erb M., Erne B., Bartsch U., Kern F., Mantei N., Sherman 
D., and Suter U. (2004). The raft-associated protein MAL is required for maintenance of 
proper axon--glia interactions in the central nervous system. Journal of Cell Biology. 166:
731-42.
Schafer, D., Bansal, R., Hedstrom, K., Pfeiffer, S., and Rasband, M. (2004). Does paranode 
formation and maintenance require partitioning of neurofascin 155 into lipid rafts? J. of 
Neuroscience. 24: 3176-3185.
Scherer, S., Xu, T., Crino, P., Arroyo, E., and Guttmann, D. (2001). Ezrin, radixin, and 
moesin are components of Schwann cell microvilli. J. of Neuroscience Research. 65: 150-
164. 
Sengar S.,Wang W., Bishay J., Cohen S., and Egan E. (1999). The EH and SH3 domain Ese 
proteins regulate endocytosis by linking to dynamin and Eps15. EMBO Journal. 18: 1159-
1171.
165
Sheikh K., Sun J., Liu Y., Kawai H., Crawford T., Proia R., Griffin J., and Schnaar R. 1999. 
Mice lacking complex gangliosides develop Wallerian degeneration and myelination defects.
Procedures Nat. Academy of Sciences. 96: 7532-7537.
Sherman D., Tait S., Melrose S., Johnson R., Zonta B., Court F., Macklin W., Meek S, Smith 
A., Cottrell D., and Brophy P. (2005). Neurofascins are required to establish axonal domains 
for saltatory conduction. Neuron. 48:737-42.
Sidman R., Lane P., and Dickie M. (1962). Staggerer, a new mutation in the mouse affecting 
the cerebellum. Science. 137: 610– 612.
Sidman R., and Green M. (1970). Nervous a mutant mouse with cerebellar disease, in: M. 
Sabourdy (Ed.), Les Mutants Pathologiques Chez L’Animal, Edition du Centre National de la 
Recherche Scientique, Orleans-la-Source, France, 1970, 69–79 pp.
Sidman R. (1983). Experimental neurogenetics, Res. Publ.-Assoc. Res. Nervous Mental 
Disorders. 63: 19–46.
Simons, M, and Ikonen, I. (1997). Functional rafts in cell membranes. Nature. 387: 569-572.
Snipes G., Suter U., Welcher A., and Shooter E. 1992. Characterization of a novel peripheral 
nervous system myelin protein (PMP-22/SR13). Journal of Cell Biology. 117: 225-238.
Soriano M., Tessier M., Certa U., and Gill R. (2000). Parallel gene expression monitoring 
using oligonucleotide probe arrays of multiple transcripts with an animal model of focal 
ischemia. Journal of Cerebral Blood Flow Metabolism. 20:1045–1055.
Spiegel, I., Salomon, D., Erne, B., Sxhaeren-Wiemers, N., and Peles, E. (2002). Caspr3 and 
Caspr4, two novel members of the caspr family are expressed in the nervous system and 
interact with PDZ domains. Molecular Cell Neuroscience. 20: 283-297.
Sotelo C. (2004). Cellular and genetic regulation of the development of the cerebellar system.
Progress in Neurobiology. 72: 295 – 339.
Stoffel W., Boison D., and Bussow H. 1997. Functional analysis in vivo of the double mutant 
mouse deficient in both proteolipid protein (PLP) and myelin basic protein (MBP) in the 
central nervous system. Cell Tissue Research. 289: 195-206. 
Stokin, G., Lillo, C., Falzone, T., Brusch, R., Rockenstein, E., Mount, S., Raman, R., Davies, 
P., Masliah, E., Williams, D., and Goldstein, L. (2005). Axonopathy and transport deficits 
early in the pathogenesis of Alzheimer's disease. Science. 307: 1282-1288.
Stolinski, C., Breathnach, A., Thomas, P., Gabriel, G., and King, R. (1985). Distribution of 
particle aggregates in the internodal axolema and adaxonal Schwann cell membrane of 
reedent peripheral nerve. J. of Neurological Sciences. 67: 213-222.
166
Suzuki A., Hoshi T., Ishibashi T., Hayashi A., Yamaguchi Y., and Baba H. (2004). Paranodal 
axoglial junction is required for the maintenance of the Nav1.6-type sodium channel in the 
node of Ranvier in the optic nerves but not in peripheral nerve fibers in the sulfatide-deficient 
mice.Glia. 46: 274- 83.
Svitkina, T., Verkhovsky, A., and Borisy, G. (1996). Plectin sidearms mediate interaction of 
intermediate filaments with microtubules and other components of the cytoskeleton. Journal 
of Cell Biology. 135: 991-1007.
Tait, S., Gunn-Moore, F., Collinson, J., Huang, J., Lubetzki, C., Pedraza, L., Sherman, D., 
Colman, D.,  and Brophy, P. (2000). An oligodendrocyte cell adhesion molecule at the site of 
assembly of the paranodal axo-glial junction. J. of Cell Biology. 150: 657-666.
Talts, J., Andac, Z., Gohring, W., Brancaccio, A. and Timpl, R., (1999). Binding of the G 
domains of laminin alpha1 and alpha2 chains and perlecan to heparin, sulfatides, alpha-
dystroglycan and several extracellular matrix proteins. EMBO J. 18: 863–870.
Tang Y., Lu A., Aronow B., Wagner K., and Sharp F. (2002). Genomic responses of the 
brain to ischemic stroke, intracerebral haemorrhage, kainate seizures, hypoglycemia, and 
hypoxia. European Journal of Neuroscience. 15:1937–1952.
Tao-Cheng, J., and Rosenbluth, J. (1983). Axolemal differentiation in myelinated fibers of rat 
peripheral nerves. Brain Research. 285: 251-263.
Tcherpakov M., Bronfman F., Conticello S., Vaskovsky A., Levy Z., Niinobe M., Yoshikawa 
K., Arenas E., and Fainzilber M. (2002). The p75 neurotrophin receptor interacts with 
multiple MAGE proteins. Journal of Biological Chemistry. 277: 49101-49104.
Thullier, F., Lalonde, R. and Lestienne, F., (1999). Effects of dopaminergic agents and of an 
NMDA receptor antagonist on motor coordination in Lurcher mutant mice. Pharm. Biochem. 
Behav. 63: 213–219. 
Traka, M, Dupree, J., Popko, B., and Karagogeos, D. (2002). The neuronal adhesion protein 
TAG-1 is expressed by Schwann cells and oligodendrocytes and is localized to the 
juxtaparanodal region of myelinated fibers. J. of Neurosciences. 22: 3016-3024.
Traka, M., Goutebroze, L., Denisenko, N., Bessa, M., Nifli, A., Havaki, S., Iwakura, Y., 
Fukamauchi, F., Watanabe, K., Soliven, B., Girault, J., and Karagogeos, D. (2003). 
Association of TAG-1 with Caspr2 is essential for the molecular organization of 
juxtaparanodal regions of myelinated fibers. J. of Cell Biology. 162: 1161-1172.
Trapp, B. (1990). The myelin associated glycoprotein: location and potential functions. In 
myelination and Dysmyelination, D. Colman, I. Duncan, and R. Skoff, eds. (New York: The 
New York Academy of Sciences), pp. 29-43.
167
Trapp B. (1988). Distribution of the myelin-associated glycoprotein and P0 protein during 
myelin compaction in quaking mouse peripheral nerve. Journal of Cell Biology. 107: 675-
685.
Trapp, B. D., Andrews, S. B., Cootauco, C., and Quarles, R. (1989). The myelinassociated 
glycoprotein is enriched in multivesicular bodies and periaxonal membranes of actively 
myelinating oligodendrocytes. Journal of Cell Biology. 109: 2417-2426.
Umemori, H., Kadowaki, Y., Hirosawa, K., Yoshida, Y., Hironaka, K., Okano, H., and 
Yamamoto, T. (1999). Stimulation of myelin basic protein gene transcription by Fyn tyrosine 
kinase for myelination. J. of Neuroscience. 19: 1393-1397.
Uschkureit T., Sporkel O., Stracke J., Bussow H., and Stoffel W. (2000). Early onset of 
axonal degeneration in double (plp-/-mag-/-) and hypomyelinosis in triple (plp-/-mbp-/-mag-
/-) mutant mice. Journal of Neuroscience. 20: 5225-5233.
Vabnick, I., Novakovic, S., Levinson, S., Schachner, M., and Shrager, P. (1996). The 
clustering of axonal sodium channels during development if the peripheral nervous system. 
Journal of Neuroscience. 16: 49140 -4922.
Vabnick, I., and Shrager, P. (1998). Ion channel redistribution and functioning during 
development of the myelinated axon. J. of Neurobiology. 37: 80-96.
Vabnick, I., Trimmer, J., Schwarz, T., Levinson, S., Risal, D., and Shrager, P. (1999). 
Dynamic potassium channel distributions during axonal development prevent aberrant firing 
patterns. J. of Neuroscience. 19: 747-758.
Valentine, W., Amarnath, V., Graham, D., Morgan, D., and Sills, R. (1997). CS2-mediated 
cross-linking of erythrocyte spectrin and neurofilament protein: dose response and temporal 
relationship to the formation of axonal swellings. Toxicol. Appl. Pharmacol. 142: 95-105.
Vyas K., Patel H., Vyas A., and Schnaar R. (2001).  Segregation of gangliosides GM1 and 
GD3 on cell membranes, isolated membrane rafts, and defined supported lipid monolayers.
Biological Chemistry. 382: 241-250.
Vyas A., Patel H., Fromholt S., Heffer-Lauc M., Vyas K., Dang J., Schachner M., and 
Schnaar R. (2002). Gangliosides are functional nerve cell ligands for myelin-associated 
glycoprotein (MAG), an inhibitor of nerve regeneration.  Procedures NAtl Academy of 
Sciences. 99: 8412-8417.
Wang, H., Kunkel, D., Martin, T., Schwartzkroin, P, and Tempel, B. (1993). 
Heteromultimeric K+ channels in terminal and juxtaparanodal regions of neurons. Nature. 
365: 75-79.
Wang K., Kim J., Sivasankaran R., Segal R., and He Z. (2002). P75 interacts with the Nogo 
receptor as a co-receptor for Nogo, MAG and OMgp. Nature. 420: 74-78.
168
Ward, R., Lamb, R. and Fehon, R., (1998). A conserved functional domain of Drosophila 
coracle is required for localization at the septate junction and has membrane-organizing 
activity. J. Cell Biol. 140: 1463–1473. 
Waxman, S. (1980). Determinants of conduction velocity in myelinated and nerve fibers. 
Muscle Nerve. 3: 141-150.
Weber, P., Bartsch, U., Rasband, M., Lang, Y., Bluethmann, H., Margolis, R., Levinson, S., 
Shrager, P., Montag, D., and Schachner, M. (1999). Mice deficient for tensacin-R display 
alterations of the extracellular matrix and decreased axonal conduction velocities in the CNS. 
J. of Neuroscience. 19: 4245-4262.
Windebank A., Wood P., Bunge R., and Dyck P. 1985. Myelination determines the caliber of 
dorsal root ganglion neurons in culture. Journal of Neuroscience. 6: 1563-1569.
Wolswijk, G. and Balesar, R. (2003). Changes in the expression and localization of the 
paranodal protein caspr on axons in chronic multiple sclerosis. Brain. 126: 1638-1649.
Wong P., Marszalek J., Crawford T., Xu Z., Hsieh S., Griffin J., and Cleveland D. (1995). 
Increasing neurofilament subunit NF-M expression reduces axonal NF-H, inhibits radial 
growth, and results in neurofilamentous accumulation in motor neurons. Journal of Cell 
Biology. 130: 1413-1422.
Workman, R., and Low, P. (1998). Biochemical analysis of potential sites for protein 4.1-
mediated anchoring of the spectrin-actin skeleton to the erythrocyte membrane. Journal of 
Biochemistry. 273: 6171-6176.
Xu Z., Marszalek J., Lee M., Wong P., Folmer J., Crawford T., Hsieh S., Griffin J., and 
Cleveland D. (1996). Subunit composition of neurofilaments specifies axonal diameter. 
Journal of Cell Biology. 133: 1061-1069. 
Yamabhai M., Hoffman N., Hardison N., McPherson P., Castagnoli L., Cesareni G., and Kay 
B. (1998). Intersectin, a novel adaptor protein with two Eps15 homology and five Src 
homology 3 domains. Journal Biological Chemistry. 20: 31401-31407.
Yamashita T., Higuchi H., and Tohyama M. (2002). The p75 receptor transduces the signal 
from myelin-associated glycoprotein to Rho. Journal of Cell Biology. 157: 565-570.
Yang, Y., Dowling, J., Yu, Q., Kouklis, P., Cleveland, D., and Fuchs, E. (1996). An essential 
cytoskeletal linker protein connecting actin microfilaments to intermediate filaments. Cell. 
86: 655-665.
Yin X., Crawford T., Griffin J., Tu P., Lee V., Li C., Roder J., and Trapp B. 1998. Myelin-
associated glycoprotein is a myelin signal that modulates the caliber of myelinated axons.
Journal of Neuroscience. 18: 1953 -1962.
169
Yiu G. and He Z. (2003). Signaling mechanisms of the myelin inhibitors of axon 
regeneration. Current Opinion of Neurobiology. 13: 545–551.
Yu W., Guo W., and Feng L. (2004). Segregation of Nogo66 receptors into lipid rafts in rat 
brain and inhibition of Nogo66 signaling by cholesterol depletion.
FEBS Letters. 577: 87-92.
Zagon, I., Higbee, R., Riederer, B., and Goodman, S. (1986). Spectrin subtypes in 
mammalian brain: an immunoelectron microscopic study. Journal of Neuroscience. 6: 2977-
2986.
Zhang, X., Davis, J., Carpenter, S., and Bennett, V. (1998). Structural requirements for 
association of neurofascin with ankyrin. J. of Biological Chemistry. 273: 30785-30794.
Zhu Q., Couillard-Despres S., and Julien J. (1997). Delayed maturation of regenerating 
myelinated axons in mice lacking neurofilaments. Experimental Neurology. 148: 299-316.
Zhou, L. Messing, A., and Chiu, S. (1999). Determinants of excitability at transition zones in 
Kv1.1-deficient myelinated nerves. J. of Neuroscience. 19: 5768-5781.
Ziai M., Sangameswaran L., Hempstead J., Danho W., and Morgan J. (1988).  An 
immunochemical analysis of the distribution of a brainspecific polypeptide, PEP-19, Journal 
of. Neurochemistry. 51: 1771 – 1776.
Zoghbi, H., and Orr, H. (2004). Molecular and Metabolic Bases of the Inherited Disease, 
McGraw Hill).
